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ABSTRACT 
 
 Evaluation of middle ear status in young infants is a challenge in both screening 
and diagnostic contexts due to a lack of valid and objective tools of middle ear 
assessment (Kei & Zhao, 2012). The standard tools used to determine the middle ear 
status in older children are neither efficient nor accurate in evaluating young infants.  
 
Wideband absorbance (WBA) is recommended as a tool for middle ear 
assessment in young infants due to its time efficiency, reliability, objectivity and ability 
to provide clinical information over a range of frequencies. Despite its clinical 
application in the assessment of middle ear function in older children, investigation into 
the use of WBA with young infants has been inadequate. Development of normative 
data and evaluation of WBA in this population have been limited. The limitation of 
using the distortion product otoacoustic emissions (DPOAE) test as a reference 
standard for evaluation of middle ear status has been acknowledged. Hence, further 
consideration must be afforded to evaluation of WBA using more robust reference 
standards in young infants.  
 
Despite the high prevalence of conductive hearing loss in Australian Aboriginal 
children, limited research has occurred into the investigation of middle ear function in 
the neonatal period. Hence the present study explored the development of normative 
data and evaluation of test performance of WBA, developmental and pathologic effects 
in middle ear function and the feasibility of using WBA as an adjunct tool in newborn 
hearing screening (NHS) programs in an Australian context. 
 
The present research study aimed to: (1) determine the prevalence of middle ear 
dysfunction and conductive hearing loss in neonates referred through a NHS program 
in Australia (2) establish normative WBA measures in healthy neonates with normal 
middle ear function (3) compare test performance of WBA against nine reference 
standards (4) compare WBA between Australian Aboriginal and Caucasian neonates 
and (5) compare WBA in healthy newborns and infants aged 1, 2, 4 and 6 months.   
 
    iii 
A chart review of 234 infants referred from a NHS program in North 
Queensland was conducted. Further, 204  neonates were tested using automated 
auditory brainstem response (AABR), high frequency tympanometry (HFT), acoustic 
stapedial reflex (ASR), transient evoked otoacoustic emissions (TEOAE), DPOAE and 
WBA. The neonates were tested prior to their discharge from the hospital. In addition, a 
total of 36, 30, 33 and 30 infants were seen at 1, 2, 4, and 6 months of age, respectively. 
These infants were tested using HFT, DPOAE and WBA.   
 
The results revealed that conductive hearing loss was common among infants 
referred through NHS. Australian Aboriginal infants had significantly higher rates of 
middle ear pathology and conductive hearing loss at birth and showed poor resolution 
of middle ear pathology over time compared to non-Aboriginal infants. Use of a test of 
middle ear function (eg. WBA) as an adjunct to the screening tool to facilitate 
management and prioritisation of infants for further testing was recommended (Chapter 
Two).  Normative ambient pressure WBA data were established for 66 neonates who 
passed a test battery of AABR, HFT, ASR, TEOAE and DPOAE tests. There was a 
significant difference in WBA across frequencies from 250 to 8000 Hz (Chapter 
Three). Test performance of WBA was compared across four single tests and five test 
battery reference standards in 192 neonates. The test performance of WBA against the 
test battery reference standards was better than that against single test reference 
standards (Chapter Four). Despite equal pass rates as determined by a test battery of 
HFT and DPOAE, the WBA of Aboriginal neonates who passed the test battery was 
significantly lower suggesting that Aboriginal neonates had more significant 
outer/middle ear conditions than Caucasian neonates. WBA appeared to be more 
sensitive to middle ear status than test battery comprising HFT and DPOAE (Chapter 
Five).  In a cross sectional study of infants, developmental effects were evident during 
the first six months of life, with WBA reducing with age. Although data from the study 
could be used as reference standard for detecting middle ear disorders, further 
development of age-specific normative WBA was recommended (Chapter Six). 
Overall, the present research study demonstrated WBA to be a feasible tool for 
evaluation of middle ear function in neonates and young infants (Chapters Three, Four, 
Five). 
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In conclusion, this thesis has evaluated WBA in neonates and young infants and 
has enhanced the minimal literature available concerning normative data, test 
performance, developmental changes and application in targeted groups such as 
Australian Aboriginal infants where the prevalence of otitis media is very high. The 
normative data developed in the study may be used as a reference for objective 
evaluation of the sound conduction pathways (outer and middle ear) in neonates and 
young infants. Ultimately, this thesis contributes to the application of WBA as a clinical 
tool in the assessment of middle ear function during screening or diagnostic assessment 
of neonates and young infants.   
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Chapter One: Introduction 
 
 
1.1 Organisation of Thesis 
The thesis is presented as a series of published articles, manuscripts accepted for 
publication and currently under review for publication. Each article is presented as a 
separate chapter and an introduction to the research study is provided to illustrate the 
relevance of the article to the research topic. Implications and recommendations 
arising from this research are discussed in the last chapter. Apart from the first and 
last chapters, this thesis consists of articles that have been written as stand-alone 
journal publications. Hence, there will be some repetition of concepts and citations 
across the chapters.  
 
1.2 Introduction 
Universal newborn hearing screening (UNHS) programs aim to detect 
congenital permanent hearing loss in newborns. However, the commonly used 
instruments, automated auditory brainstem response (AABR) and otoacoustic 
emission (OAE) tests, cannot distinguish between conductive and sensorineural 
hearing impairments. A “refer” outcome due to the presence of outer and middle ear 
dysfunction is often classified as a false positive result. Management of false positive 
results is an important issue in UNHS programs (Boone, Bower & Martin, 2005; 
Doyle, Rodgers, Fujikawa & Newman, 2000; Sanford et al., 2009). Apart from 
increased false positive referrals, transient middle ear conditions such as middle ear 
effusion (MEE) can also delay definitive diagnosis of sensorineural hearing loss 
(Boone et al., 2005; Vartiainen, 2000).  
 
 Assessment of middle ear function in neonates and young infants is 
challenging due to a lack of valid, objective tools of middle ear assessment in this 
population (Kei & Zhao, 2012). Several studies conducted in the last decade have 
recommended 1000 Hz tympanometry for the assessment of middle ear function in 
infants from birth to six months of age (Calandruccio, Fitzgerald & Prieve, 2006; Kei 
et al., 2003; Margolis, Bass-Ringdahl, Hanks, Holte & Zapala, 2003; Mazlan, Kei & 
Hickson, 2009; Swanepoel et al., 2007).  However, recent studies by Sanford et al. 
(2009) and Hunter, Feeney, Miller, Jeng, and Bohning (2010) have shown 1000 Hz 
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tympanometry to be less accurate in predicting the effects of sound conduction 
deficits. Similarly, other measures such as acoustic stapedial reflex (ASR) and 
automated auditory brainstem response (AABR) have not had much success in 
detecting subtle middle ear dysfunction in this population (Hunter, Prieve, Kei & 
Sanford, 2013; Stapell, 2011). Due to these constraints, there is a need for sensitive, 
specific and user friendly screening tools that permit better interpretation of middle 
ear status in infants and young children (Hunter et al., 2013).  
 
Wideband absorbance (WBA), an emerging technique, has been suggested as 
an alternate tool for the assessment of middle ear disorders in infants and children 
(Hunter et al., 2010; Keefe, Bulen, Arehart & Burns, 1993; Keefe et al., 2000; Sanford 
et al., 2009). Although WBA is reported to be sensitive to various middle ear 
disorders in children (Beers, Shahnaz, Westerberg & Kozak, 2010; Ellison et al., 
2012; Hunter, Bagger-Sjöbäck, & Lundberg 2008a; Jeng, Levitt, Lee & Gravel, 1999; 
Keefe & Simmons, 2003; Keefe, Sanford, Ellison, Fitzpatrick & Gorga, 2012; 
Piskorski, Keefe, Simmons & Gorga, 1999) and adults (Allen, Jeng & Levitt, 2005; 
Feeney, Keefe & Maryott, 2003; Keefe et al., 1993; Keefe & Simmons, 2003; 
Shahnaz et al., 2009), there is limited research on WBA in neonates and young 
infants. Available research suggests that WBA can predict OAE outcomes more 
accurately than 1000 Hz tympanometry (Hunter et al., 2010; Sanford et al., 2009). 
Inclusion of WBA in newborn hearing screening (NHS) programs has shown to 
decrease the false positive rates from 5% to 1% (Keefe, Zhao, Neely, Gorga & Vohr, 
2003b). Consequently, WBA has been recommended as an adjunct tool in UNHS 
programs (Feeney and Sanford, 2012; Hunter et al., 2010; Merchant, Horton & Voss, 
2010; Sanford et al., 2009; Vander Werff, Prieve & Georgantas, 2007; Werner, Levi 
& Keefe, 2010).   
 
Apart from the limited normative WBA data available with neonates, 
evaluating the test performance of WBA is challenging. While tone burst air and bone 
conduction ABR may be used as a surrogate gold standard for detecting conductive 
hearing loss in United Kingdom, Canada and United States of America, this threshold 
ABR measure is time consuming and is done diagnostically at some point later in time 
rather than in newborn hearing screening programs. Most studies circumvent this 
issue by using either distortion product otoacoustic emission (DPOAE) or high 
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frequency (1000 Hz) tympanometry (HFT) as a reference standard for determining the 
status of the outer and middle ear (Sangster, 2011). However, DPOAE or HFT alone 
may not accurately identify minor middle ear pathologies (Hunter et al, 2010; Kemp, 
2002; Sanford et al., 2009) and, hence, may not serve as an ideal reference standard.  
Therefore, the use of DPOAE or HFT as a reference standard represents a significant 
shortcoming in assessing outer and middle ear function in neonates.  
 
In order to evaluate the efficacy of WBA as a clinical tool in neonates and 
young infants, it is important to use a better reference standard than current standards 
(Hunter et al., 2013). Since a reference standard based on the outcomes of a surgical 
procedure cannot be used in view of ethical considerations, an optimal reference 
standard based on the outcomes of a combination of tests such as HFT, DPOAE and 
transient evoked otoacoustic emission (TEOAE) may be used. 
 
 Despite the introduction of NHS across Australia, the use of WBA in 
evaluating the conductive pathways (outer and middle ear) in neonates and young 
infants has not been systematically investigated. Earlier attempts to determine the 
prevalence of conductive conditions in neonates (Caucasian and Aboriginal descent) 
using traditional techniques such as 226 Hz tympanometry and OAEs found that 
conductive conditions are more prevalent in Aboriginal than non-Aboriginal neonates 
(Boswell & Nienhuys, 1995, 1996; Lehmann et al. 2008).  These prevalence rates, 
however, need updating using a new and more accurate technique such as WBA.   
 
1.3 Chapter Synopsis 
The aim of the present chapter is to review the application of currently 
available audiological and non-audiological tests in the assessment of outer and 
middle ear function in neonates and young infants. In this chapter, the literature is 
discussed in relation to the issue of false positive referrals in UNHS programs, 
conductive hearing loss and middle ear pathology in neonates and young infants, otitis 
media (OM), as well as conductive hearing loss in Australian Aboriginal and 
Caucasian infants and children. In particular, this chapter will introduce a new 
technology, wideband absorbance (WBA) as an alternate measure of outer and middle 
ear function in this population. The application of WBA in neonates, infants, children 
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and adults are reviewed. Finally, the rationale for the current study is discussed and 
specific aims and major hypotheses are outlined.  
 
1.4 Universal Newborn Hearing Screening Program – Identification of 
Sensorineural vs Conductive Hearing Loss 
The primary goal of any early hearing detection program is to correctly 
differentiate ears with hearing loss from healthy ears (Keefe et al., 2000; Sanford et 
al., 2009).  Currently, UNHS programs use OAE and/or AABR for hearing screening.  
The limitation of both screening technologies is that the outcomes are influenced by 
both outer/middle and inner ear conditions.  In healthy neonates screened for 
sensorineural hearing loss using either technology, a common finding is a false 
positive response due to transient ear canal and/or middle ear obstruction (Allen et al., 
2005; Doyle, Burggraaff, Fujikawa, Kim & Macarthur, 1997; El-Rafaie, Parker, & 
Bamford, 1996; Gorga, Preissler, Simmons & Hoover, 2001; Keefe et al., 2000; 
Orlando & Prieve, 1998; Thornton, Kimm, Kennedy, & Cafarelli-dees, 1993; Watkin 
& Baldwin, 1999; White, Vohr & Beherns, 1993).  For example, the prevalence of 
bilateral sensorineural hearing loss in neonates has been estimated to be between one 
and two per 1000 (Aidan, Avan, & Bonfils, 1999; Australian Hearing, 2005; 
Cunningham & Cox, 2003; Feinmesser, Tell, & Levi, 1982; Kemper & Downs, 2000; 
Thringer, Kankkunen, Linden & Niklasson, 1984).  In contrast, it has been reported 
that conductive hearing losses due to congenital MEE or more permanent outer and 
middle ear conditions occur at a rate thirty times greater than sensorineural hearing 
losses in young infants (Gorga et al., 2001; Orlando & Prieve, 1998; White et al., 
1993).     
 
 White et al. (1993) reported that 17/1000 well babies and 36/1000 babies in 
the newborn intensive care unit (NICU) had a conductive hearing loss. Boone et al. 
(2005) noted that MEE may contribute up to 67% of the false positive newborn 
hearing screens.  Boudewyns et al. (2011) reported that 53.5% of 152 infants, who 
were referred because of unilateral or bilateral failure on AABR screening, had MEE.  
The above studies demonstrate that middle ear conditions are more prevalent than 
sensorineural conditions in neonates.  
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Apart from increased referral rates, middle ear pathology can also delay the 
diagnosis of permanent hearing loss due to ambiguous results (Boone et al., 2005; 
Vartiainen, 2000). In order to reduce false positive rates and improve identification of 
infants with permanent hearing loss in UNHS programs, it is important to be able to 
discriminate ears with transient conductive problems from ears with a sensorineural 
hearing loss.  Hence, there is a need for a screening tool that is sensitive, specific and 
user-friendly that can permit better identification of outer and middle ear status and 
can be used as an adjunct to OAE/ABR screening in neonates (Gravel et al., 2005; 
Hunter et al., 2013).  
 
1.5 External/Middle Ear Pathology and Conductive Hearing Loss in Neonates 
As mentioned previously, transient conductive hearing loss due to MEE and/or 
occluded ear canals accounts for the majority of referrals in a NHS program (Doyle et 
al., 2000; Doyle, Kong, Strobel, Dallaire & Ray, 2004; Keefe et al., 2000; Kok, 
vanzanten, & Brocaar, 1992; Rosenfeld et al., 2004; Takahara, Sando, Hashida, & 
Shibahara, 1986; Thornton et al., 1993).  For instance, external canal obstruction due 
to vernix caseosa, a waxy substance that covers the skin of the neonate, is reported to 
be related to increased failure rates in NHS.  In a study of 82 ears of neonates with a 
mean age of 43 hours, Chang, Vohr, Norton, and Lekas (1993) found that 76% of ears 
passed OAE before otoscopic examination and that the pass rate improved to 91% 
following vernix removal, thus, attributing 15% of the failure rate to external canal 
obstruction.  Doyle et al. (1997) studied 400 ears of healthy neonates aged 5 to 48 
hours and found that cleaning of vernix resulted in a 5% improvement in the ABR 
pass results from 91 to 96% and a 10.5% improvement in the OAE pass results from 
58.5 to 69%.   
 
Other studies have used otoscopic examination to determine the prevalence of 
vernix caseosa in the external ear canal and the degree of obstruction it creates. 
Balkany, Berman, Simmons, and Jafek (1978) studied 50 infants less than 24 hours of 
age and reported that all infants had at least partial obstruction of the ear canal. 
Cavanaugh (1987) found that on day 1, 56% of the ear canals were obscured and this 
reduced to 19% by day 3.  On otoscopic examination of 400 ears of infants aged 5 to 
48 hours, Doyle et al. (1997) found vernix obscuring the view of the tympanic 
membrane in 53 (13%) ears.  
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In addition to vernix, which can influence the outcomes of NHS in the first 
few days of life, residual mesenchyme and amniotic fluid have also been reported to 
contribute to conductive conditions in neonates.  Temporal bone studies have 
demonstrated that the condition of the middle ear in neonates is seldom pristine 
(Benner, 1940; Buch & Jorgensen, 1964; deSa, 1973, 1983; Hemsath, 1936) with 
MEE present in up to 50% of ears (deSa, 1973; Eavey, 1993).  The middle ear and 
antrum of a neonate have been reported to contain some amniotic fluid or residual 
mesenchyme and its cellular content.  Studies have shown that in the early stages of 
foetal development, the middle ear is filled with mesenchyme, which resolves 
between 8 foetal months to 13 postnatal months (Guggenheim, Clements, & 
Schlesinger, 1956; Jaisinghani, Paparella, Schachern, & Le, 1999; Piza, Gonzalez, 
Northrop, & Eavey, 1989; Takahara et al., 1986).   
 
Amniotic fluid contents aspirated into the middle ear have often been reported 
to contribute to MEE and conductive hearing loss in newborns (deSa, 1973; Northrop, 
Piza, Karmody, & Eavey, 1999; Roberts et al., 1995).  The volume of aspirated 
amniotic fluid has been reported to vary markedly from a very scant amount to a 
sizeable inoculum that fills up a substantial portion of the middle ear and antral space 
(Northrop, Piza, & Eavey, 1986; Piza et al., 1989).  The aspirated amniotic debris, 
instead of being cleared rapidly from the airways and the middle ears, may persist for 
several days (deSa, 1973).  Histologic observations have shown that this material 
induces a significant inflammatory response of a foreign body giant cell reaction that 
produces a large volume of granulation tissue as well as advanced inflammatory 
responses resulting in extensive damage to the major attic compartments and under-
pneumatisation of the mastoid (deSa, 1973; Eavey, Camacho, & Northrop, 1992; 
Palva, Northrop, & Ramsay, 2001; Piza et al., 1989; Ramsay, Palva, & Northrop, 
2001).     
 
Therefore, it is likely that during the immediate postnatal period, a conductive 
hearing loss may be present due to this amniotic fluid, followed by improvement in 
hearing as this fluid is cleared (Priner, Freeman, Perez, & Sohmer, 2003).  The 
majority of the studies of MEE in neonates have been histopathological and temporal 
bone studies.  However, the prevalence of middle ear pathology and conductive 
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hearing loss (presumably due to MEE) has been derived from the NHS results.  For 
instance, Stuart, Yang and Green (1994) attributed an ABR air bone gap (ABG) of 
more than 12 dB within the first 48 hours after birth to residual amniotic fluid in the 
middle ear. Kok et al. (1992) reported the inability to record OAEs in 50% of neonatal 
ears 3 to 51 hours after birth, while 24 hours later OAEs could be recorded in all ears.  
They explained that this improvement could be due to the clearance of fluid from the 
middle ear during that period.  Using a combination of otoscopy, OAE and ABR in 
their study of 200 neonates aged 5 to 48 hours, Doyle et al. (1997) found the 
prevalence of MEE to be 9%.  Infants with decreased tympanic membrane mobility 
by pneumatic otoscopy had failure rates of 50% and 62.5% for ABR and OAE, 
respectively, compared with failure rates of 11.5% and 21% for the entire sample.  
Boone et al. (2005) identified MEE in 64.5% of 76 infants referred for diagnostic 
evaluation through NHS and attributed it to residual amniotic fluid.  Using a 
combination of otoscopy, acoustic reflex measurements and tympanometry, Roberts et 
al. (1995) reported MEE to be present in all 68 babies examined in the first three 
hours of life.  By the third day, MEE had resolved in 73% of ears by otoscopy, 88% 
by acoustic reflex measurements and 92% by tympanometry. MEE is, therefore, a 
condition that can affect hearing in neonates and in turn influence the outcomes of 
UNHS programs.  
 
In summary, vernix in the ear canal and mesenchyme or amniotic fluid in the 
middle ear have been reported to be the common causes of false positive results 
during NHS.  In order to reduce the false positive rates, there is an urgent need to 
assess the conductive system at the time of screening in order to differentiate the ears 
with transient outer and middle ear pathologies from the ears with a sensorineural 
hearing loss.  
 
1.6 Otitis media and Conductive Hearing Loss in Australian Infants 
Otitis media (OM) is a generic term for inflammation within the middle ear cleft, 
while MEE denotes a liquid in the middle ear cleft regardless of etiology (Gates, 
1996). Australian Aboriginal infants and children are reported to have a high 
prevalence of OM compared to Caucasian infants and children. However, there has 
been limited research into the ear health status of Aboriginal infants at birth.  
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1.6.1. Aboriginal infants 
Several prospective otoscopic and audiological studies have documented a 
very high prevalence of OM in young Aboriginal infants.  Rebgetz, Trennery, Powers, 
and Mathews (1989) showed that the tympanic membrane perforations began in early 
infancy, from as early as eight weeks.  Douglas and Powers (1989) found that, by one 
year, up to two thirds of Aboriginal infants had at least one perforated ear drum.  Peak 
incidences of first ear drum perforation occurred at around 18 weeks and at 50 weeks.  
Foreman, Boswell, and Mathews (1992) reported that 16% of Aboriginal infants aged 
4 to 6 months and 30% of older children in three Northern Territory communities had 
perforated tympanic membranes.  In another study, Foreman (1987) found that of 425 
ears examined in Aboriginal infants and young children, only five ears (1.2%) were 
normal and 420 ears (98.8%) had evidence of abnormality.  The prevalence of 
perforation was 11% at age 0 to 6 months, 43% at 7 to 12 months and 30% at 13 to 24 
months.  Discharge from ears commenced from three months of age with a maximum 
incidence of 50% in the 10 to12 months age group.  For those with intact ear drums in 
the youngest group, there was a high prevalence of otoscopic abnormalities: 20% 
were inflamed and 35% were dull at 0 to 6 months.  While studies suggest genetic 
predisposition to ear infections as a contributing factor (Wiertsema and Leach, 2009), 
more research is required to substantiate this claim. Nevertheless, environmental 
factors such as high rates of cross infection due to overcrowding, poor hygiene and 
high rates of early bacterial colonisation have been reported to major causes of ear 
disease in Aboriginal neonates (Hill, 2012; Leach, Boswell, Asche, Nienhuys, & 
Mathews, 1994; Morris et al., 2009).   
 
Despite the high prevalence of ear diseases in young Aboriginal children, there 
is limited research on outer and middle ear function during the neonatal period.  In a 
longitudinal study of 22 Aboriginal infants, Boswell and Nienhuys (1995) showed 
that Aboriginal infants had middle ear aeration and normal hearing shortly after birth 
and otitis media with effusion (OME) or acute OM was diagnosed in 95% of these 
infants within six to eight weeks of birth.  They also reported that once middle ear 
disease started early in life, it became persistent despite treatment.  Lehmann et al. 
(2008) studied 100 Aboriginal children from birth to two years of age with routine 
check up by an ear, nose and throat (ENT) specialist thrice a year and hearing 
assessment by an audiologist twice a year. They found that at routine ENT specialist 
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clinics, OM was detected in 55% of 184 examinations in Aboriginal children and the 
peak prevalence was 72% at age 5 to 9 months. TEOAEs were present in 90% (46/51) 
of Aboriginal children aged less than one month and in 62% (21/34) children aged 1 
to 2 months. The children who failed TEOAEs at age 1 to 2 months were 2.6 times 
more likely to develop OM subsequently than those who passed. In view of this high 
prevalence of middle ear pathology in the Aboriginal infants, it is important to 
document the middle ear function at birth for this population.  
 
1.6.2 Caucasian infants versus Aboriginal infants 
When compared to Australian Aboriginal infants, Caucasian infants have a 
lower prevalence of ear disease.  McGilchrist and Hills (1986) estimated that by 14 
years, an Aboriginal child is likely to have spent two of those years with ear 
infections, compared to two months for his/her Caucasian counterpart.  Moran, 
Waterford, Hollows and Jones (1979) found that only 1.3% of the 15,540 Caucasian 
children had OM in one or both ears compared to 16.5% of 21,988 Aboriginal 
children.  Boswell and Nienhuys (1995) reported that compared to 95% of 22 six-to-
eight-week old Aboriginal infants with MEE, only 30% of 10 Caucasian infants had 
MEE. Lehmann et al. (2008) found that 26% of 180 Caucasian children had OM 
during routine ENT examination between birth and 2 years of age. Peak prevalence 
was 40% at 10 to 14 months. TEOAE responses were present in 99% (120/121) of 
Caucasian children aged less than one month and in 93% (108/116) of children at 1 to 
2 months of age. Leach et al. (1994) attributed the difference in ear disease in 
Aboriginal and Caucasian infants to differences in bacterial colonisation.  They found 
that Caucasian infants had colonisation by only one species at a rate of 1% per day in 
comparison with Aboriginal infants who had colonisation with multiple species of 
respiratory bacteria at a rate of 5% per day.   
 
Except for studies by Boswell, Nienhuys, Rickards, and Mathews (1993), 
Boswell and Nienhuys (1995) and Lehmann et al. (2008), there have been no other 
studies that have compared middle ear function at birth between these populations. 
Further, the existing studies have investigated middle ear function in Aboriginal 
neonates and young infants using otoscopy, 226 Hz tympanometry or TEOAE. It is 
well known that otoscopy and 226 Hz tympanometry are not reliable measures of 
middle ear function in young infants. Driscoll, Kei and McPherson (2000) suggested 
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that TEOAE alone is not sensitive to minor middle ear dysfunction and TEOAEs 
should be used along with another measure of middle ear function such as 
tympanometry.  
 
 Further research is needed to compare the outer and middle ear status at birth 
between Aboriginal and Caucasian neonates using appropriate methods such as 1000 
Hz tympanometry and other middle ear measures. This comparison would provide 
evidence of any differences in the outer and middle ear function between the two 
groups at birth.  This information would be useful for designing appropriate screening 
and intervention programs in relation to early detection, audiological and medical 
management, community health promotion and hearing loss prevention. 
 
1.7 Non-Audiological Diagnosis of Middle Ear Effusion in Neonates and Infants 
There are many ways to diagnose MEE in humans. Non-audiologic methods 
include otoscopy, pneumatic otoscopy, otomicroscopy and myringotomy. The 
accuracy in detecting MEE depends on the method, the client and the tester’s skills 
and experience in performing the procedure. 
 
1.7.1 Otoscopy. 
Otoscopy is the most common clinical tool used to identify MEE in older 
children and adults. However, the accuracy of otoscopy in identifying MEE in young 
infants has been questioned as changes in colour, reflexive reaction to light, 
translucency and mobility of the eardrum have been found in healthy full term infants 
from birth to beyond 4 months of age (Cavanaugh, 1987; Jaffe, Hurtado & Hurtado, 
1970; McLennan & Webb, 1957).  Anatomical differences in the tympanic 
membranes and external auditory meati of neonates compared to older infants have 
been suggested to contribute to these otoscopic changes (Jaffe et al., 1970; McLellan 
& Webb, 1957).  Anatomical development in early infancy include changes in the 
orientation and flexibility of the tympanic membrane and ossicular chain, rapid 
increase in the ear canal diameter and length (Keefe et al., 1993), formation of bony 
floor by 12 months (Kenna, 1990),  and the middle ear cavity reaching adult size by 
six months of age (Eby & Nadol, 1986).  
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Even experienced physicians have found otoscopy in neonates to be onerous 
due to difficulties in visualising the tympanic membrane (Doyle et al., 1997; Zarnoch 
and Balkany, 1978). When successfully viewed, interpretation has been problematic 
due to less distinct landmarks (McLennan & Webb, 1957).  Furthermore, inter-
observer agreement regarding the presence of MEE in neonates has been reported to 
vary from 27% (laRossa, Mitchell, & Cardinal, 1993) to 85% (Marchant et al., 1986). 
Due to this large variation, Roberts et al. (1995) concluded that otoscopy could not be 
relied upon in this age group. 
 
1.7.2 Pneumatic otoscopy. 
Although pneumatic otoscopy has often been used with children and adults to 
identify MEE (Finitzo, Friel-Patti, Chinn, & Orval, 1992; Toner & Mains, 1990; 
Vaughan-Jones & Mills, 1992), it has not been successfully utilised with young 
infants.  
 
Cavanaugh (1987) performed pneumatic otoscopy on 81 healthy full term 
babies during the first 72 hours of life and at routine well baby follow up visits. He 
found that limited mobility, changes in colour, poor lustre and relative opacity of the 
tympanic membrane occur in healthy neonates and may reflect the physiologic 
changes unique to the neonate period. Cavanaugh found that only 14 of 115 (12%) of 
the eardrums were visualised during the first three days of life. The success rate 
increased to 29 of 65 (44%) and 50 of 71 (71%) by 3 weeks and 10 weeks of age, 
respectively.  In conclusion, Cavanaugh remarked that dullness of the tympanic 
membrane, decreased light reflex and diminished translucence occurred in greater 
than 90% of the neonates during the first three days of life. These occurrences 
declined to 26% or less by four months of age.   
 
Marchant et al. (1984) reported that in infants, especially preterm infants, the 
ear canals are narrow and their tympanic membranes are less compliant to pneumatic 
insufflation than are those of older infants and children.  Cavanaugh (1989) recorded 
pneumatic otoscopy in 53 healthy paediatric patients and found that there was a wide 
variation in pressures generated with the pneumatic otoscope.  Hence, Cavanaugh 
suggested exploring the feasibility of modifying the instrument into a standardized 
objective system. In conclusion, due to a combination of physiological development 
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and difficulty in interpretation, pneumatic otoscopy has limited use with young 
infants.  
 
1.7.3. Otomicroscopy. 
Otoscopy using a binocular microscope, referred to as otomicroscopy, is 
reported to be superior to other methods of otoscopy because of significant 
improvement in sight due to magnification and three dimensional vision offering 
depth perception (McHugh  & Traynor, 2009).   
 
Young, TenCate, Ahmad, and Morton (2009) compared the findings of 
otomicroscopy by two specialist otolaryngologists with myringotomy results and 
found that otomicroscopy had overall accuracy of 94.1% with a sensitivity of 94.4% 
and specificity of 93.8%.  The authors concluded that otomicroscopy performed by a 
specialist otolaryngologist is an accurate tool for the diagnosis of MEE.  Lee and Yeo 
(2004) compared the findings of otomicroscopy, pneumatic otoscopy and 
tympanometry with myringotomy outcomes and found that otomicroscopy was the 
most sensitive (sensitivity of 100%) and specific (specificity of 61.5%) of the three 
diagnostic tests.  However, despite high accuracy of otomicroscopy in the 
identification of MEE, its use with young infants has been limited as it needs to be 
done by a specialist and often requires anaesthetisation which is not justified in young 
infants with suspected MEE.  
 
1.7.4 Myringotomy. 
Myringotomy and aspiration of middle ear fluid under general anaesthesia is 
the current ‘gold standard’ for diagnosis of MEE (Maw, 1995). Myringotomy is a 
surgical procedure that involves making a tiny incision on the ear drum to relieve 
pressure caused by the build up of fluid in the middle ear.  However, the main 
limitation of myringotomy is that it can only be justified in patients with specific 
indications, such as prolonged MEEs or recurrent OM.  In young infants, wherein the 
findings can be influenced by normal age-related physiological changes, the use of 
myringotomy in research involving healthy cases is neither ethical nor justified.  
 
1.8 Audiological Diagnosis of MEE in Neonates and Young Infants 
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Since MEE and associated conductive loss have been reported to cause 
increased referrals from newborn hearing screening, audiologists have become 
involved with the identification of middle ear pathology in infants in an attempt to 
differentiate sensorineural from conductive conditions.  A variety of objective 
audiological tests have been utilised in the assessment of the outer and middle ear 
functions in neonates and young infants.  
 
1.8.1 Tympanometry using low frequency probe tones (220/226 Hz). 
Although tympanometry using a low frequency probe tone of 220/226 Hz has 
been accepted as the standard and objective clinical test for evaluation of middle ear 
problems (except for ossicular chain fixation) in older children and adults, its 
application has been limited in young infants (Hunter & Margolis, 1992; Paradise, 
Smith, & Bluestone, 1976; Shahnaz et al., 2009).  Traditional 226 Hz tympanometry 
has been reported to produce incorrect test outcomes in young infants because normal 
results have been obtained in the presence of confirmed middle ear diseases in infants 
less than six months of age (Balkany et al., 1978; Beery, Andrus, Bluestone, & 
Cantekin, 1975; Hunter & Margolis, 1992; Keefe et al., 1993; Keefe & Levi, 1996; 
McKinley, Grose, & Roush, 1997; Meyer, Jardine, & Deverson, 1997; Paradise et al., 
1976; Rhodes, Margolis, Hirsch, & Napp, 1999; Shurin, Pelton & Klein, 1976; 
Weatherby & Bennett, 1980; Wiliams et al., 1995; Zarnoch & Balkany, 1978).  
Paradise et al. (1976) found that about 40% of infants aged less than six months with 
confirmed MEE via pneumatic otoscopy and myringotomy findings exhibited normal, 
single peaked (Type A) tympanograms based on the Liden/Jerger classification 
system (Jerger, 1970; Liden, 1969).  Other studies have found type A tympanograms 
in 20 to 94% of infants with confirmed MEE (Pestalozza & Cusmano, 1980; Schwartz 
& Schwartz, 1980).   
 
Investigators have also found that low-frequency (e.g., 226 Hz) probe tone 
tympanometry can produce Type B tympanograms (i.e., no change in static 
compliance with pressure variation) in normal middle ears of young infants (Keefe et 
al., 1993; Keefe & Levi, 1996).  Groothuis, Sell and Wright (1978) found that 7% of 
71 infants aged 4 weeks to 17 months with normal otoscopic findings had type B 
tympanograms.  Wright, McConnel, Thompson, Vaugh and Sell (1985) found that 
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37% of infants aged less than 6 months with normal pneumatic otoscopy results had 
type B tympanograms. 
 
Furthermore, a high proportion of complex multi-peaked tympanograms have 
been obtained in infants compared with adults and older children with low frequency 
probe tones (Holte, Margolis & Cavanaugh, 1991; Keith, 1973; Sprague, Wiley, & 
Goldstein, 1985).  These complex multi-peaked tympanograms did not fit to any 
category in either the Liden/Jerger scheme (Jerger, 1970; Liden, 1969) or the 
Vanhuyse model (Vanhuyse, Creten, & van Camp, 1975), thereby rendering the 
interpretation of results difficult and susceptible to errors.  
 
Several studies have suggested that developmental changes in the outer and 
middle ear of infants and their physical properties in the first few months of life 
contribute to the differences in the tympanometry patterns seen with infants 
(Himelfarb, Popelka & Shanon, 1979; Holte et al., 1991; Hunter & Margolis, 1992; 
Keefe et al., 1993; McKinley et al., 1997; Meyer et al., 1997).  Some of the 
developmental changes in the infant ear include an overall increase in the size of the 
ear canal and middle ear space, decrease in the length of the cartilaginous portion of 
the ear canal due to growth of the bony portion of the canal wall, decrease in the 
overall mass of the middle ear due to loss of residual mesenchyme and changes in the 
ossicular bone density and ossification, changes in the orientation and flexibility of 
the tympanic membrane and ossicular chain, ossicular joint tightening, and a lesser 
coupling between the stapes and the annular ligament (Ikui, Sando, Sudo, & Fujita, 
1997; Ruah, Schachern, Zelterman, Paperella & Yoon, 1991; Saunders, Kaltenback, 
& Relkin, 1983).   
 
Cumulatively, these developmental changes result in a mass-governed middle 
ear transmission system which gradually transforms into an adult-like stiffness-
dominated system (Himelfarb et al., 1979; Holte et al., 1991; Hunter & Margolis, 
1992; McKinley et al., 1997; Meyer et al., 1997; Saunders et al., 1983).  As the infant 
ear changes from a mass-dominated to a stiffness-dominated system, the resonance 
frequency of the outer and middle ear system increases.  Meyer et al. (1997) found the 
resonance frequency to be below 550 Hz in an infant till she was 14 weeks old. By 
three to four months, the resonance frequency reached 800 to 1200 Hz similar to that 
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of adults.  For this reason, they suggested that low frequency tympanometry that is 
used to evaluate a stiffness based middle ear system was not appropriate for the mass 
governed middle ear of the young infant.  Other studies too have supported this view 
and suggest that due to these maturational changes, tympanometry using 226 Hz is 
invalid in infants below six months of age (Holte et al., 1991; Keefe & Levi, 1996).   
 
1.8.2 Tympanometry using high frequency probe tones (600/678 and 1000  
Hz). 
Due to the limitation of 226 Hz probe tone tympanometry in young infants, the 
use of high frequency probe tone has been recommended for this population. 
Investigators have used probe tones of 660/678 Hz and 1000 Hz in evaluating the 
infant middle ear (Alaerts, Luts & Wouters, 2007; Baldwin, 2006; Beery et al., 1975; 
Calandruccio et al., 2006; Harris, Hutchinson, & Moravec, 2005; Kei et al., 2003; 
Marchant et al., 1986; Margolis et al., 2003; Purdy & Williams, 2002; Swanepoel et 
al., 2007).  
 
1.8.2.1 Tympanometry using a 660/678 Hz probe tone 
Several studies have shown that 660/678 Hz probe tones are more accurate in 
diagnosing MEE than the traditional 220 Hz probe tone in infants (Himelfarb et al., 
1979; Marchant et al., 1986; Shurin et al., 1976; Sprague et al., 1985; Sutton, Gleadle, 
& Rowe, 1996).  In 1986, Marchant and colleagues demonstrated good agreement 
between otoscopy and 660 Hz probe tone tympanometry (Kappa coefficient = 0.86) in 
86 infants less than 5 months of age.  Shurin et al. (1976) found that 660 Hz 
tympanometry provided better separation between normal ears and ears with MEE 
than 220 Hz tympanometry.  Based on a combination of pattern classification and 
susceptance criteria in 91 children, Beery et al. (1975) found oto-admittance at 660 Hz 
to be a better indicator of effusion than at 220 Hz.  They found that 660 Hz 
tympanometry performed just before myringotomy accurately predicted MEE in 96% 
of ears when effusion was present and in 93% of ears predicted no effusion when the 
ears were actually dry.  
 
However, the clinical utility of 660/678 Hz tympanometry has been questioned 
due to the presence of complex multi-peaked tympanograms with this probe tone. 
McKinley et al. (1997) used a 678 Hz probe tone in evaluating the middle ear function 
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of 55 healthy neonates and found that 18% of the multi-peaked tympanograms were 
classified as unusual or “other”.  In another study, Himelfarb et al. (1979) found that 
85% of the tympanograms recorded were multi-peaked. They attributed this 
phenomenon to the high compliance of infants’ external ear canal walls.  This finding 
is substantiated by Keefe et al. (1993) who measured acoustic impedance, admittance 
and reflection from 125 to 10,700 Hz and found the transmission of sounds between 
220 and 660 Hz into the middle ear was not efficient due to ear canal wall vibration 
and resonance.  Hence, Keefe et al. concluded that 220 to 660 Hz is a poor frequency 
range to use for tympanometry with infants. They recommended that frequencies 
between 1000 and 4000 Hz should be used for testing infants because this sound can 
be most efficiently transmitted into the middle ear. 
  
1.8.2.2 Tympanometry using a 1000 Hz probe tone  
Tympanometry utilising a probe tone of 1000 Hz can produce more reliable 
and accurate results than 226 Hz or 600/678 Hz tympanometry in detecting MEE in 
young infants (Baldwin, 2006; Kei et al., 2003; Margolis et al., 2003; Mazlan et al., 
2007; Meyer et al., 1997; Purdy & Williams, 2002; Rhodes et al., 1999; Williams, 
Purdy & Barber, 1995).  Williams et al. (1995) studied 26 infants under four months 
of age and found that the peak susceptance at 1000 Hz provided the best agreement 
with otomicroscopy and pneumatic otoscopy.  In their study of 87 NICU babies, 
Rhodes et al. (1999) found that 30 to 67% of babies who failed the 226 Hz and 678 
Hz tympanometry actually passed a series of electrophysiological tests including OAE 
and ABR.  In contrast, they found that the three ears that failed 1000 Hz 
tympanometry also failed the OAE and ABR tests.  In a longitudinal study of a child 
from two weeks to 6.5 months of age, Meyer et al. (1997) utilised both 226 and 1000 
Hz probe tones and found that 1000 Hz tympanometry provided better diagnostic 
sensitivity to middle ear dysfunction than conventional 226 Hz tympanometry.  
 
However, routine adoption of 1000 Hz tympanometry for neonates has been 
hindered by difficulties surrounding trace interpretation.  While interpretation of 226 
Hz tympanograms obtained from adults has been well established (Beery et al., 1975; 
Jerger, 1970; Liden, 1969), there is no agreement on the interpretation of 1000 Hz 
tympanograms in infants.  Several researchers have created their own methods to 
classify tympanometric findings in infants (Baldwin, 2006; Marchant et al., 1986; 
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Sutton et al., 1996; Williams et al., 1995).  For example, Baldwin (2006) utilised the 
shape classification method initiated by Marchant et al. (1986) and proposed a 
classification system based on identifying positive versus negative peaks above a 
baseline between +200 and -400 daPa.  Using this method of classification in the 
study of 211 young infants, Baldwin found that normal tympanograms were 
characterised by a positive peak while abnormal ones were of a negative or trough 
configuration. Using air and bone conduction ABR as the gold standard, Baldwin 
found the sensitivity and specificity of 1000 Hz tympanometry to be 0.99 and 0.89, 
respectively.  
 
Other researchers have used simple visual classification systems in which the 
presence of a peak or notching is indicative of normal middle ear function and a flat 
or sloping tympanogram is suggestive of MEE.  Using this method with 122 normal 
healthy neonates, Kei et al. (2003) found that 92.3% had single peaked (Type 1) 
tympanograms, 5.7% had flat (Type 2) tympanograms, 1.2% had double peaked 
(Type 3) tympanograms and 0.8% did not fit into any categories (others). The 
majority of infants had Type 1 tympanograms, similar to the Type A tympanograms 
of the conventional Liden/Jerger classification (Jerger, 1970; Liden, 1969) that are 
often seen in adults and children with normal middle ear function.  Kei et al. (2003) 
concluded that the Type 1 tympanogram is indicative of normal middle ear function 
given the presence of normal TEOAEs, uneventful birth history and no predisposing 
high risk factors for hearing loss.  This result corresponded well with the findings by 
Alaerts et al. (2007) who evaluated 110 children from birth to 32 months and found 
that 91% of infants younger than 3 months had Type 1 tympanograms.  These 
findings are also consistent with that of Margolis et al. (2003) who found that the 
tympanograms obtained using a 1000 Hz probe tone in neonates were almost always 
single-peaked and free of artefacts and irregular patterns.  
 
Swanepoel et al. (2007) classified 1000 Hz tympanograms from 278 ears of 
143 healthy neonates aged one to four weeks and recorded only two types of 
tympanograms, single and double peaked patterns with a prevalence of 94% and 6%, 
respectively.  However, in contrast to the findings of Kei et al. (2003), Swanepoel et 
al. (2007) suggested that double-peaked tympanograms were indicative of normal 
middle ear transmission because strong TEOAEs were obtained from these ears.  
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Several researchers have suggested the use of the Vanhuyse model (Vanhuyse 
et al., 1975) to interpret tympanometric results in infants and young children (Alaerts 
et al., 2007;  Calandruccio et al., 2006; Holte et al., 1991; Sprague et al., 1985; Sutton 
et al., 1996). The Vanhuyse model defines four patterns of admittance tympanograms, 
based on the combined minima and maxima in both susceptance (B) and conductance 
(G) tympanograms, namely 1B1G, 3B1G, 3B3G and 5B3G. Alaerts et al. (2007) 
found the Vanhuyse model to be suitable for identifying 1000 Hz tympanograms in 
110 children from birth to 32 months and in adults.  An equal distribution of 1B1G 
and 3B1G types in the youngest children changed into a distribution with 
predominantly 3B1G types in adults.  Calandruccio et al. (2006) found the Vanhuyse 
et al. model to be useful in classifying 1000 Hz tympanograms in young infants.  They 
reported that the majority of infants (4 weeks to 6 months) had equal distribution 
between 1B1G and 3B1G tympanograms, while adults had predominantly 3B1G 
tympanograms. Similarly, both Alaerts et al. and Calandruccio et al. found an equal 
distribution of 1B1G and 3B1G types in the young infants while adults had 
predominantly 3B1G tympanograms.  
 
Nevertheless, with the use of the Vanhuyse model, the interpretation of 
tympanometric patterns is more complicated compared with the simple visual 
admittance classification method.  For example, McKinley et al. (1997) found that 
more than half of the 55 neonatal ears studied exhibited susceptance and conductance 
that could not be classified using the Vanhuyse multi-component tympanogram 
models.  They found no clear relationship between the presence of TEOAEs and 
tympanograms, using 226, 678 and 1000 Hz probe tones, classified according to the 
Vanhuyse model of tympanometric shapes (Vanhuyse et al., 1975) and concluded that 
this model was not adequate for classifying and interpreting the majority of their high 
frequency neonatal tympanograms. Moreover, by merely looking at susceptance (B) 
and conductance (G) patterns, middle ear pressure and the extent of tympanic 
membrane movement are not taken into account.  These constraints make the 
Vanhuyse model less applicable for middle ear assessment in neonates and young 
infants. 
 
Alaerts et al. (2007) suggested the use of a combination of tympanogram 
shape and middle ear pressure for assessment of middle ear function in young infants. 
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They recommended pass criteria as presence of single peak and tympanic peak 
pressure around 0 daPa (Type 1 tympanogram) was equivalent to Type A of the 
Liden/Jerger classification system (Jerger, 1970; Liden, 1969).  Tympanograms with a 
single peak and negative pressure of <-150 daPa were classified as Type 3 (or Type C 
in the Liden/Jerger classification system).  More recently, attempts have been made to 
describe the characteristics of 1000 Hz tympanograms in neonates passing an OAE 
screen (Kei et al., 2003; Margolis et al., 2003).  These studies have produced 5th and 
95th percentile data for a variety of test parameters which, the authors believe, may 
serve as pass/fail criteria for 1000 Hz tympanometry (Kei et al., 2003; Margolis et al., 
2003).  Peak compensated static admittance (compensated at either the negative or 
positive pressure end) appears to be a common measure employed by researchers.  
For example, Mazlan et al. (2009) suggested using the 5th percentile (0.23 mmho) for 
positive tail (+200 daPa) peak compensated static admittance as a pass/fail criterion. 
However, this criterion was not evaluated with infants with abnormal middle ear 
function and, hence, the sensitivity and specificity of the test are not known.  Margolis 
et al. (2003) recommended compensation performed at the negative pressure end (-
400 daPa) and suggested a cut-off of at least 0.6 mmho as a pass criterion for infants 
up to four weeks of age.  In a study of 278 neonatal ears, Swanepoel et al. (2007) 
found increased variability in the 95th percentile and suggested a 5th percentile cut off 
value at 1.4 mmho.   
 
Mazlan et al. (2009) used a different approach with 1000 Hz tympanometry 
and compared two methods of obtaining middle ear admittances, namely, peak 
compensation and component compensation, in 42 neonates.  They found that mean 
middle ear admittances obtained by compensating for the susceptance and 
conductance components at a pressure of +200 and −400 da Pa (YCC200 = 1.00 mmho 
and YCC-400 = 1.24 mmho, respectively) were significantly greater than those obtained 
using the traditional baseline compensation method (YBC= 0.65 mmho).  Although 
YCC-400 had the highest mean value, it had the lowest test-retest reliability.  Therefore, 
they suggested that the component approach compensated at 200 daPa (YCC200) holds 
promise as an alternative method for estimating middle ear admittance in neonates.  
 
From the above description of 1000 Hz tympanometry, it can be seen that 
there is no unanimous agreement on either the tympanometric shape classification or 
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the optimal test parameter for assessing middle ear function in infants.  The 
meaningfulness of using conventional tympanometry, peak compensated admittance, 
tympanometric peak pressure, equivalent ear canal volume and tympanometric width 
to assess middle ear function in infants has not been clearly demonstrated.  There are 
significant differences in the mean admittance proposed by various studies (Kei et al., 
2003; Margolis et al., 2003; Swanepoel et al., 2007) which  can be attributed to 
differences in using single versus both single- and double-peaked tympanograms, as 
well as differences in equipment, age of subjects and measurement techniques.  
 
In general, research recommends that 1000 Hz tympanometry be used in the 
assessment of middle ear dysfunction in infants compared to 220 or 660 Hz 
tympanometry.  However, further research is needed to develop standardised 
measures of the 1000 Hz tympanogram that can be universally accepted in the 
assessment and interpretation of test findings for this population.  Until such measures 
are developed, 1000 Hz tympanometry should be used with caution along with other 
measures of middle ear function.  
 
1.8.3 Acoustic stapedial reflex (ASR).    
Although the ASR test has often been used for site of lesion testing to 
diagnose conductive, cochlear and retrocochlear pathologies in adults (Ferguson et al., 
1996; Handler & Margolis, 1977; Jerger, Burney, Mauldin, & Crump, 1974), its 
application to young infants has been limited. Earlier studies using probe tone 
frequencies of 200 Hz have shown large variations in the prevalence of the ASR in 
neonates.  Vincent and Gerber (1987) studied the ASR in neonates and six-week-old 
infants using activating stimuli (broadband noise and pure tones of 500, 1000, 2000 
and 4000 Hz) and a probe tone of 220 Hz. They found that reflexes were present for 
all the five stimuli in 92.5% of 40 ears of neonates and 95% of 40 ears of six-week-
old infants.  In contrast, other studies that have used a 220 Hz probe tone to measure 
the ASR in neonates and young infants have observed absent reflexes in 90% of 
infants (Abahazi and Greenberg, 1977; Keith, 1973; Stream, Stream, Walker, & 
Breningstall, 1978).  
 
Other normative studies with neonates using 660/678 Hz probe tones have also 
demonstrated large variations in the prevalence of the ASR. Sprague et al. (1985) 
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utilised a probe tone of 660 Hz and found reflexes in 81% of 53 neonates.  Sutton et 
al. (1996) used a probe tone of 678 Hz with neonates and found reflexes in 42% of 
168 ears.  In contrast, Keith (1973) found ASRs to 500 and 1000 Hz tones at 100 dB 
HL in only 6% of 40 healthy neonates aged 36 to 151 hours after birth, while Keith 
and Bench (1978) found ASRs in only 5.4% of infants.  
 
Higher probe frequencies have been successfully employed in obtaining ASRs 
from neonates and young infants, with several studies demonstrating higher 
prevalence with higher frequencies.  In a study utilising multiple probe tone 
frequencies from 220 to 2000 Hz, Weatherby and Bennett (1980) found that ASRs 
could be elicited in all 44 healthy neonates for a broadband noise activator when 
probe frequencies from 800 to 1800 Hz were used.  Other studies that used a probe 
tone of 1000 Hz to elicit the reflex have also obtained similar findings (Mazlan et al., 
2007, 2009; Rhodes et al., 1999; Swanepoel et al., 2007).  For example, Rhodes et al. 
(1999) demonstrated ASRs in 87% of 173 babies in an NICU when a 1000 Hz probe 
tone and an activating stimulus of 2000 Hz was used. Bennett and Weatherby (1982) 
used a 1200 Hz probe tone to measure the ASR in neonates and were able to obtain 
the ASR in 26 out of 28 infants.  Swanepoel et al. (2007) successfully reported ASRs 
in 94% of healthy young infants aged 1 to 28 days using a 1000 Hz probe tone and 
1000 Hz activator.  Using a 1000-Hz probe tone, Mazlan et al. (2007) demonstrated 
that ASRs could be recorded from all 42 healthy full term neonates when stimulated 
ipsilaterally by either a 2000 Hz pure tone or broadband noise stimulus.  
 
Apart from the difference in the incidence of ASR with various probe tones, a 
large variation in the ASR threshold with probe tone frequencies has also been 
reported.  For example, the mean acoustic reflex threshold has been shown to be 11 
dB higher with a 1000 Hz probe tone compared to other probe tones.  Swanepoel et al. 
(2007) obtained a reflex threshold of 93 dB using a 1000 Hz probe tone and 1000Hz 
ipsilateral stimulus for neonates.  This threshold was higher compared to the mean 
threshold of 82 dB using a 660 Hz probe tone to elicit ipsilateral ASRs in neonates 
(Sprague et al., 1985) and 82 dB using a 220 Hz probe tone in adults (Wiley, Oviat, & 
Block, 1987).  Hirsch, Margolis, and Rykken (1992) utilised a probe tone of 800 Hz 
with high risk infants and found that the mean ASR threshold was approximately 15 
dB lower for the broadband noise compared to pure tone stimulus.  This finding is 
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consistent with that obtained by Mazlan et al. (2007), who found a 13.7 dB difference 
in ipsilateral ASR thresholds between the 2000 Hz and broadband noise stimuli while 
testing 42 healthy neonates. In another study of 194 neonates, Mazlan (2009) found a 
11.3 dB difference between 2000 Hz and broadband noise using a 1000 Hz probe 
tone.  
 
In addition to the increased variation in the frequency and threshold of ASRs 
in infants, earlier studies have shown contrasting findings regarding the clinical utility 
of the ASR in the middle ear assessment of infants.  For example, Hirsch et al. (1992) 
used ASR in conjunction with ABR for screening 76 babies from an NICU and found 
that 12 ears with elevated or absent reflexes also had delayed ABR wave latencies and 
concluded that combined information from ABR and ASR might be valuable for early 
detection of MEE in infants.  In another study, Plinkert, Sesterhenn, Arold, and 
Zenner (1990) used ABR, ASR and TEOAE to screen 53 infants and found that ASR 
correctly predicted normal hearing in 78% of ears that had normal ABR thresholds 
(<30 dB nHL), compared with 91% for TEOAEs.  They proposed that the ASR-
TEOAE combination could be an efficient screening tool.  
 
Marchant et al. (1986) measured ipsilateral acoustic reflex thresholds using a 
660 Hz probe tone in 86 infants below five months of age, and found that optimal 
agreement was obtained between otoscopically normal ears and those with middle ear 
effusion using a threshold of >100 dB HL as the criterion for MEE.  However, 
improved agreement could not be achieved by adding reflex thresholds to peak 
susceptance.  Therefore, they recommended that either peak susceptance or ipsilateral 
ASR could be used for the detection of MEE in early infancy.  
 
Despite conflicting reports on the clinical utility of ASRs in neonates and 
young infants, ASR testing with a probe tone of 1000 Hz has been found to give 
optimal results.  Apart from the studies by Mazlan et al. (2007, 2009), there are very 
few normative studies on ipsilateral ASR using 1000 Hz tone in infants.  Hunter et al. 
(2013), however, reported that standard acoustic reflex tests may have a risk of 
iatrogenic hearing loss due to the need for high stimulus levels. More research on the 
application of ASR with infants is required before it can be used routinely in 
paediatric audiology clinics. 
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1.8.4 Transient evoked otoacoustic emissions (TEOAE) and Distortion 
Product otoacoustic emissions (DPOAE). 
The presence of OAEs has often been used as an indicator of normal middle 
ear function, especially in infants, in lieu of procedures like pneumatic otoscopy or 
myringotomy.  There are two main types of evoked OAEs, namely TEOAE and 
DPOAE. Studies utilising TEOAE as an indicator of normal middle ear function have 
utilised the frequency range of 1500 to 4000 Hz (Kei et al., 2003; Margolis et al., 
2003; Swanepoel et al., 2007). Studies utilising DPOAE as an indicator of normal 
middle ear function have utilised the frequency range of 2000 to 6000 Hz (Merchant 
et al., 2010; Sanford et al., 2009; Swanepoel et al., 2007; Vander Werff et al., 2007).  
 
As OAEs require efficient transmission of sound from the outer to the inner 
ear and vice versa, normal OAE results provide some level of assurance of normal 
outer and middle ear function (Hunter et al., 2010; Kei et al., 2003; Margolis et al., 
2003; Sanford et al., 2009; Shahnaz, 2008). OAEs are affected by even slight changes 
in the condition of the outer and middle ear (Prieve & Dreisbach, 2011).  For instance, 
TEOAE and DPOAE levels are reduced in infants and children having negative 
tympanometric peak pressure (TPP) (Choi, Pafitis, & Zalzal, 1999; Hof, Anteunis, 
Chenault, & Van Dijk, 2005; Hof, Van Dikj, Chenault, & Anteunis, 2005; Koike & 
Wetmore, 1999; Koivunen, Uhari, Laitakari, Alho, & Luotonen, 2000; Lonsbury-
Martin, Martin, McCoy, & Whitehead, 1994; Owens, McCoy, Lonsbury-Martin, & 
Martin, 1992; Prieve, Calandruccio, Fitzgerald, Georgantas, & Mazevski, 2008).  
Prieve and colleagues (2008) measured TEOAEs in infants when their TPP was 
normal and again when it was negative.  They found an approximately 4 dB reduction 
in TEOAE response level for the frequency bands from 1000 to 4000 Hz, while the 
mean change in TPP between the two measurements was -169 daPa.  In comparison, 
children with flat tympanograms show dramatically reduced OAE level or no 
measurable OAEs (Choi et al., 1999; Koike & Wetmore, 1999; Koivunen et al., 2000; 
Lonsbury-Martin et al., 1994).  Absent TEOAEs has been reported to be a common 
finding in children with confirmed OM, most often when middle ear fluid is viscous 
(Amedee, 1995) or when there is a large quantity of effusion (Koivunen et al., 2000).  
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 However, passing the TEOAE or DPOAE, in its strictest sense, cannot serve 
as a “gold-standard” for normal middle ear function because both TEOAE and 
DPOAE have been found to be present in some ears with middle ear dysfunction in 
children and adults (Driscoll et al., 2000; Kemp, 2002; Sanford et al., 2009; Taylor & 
Brooks, 2000; Thornton et al., 1993; Van Cauwenberge, Vinck, De Vel and Dhooge, 
1995).  Despite this limitation, the OAE test has been widely used to assess the 
integrity of the conductive pathway (outer and middle ear) in neonates and young 
infants without resorting to invasive procedures, such as myringotomy, that carry risk 
and are not ethical in otherwise healthy neonates.  Presently, TEOAEs/DPOAEs serve 
as a surrogate gold standard for evaluating the test performance of other measures in 
identifying OM in young infants.  
 
1.8.5 Auditory brainstem response (ABR). 
ABR is currently considered as the gold standard measure for assessing the 
auditory function of infants referred from NHS. ABR thresholds can be measured 
using either clicks or tone bursts as stimuli. ABR using click stimuli provides a global 
measure of physiological thresholds. In contrast, ABR using tone burst stimuli 
provides frequency specific threshold information.  Normal hearing infants show 
mean thresholds of about 15 to 20 dB nHL from 500 to 4000 Hz (Lee, Hsieh, Pan, & 
Hsu, 2007; Rance, Tomlin, & Rickards, 2006; Stapells, 2000, 2011; Vander Werff, 
Prieve, & Georgantas, 2009).  
 
The most common cause of elevated ABR thresholds in young infants, 
especially those referred from NHS, is conductive hearing loss (Boone et al., 2005; 
Gravel, 2002).  Immittance and OAE measures are unable to quantify the degree of 
conductive hearing loss. In the presence of conductive pathology, these measures are 
typically abnormal irrespective of whether the conductive component is relatively 
minor or substantial (Stapells, 2011).  Analysis of ABR wave V or wave I latencies in 
response to air conducted clicks is reported to differentiate conductive from 
sensorineural losses and even quantify the conductive component (Fria & Sabo, 1979; 
McGee & Clemis, 1982; Yamada, Yagi, Yamane, & Suzuki, 1975).  However, 
attempts to quantify the amount of conductive component using air conduction click 
ABR wave V or wave I latency shifts have not proven to be reliable with large errors 
in many infants (Eggermont, 1982; Mackersie & Stapells, 1994) and relatively low 
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correlations between latency and the size of the air-bone gap (Vander Werff et al., 
2009). For example, Stapells (2011) reported differences in ABR patterns in an infant 
with bilateral OM. Bone conduction thresholds were normal.  Wave V thresholds to 
air conducted stimuli were normal (20 dB nHL or better) for the left ear, but mildly 
elevated (40 dB nHL) for the right ear. Despite the difference in thresholds, wave V 
latencies were well within normal limits in both ears. It is, therefore, not possible to 
reliably determine the presence or degree of a conductive component using air 
conduction ABR latency information.  
 
While air and bone conduction (AC and BC) tone burst ABR may be regarded 
as a surrogate gold standard for detecting conductive conditions, this threshold ABR 
measure requires long testing time to complete and is done as a diagnostic measure at 
some point later in time rather than during the hearing screening period. This measure 
is not sensitive to detecting subtle conductive conditions where the AC tone burst 
ABR thresholds are within normal limits.   Despite the practice of BC tone burst ABR 
being in place for over two decades (Gravel, Kurtzberg, Stapells, Vaughan, & 
Wallace, 1989; Stapells & Ruben, 1989), Stapells (2011) reported that many 
clinicians do not routinely obtain ABR results for BC stimuli after finding elevated 
AC thresholds. Instead, they rely on immittance results for determining the middle ear 
status.  Stapells attributed this to several reasons including limited dynamic range, the 
use of 10-dB step size and lack of published data for AC-BC differences in infants.  
Stapells also reported that when BC testing is performed, the results are not used to 
calculate the air-bone gap but are primarily used to indicate whether bone thresholds 
are normal or elevated.  
 
 
1.8.6 Auditory steady state response (ASSR). 
The ASSR responses to stimuli presented using repetition (or modulation) 
rates in the 70 to 110 Hz range have recently gained considerable attention in the 
clinical evaluation of infants.  An ASSR is a repetitive evoked potential, which is best 
considered in terms of its constituent frequency components rather than in terms of its 
waveform (Regan, 1989).  The primary goal of ASSR audiometry is to estimate 
behavioural thresholds with application of regression formula or correction factors 
(Rance et al., 2005; Stapells, Gravel, & Martin, 1995).  
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The normative ASSR database for infants has only been developed in recent 
years   (Han, Mo, Liu, Chen, & Huang, 2006; Luts, Desloovere, & Wouters, 2006; 
Rance & Briggs, 2002) and is less than well understood.  Its application in the 
evaluation of conductive hearing loss has been limited as there is no agreement across 
the studies due to differences in the stimuli (single or multiple frequencies) or analysis 
techniques (signal-to-noise ratio or noise criteria) used  (Stapells, 2011).  
 
Assessment of conductive hearing loss in infants and children using ASSR has 
received very little attention.  There appears to be only one study of AC ASSR 
thresholds in children with various types of hearing loss including conductive hearing 
loss (Swanepoel, Ebrahim, Friedland, Swanepoel, & Pottas, 2008). Despite the 
promising results in Swanepoel et al.’s (2008) study, Stapells (2011) pointed out that 
the degree of conductive loss could not be estimated based on the frequency-specific 
AC and BC thresholds. Instead AC click ABR, TEOAE, tympanograms and otoscopy, 
none of which can provide an estimate of the size of the conductive component, were 
used.  
 
ASSRs to BC stimuli have not been thoroughly investigated.  BC ASSRs have 
been reported on normal and premature infants (Hulecki & Small, 2011; Small & 
Hansen, 2012; Small & Stapells, 2008; Stapells, 2011).   But, currently there are no 
published BC ASSR studies in infants with middle ear pathology and hearing loss.  
Further research is required especially in infants with confirmed middle ear pathology 
and hearing loss confirmed by behavioural tests or tone burst ABRs to AC and BC 
stimuli.  
 
It can be seen from the above studies that there is no single clinical measure 
that can be effectively utilised to measure middle ear function in neonates and young 
infants. The available audiological and non-audiological measures do have 
limitations. Assessing conductive disorders in young infants is a real challenge due to 
the lack of effective and objective tools for detecting these disorders for this 
population (Kei and Zhao, 2012). Paediatric audiologists, therefore, need sensitive, 
specific and user friendly screening and diagnostic tool that permit accurate 
determination of outer and middle ear status (Hunter et al., 2013).  
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1.9 Wideband Acoustic Immittance (WAI) 
Wideband acoustic immittance (WAI) refers to a family of wideband measures 
including power absorption, transmittance or power absorption in decibels, acoustic 
impedance (resistance and reactance) and admittance (conductance and susceptance). 
These physiological measures evaluate outer and middle ear function independently 
of the inner ear. They provide detailed information about acoustic-mechanical 
properties of the outer and middle ear across the frequency range most important for 
speech perception (Keefe, 2008; Keefe et al., 1993; Keefe & Levi, 1996). Currently, 
the most commonly used measures are wideband reflectance and absorbance. WAI 
measures can be performed under ambient pressure or pressurised conditions.  
 
 
1.9.1 WAI under ambient pressure conditions.  
1.9.1.1 Wideband reflectance 
Wideband reflectance (WBR) is the most frequently used measure of WAI.  It is 
also known as power reflectance, energy reflectance or reflectance. WBR is the ratio 
of reflected power to incident power. It ranges from 0 (representing complete transfer 
of sound into the middle ear) to 1 (representing no sound transferred to the middle 
ear) (Voss & Allen, 1994). WBR is the square of the pressure reflectance. 
Mathematically, WBR is a real number expressed only in magnitude and not phase. 
 
1.9.1.2 Wideband absorbance 
Wideband absorbance (WBA), also known as power absorbance, energy 
absorbance or absorbance, is the complement of WBR and expressed as WBA = 1 – 
WBR (Sanford et al., 2013; Neely, Stenfalt, & Schairer, 2013). Similar to WBR, 
WBA is also a real number without a phase component. WBA is defined as the ratio 
of energy absorbed by the middle ear to the incident energy and varies from 0 (no 
energy transferred to middle ear) to 1 (complete transfer of energy into middle ear) 
(Feeney & Sanford, 2012). In the present study, WBA rather than WBR was 
measured in neonates and young infants as recommended by Feeney et al. (2013). The 
terms WBA and absorbance are used interchangeably in this thesis. To ensure 
consistency and ease of understanding of earlier studies, the findings of these studies 
are discussed in terms of the WBA measure, although WBR was actually measured in 
these studies.  
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Several normative studies have shown that, at all ages, power absorbance is 
lowest at frequencies below 1000 Hz and above 4000 Hz and highest in the frequency 
region between 1000 and 4000 Hz, which corresponds to the most effective frequency 
region of the middle ear transfer function (Feeney et al., 2003; Keefe et al., 1993; 
Hunter, Tubaugh, Jackson & Propes, 2008b; Margolis, Saly & Keefe, 1999; Sanford 
& Feeney, 2008; Sanford et al., 2009; Voss & Allen, 1994).   
 
According to Keefe et al. (2000), WBA has several advantages over 
tympanometry, OAE and ABR:  WBA is a very fast test, requiring only several 
seconds to acquire a response; unlike tympanometry, it can measure energy 
transmission under ambient pressure conditions; it measures a wide range of 
frequencies from 250 to 8000 Hz and provides more detailed information on the status 
of the outer and middle ear; it provides clinical information on the range of 
frequencies crucial for speech perception, and it is less susceptible than OAE and 
ABR measurements to environmental and subject noise.  
 
1.9.1.3 WBA in adults. 
 Earlier reports on WBA described the absorbance pattern across the 
frequencies in adults. Margolis et al. (1999) studied 20 adults aged 20 to 53 years and 
found that the absorbance pattern was characterized by low absorbance at low 
frequencies, two distinct maxima at approximately 1200 and 3500 Hz, and decreasing 
absorbance below 1200 and above 3500 Hz. Other studies have reported increased 
absorbance between 1000 and 4000 Hz (Keefe et al., 1993; Sanford and Feeney, 
2008; Shaw & Stinson, 1981; Voss & Allen, 1994). Figure 1.1 illustrates this WBA 
pattern in normal adults across two studies (Keefe et al., 1993; Sanford & Feeney, 
2008). On the other hand, Zhao, Lowe, Meredith, and Rhodes (2008) studied WBA in 
50 normal ears of 25 adults and described three types of WBA configurations: (i) 
Type I with symmetric ‘M’ shape wherein two peaks were present in the low to mid 
and high frequency bands with central frequency of each peak around 1000 Hz and 
4000 Hz, respectively; (ii) Type II with asymmetric ‘M’ shape wherein two peaks 
were present with the central frequency of the peak in the low to mid frequency band 
being shallower than that of the  high frequency band, and; (iii) Type III with 
‘inverted U’ shape with a single rounded peak with the central frequency between 
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2000 and 5000 Hz. Zhao et al. (2008) attributed the peaks to the resonances in the 
outer and middle ear. 
 
It can be seen that normative WBA patterns obtained in adults across the 
studies have not been consistent. Further studies are necessary to develop normative 
WBA data in adults. Such studies are necessary in order to analyse differences in 
WBA across age, gender and ethnicity (Shahnaz, Feeney & Schairer, 2013).    
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          Figure 1.1: Wideband absorbance in adults across two studies.  
 
  1.9.1.4 WBA in children. 
 There are very few studies investigating WBA in children. Beers et al. (2010) 
established normative WBA data for 78 children with an average age of 6.15 years.  
Several studies have measured WBA in children with normal auditory function with 
the purpose of comparing results with those obtained from children with middle ear 
dysfunction (Beers et al., 2010; Jeng et al., 1999; Keefe & Simmons, 2003; Margolis, 
Saly & Hunter, 2000).  Jeng et al. (1999) obtained WBA measurements on 30 normal 
ears from 15 children in the age of range of two and a half to five years and found the 
associated absorbance pattern to be similar to that obtained from normal adults by 
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other researchers (Keefe and Bulen, 1992; Keefe et al., 1993; Voss & Allen, 1994).  
Jeng et al. reported that relatively little power was absorbed by the ear at low 
frequencies with the amount of power absorption increasing steadily with increasing 
frequency. At 1000 Hz, just over half of the acoustic power entering the ear canal was 
absorbed by the middle ear and cochlea.  Peak power absorption was reached in the 
3000 to 5000 Hz region for most of the subjects and almost all of the acoustic power 
was absorbed at these peak frequencies.  Power absorption then rapidly decreased at 
higher frequencies above 5000 Hz. Margolis et al. (2000) also obtained similar results 
in a WBA study of 12 normal ears from eight subjects aged nine to 16 years.  
 
 Keefe and Simmons (2003) studied 42 normal functioning ears in adults and 
children aged 10 years and up and found absorbance of approximately 0.2 near 250 
Hz, increasing with increasing frequency to a maximum of approximately 0.9 in the 
frequency range of 2500 to 3000 Hz and decreasing to lower values at 8000 Hz.   
 
 From this review of WBA studies in children, it can be seen that there is a lack 
of large scale, normative reports in this population.  In particular, the age range of 
children in the available WBA studies varied greatly. Further studies are needed to 
obtain age-specific normative data for children, which may show changes in WBA 
with age. 
  
1.9.1.5 WBA in neonates  
WBA has been successfully measured in healthy neonates as well as neonates 
in NICU.  A summary of studies that have investigated WBA under ambient pressure 
conditions in neonates is provided in Table 1.1. The general pattern of WBA in 
neonates is reported to be similar to that seen in children and adults with absorbance 
being highest between 1000 and 4000 Hz and decreasing below 1000 and above 4000 
Hz.  Figure 1.2 illustrates WBA measured in neonates across five studies.  
  
Keefe et al. (2000) conducted the first study of WBA in 2081 neonates. The 
participants were divided into three groups: neonates in NICU, neonates in the well 
baby nursery without any risk factors for hearing loss and neonates in the well baby 
nursery with one or more risk factors associated with hearing loss.  The investigators 
found a median absorbance of about 0.8 across all frequencies from 250 to 8000 Hz.  
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They also found significant ear and gender effects on absorbance in some frequency 
bands.  In particular, the Keefe et al data showed greater WBA at low frequencies 
than those of other studies. Contributing factors include evidence of inadequate probe 
seal during testing in 13% of neonates and that the neonates were not screened for any 
conductive conditions before participating in the study.  
 
In a study of WBA in NICU infants, Shahnaz (2008) investigated 26 neonates 
with a mean gestational age of 37.8 weeks and compared the results to WBA 
measures obtained from normal hearing adults.  Shahnaz found a clear separation 
between NICU babies and adults below 727 Hz, with NICU babies having higher 
absorbance values than adults.  The NICU neonate mean absorbance was larger at all 
frequencies than the corresponding mean for one-month-old infants from Keefe and 
Levi (1996).  
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Figure 1.2: Comparison of median wideband absorbance in neonates across 
five studies 
 
Subsequent studies have reported WBA data from a population of normal 
hearing healthy full term neonates (Sanford et al., 2009; Hunter et al., 2010; Merchant 
et al., 2010; Silva, Urosas, Sanches, & Carvallo, 2013) and evaluated its usefulness in 
relation to NHS programs. Sanford et al. (2009) were the first to report WBA in 
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relation to NHS and 1000 Hz tympanometry outcomes from a large number of 
neonates in a well baby nursery. They reported WBA data on 375 ears of healthy, full 
term neonates who passed DPOAE screening and 80 ears of neonates who failed 
DPOAE hearing screening during the first two days of life. Median absorbance in ears 
that passed DPOAE on day 1 varied between 0.39 and 0.67 while that in ears that 
failed DPOAE varied between 0.20 and 0.40 with the best separation between the two 
groups observed at 1400 to 2500 Hz (Figure 1.3).  Ears that passed DPOAE screening 
had higher absorbance compared with those that referred indicating that neonates who 
passed the DPOAE UNHS had a more acoustically efficient conductive pathway.  
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Figure 1.3: Median absorbance in neonates who passed (n = 375) or failed (n = 
80) DPOAE screening test in Sanford et al. (2009) study 
 
 
Similarly, Hunter et al. (2010) investigated WBA in relation to NHS and 1000 
Hz tympanometry outcomes from a large number of healthy neonates. The 
investigators developed normative data for WBA between 1000 and 6000 Hz in 352 
neonates who passed DPOAE screening and compared it with 141 neonates who 
failed the DPOAE screen. Hunter et al. defined the WBA normative region to be 
between 0th percentile of the DPOAE pass group and 10th percentile of the DPOAE 
refer group. They also developed area indices wherein the absorbance values were 
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integrated or averaged over a specified frequency range. Test performance analyses 
demonstrated that the regions involving 2000 Hz (1000 to 2000 Hz, 1000 to 4000 Hz 
and 2000 Hz alone) provided the greatest discrimination between DPOAE pass and 
refer groups. There were no significant ear or gender effects.  
 
 
 
 
Table 1.1: Summary of studies that have investigated WBA under ambient 
pressure conditions in neonates  
 
Study Method Subjects Summary of findings 
Keefe et al. 
(2000) 
WBA measured  
in well babies 
without risk 
indicators, with 
at least one risk 
indicator and 
NICU graduates  
2081 neonates 
divided into 3 
groups 
 
Median absorbance of 0.8 across 
all frequencies. 
 
Significant ear and gender effects 
present  
 
Variation of WBA with age 
present in the first few days of 
life. 
 
Keefe et al. 
(2003b) 
Retrospective 
analysis of 
WBA in relation 
to TEOAE, 
DPOAE and 
AABR 
 
1405 neonate 
ears 
High frequency absorbance was 
the most important factor in 
classifying OAE results that 
classified OAEs with ROC of 
0.79 and ABR of 0.64.   
 
Keefe et al. 
(2003a) 
Developed 
model for 
middle ear 
dysfunction  
 
Model applied 
to a different 
neonate group 
 
2638 ears used 
to construct the 
model   
 
 
1027 normal 
hearing ears.   
High frequency absorbance was 
the best predictor (AROC = 
0.87). 
 
 
Inclusion of this model decreased 
false positive from 5% to 1.1%. 
Vander 
Werff et al. 
(2007) 
Infants tested 
during screening 
and diagnostic 
testing.  
 
127 infants aged 
2 weeks to 24 
months 
 
screening group 
– n = 61  
 
Smaller test-retest differences for 
the diagnostic group   
 
Test-retest differences largest for 
frequencies below 500 Hz and 
smallest in the mid-frequency 
range.  
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Study Method Subjects Summary of findings 
 Diagnostic 
group- n = 66   
 
Control group – 
10 normal  
 
No difference in test-retest 
performance between infants 
who passed or failed OAE 
screening.  
 
Low WBA from 630 to 2000 Hz 
in infants who failed OAE 
screening  
 
Hunter et 
al. (2008a) 
Ears classified 
as normal or 
poor ear status 
using otoscopy, 
tympanometry 
and DPOAE 
97 (194 ears) 
infants and 
children aged 3 
days to 47 
months 
 
3 days - 2 
months 
 n = 18 
3 - 5 months n = 
15 
6 - 11 months  
n = 25 
12 - 23 months 
 n = 20 
24 - 47 months 
 n = 19 
Low absorbance in ears with 
poor ear status. 
 
WBA significantly different 
between 1000 and 3000 Hz for 
normal ears  
Shahnaz 
(2008) 
Inclusion 
criteria- NICU 
babies with pass 
in both TEOAE 
and AABR  
 
 
 
54 ears (49 pass, 
5 fail) from 31 
NICU babies  
 
56 adults (age 
18 – 32 years) 
with normal 
hearing and pass 
in TEOAE 
 
Clear separation of absorbance 
between NICU babies and adults 
below 727 Hz. 
 
Absorbance high in NICU babies  
 
Maximum absorption from 1200 
to 2700 Hz in normal NICU 
babies and from 2800 to 4800 Hz 
in adults  
Sanford et 
al. (2009) 
Test 
performance of 
WBA and 1000 
Hz 
tympanometry 
used to predict 
DPOAE 
outcomes   
 
 
455 ears (375 
pass and 80 fail 
DPOAE)   
AROC 0.87 for ambient WBA 
and 0.75 for 1000 Hz 
tympanometry  
 
High absorbance in ears with 
DPOAE pass  
 
Best separation of WBA between 
pass and fail groups from 1400 to 
2500 Hz  
 
Hunter et  Test 493 ears from Normative data provided for 
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Study Method Subjects Summary of findings 
al. (2010) performance of 
WBA and 1000 
Hz 
tympanometry 
used to predict 
DPOAE 
outcomes   
 
 
324 neonates – 
352 passed and 
141 referred 
with DPOAE 
screening 
1000 to 6000 Hz frequency range 
and for absorbance area indices. 
 
2000 Hz was best predictor of 
DPAOE outcome   
 
AROC high for WBA (0.90 and 
0.82 at 2000 and 1000 Hz 
respectively) and 0.72 for 1000 
Hz tympanometry. 
 
Absorbance differed significantly 
as a function of DPOAE status 
and frequency.  
 
Merchant et 
al. (2010) 
Only infants that 
passed DPOAE 
screening 
included 
 
12 ears from 
seven neonates 
 
19 ears from 11 
1-month old 
infants  
 
Absorbance similar in both 
groups at most frequencies  
 
 
Pitaro 
(2013) 
Otoscopy and 
WBA done on 
healthy neonates  
 
Ear canal 
occlusion given   
on a scale of 0 
to 100%.   
 
156 neonates Absorbance significantly 
different between 0 to 70% and 
80 to 100% occlusion groups   
 
Significant decrease in 
absorbance with 70 to 80% 
occlusion of ear canal diameter  
 
 
Silva et al. 
(2013) 
Neonates with 
TEOAE and 
tympanogram 
included    
144 ears from 
77 infants 
Normative WBA data provided   
 
Energy absorbance less from 250 
to 750 Hz and high from 1000 to 
3000 Hz 
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Merchant et al. (2010) studied WBA in 12 ears from seven neonates who 
passed DPOAE and found that the power absorbance was minimum (near 0.4) at 500 
Hz and increased with frequency until about 2000 Hz where it reached a maximum of 
0.82. Above 2000 Hz, power absorbance decreased with frequency.  There was no 
difference in absorbance between males and females. There were small, albeit 
significant, differences between mean absorbance measures of right and left ears.  
 
 In a recent study, Silva et al. (2013) studied 77 neonates who passed TEOAE. 
At low frequencies (250 to 750 Hz) less energy absorbance was observed while at mid 
frequencies (1000 to 3000 Hz) greater energy absorption was observed. There was no 
significant difference between ears or between genders.  
 
 In addition, several studies have measured ASR including WBA and 
admittance (Feeney & Keefe, 2001; Feeney & Sanford, 2005). Keefe, Fitzpatrick, Liu, 
Sanford and Gorga (2010) studied wideband ASR in 455 ears of 230 infants aged one 
to two days passed or referred a DPOAE based NHS test. They found that an optimal 
combination of WBA and ASR tests performed better than either test alone in 
predicting NHS outcomes, and wideband tests performed better than 1000 Hz 
tympanometry.  
 
Overall, the above studies have provided evidence that WBA could be used to 
detect middle ear dysfunction and interpret screening results in neonates. However, a 
limitation of these studies is lack of an easily accessible tool to confirm presence of 
conductive hearing loss during the neonatal screening period (Hunter et al., 2013). 
Most studies circumvent this issue by using DPOAE as a gold standard measure to 
determine normal middle ear status in healthy neonates since it is already used in 
screening programs (Sangster, 2011).  Nonetheless, presence of OAE alone does not 
rule out effusion or abnormal pressure in the middle ear (Driscoll et al., 2000; Kemp, 
2002). Despite using DPOAE as a gold standard in their studies, Sanford et al. (2009) 
and Hunter et al. (2010) conceded that the presence of DPOAE alone could not be 
considered as a gold standard measure for middle ear function because DPOAEs may 
be present despite minor middle ear dysfunction. Use of OAE as a gold standard 
represents a significant shortcoming and limits the clinical applicability of WBA in 
neonates (Sangster, 2011). Therefore, further WBA research needs to consider more 
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robust gold standards such as composite of tests to assess the clinical effectiveness of 
WBA.   
1.9.1.6 Developmental trends in WBA.    
 Studies that have investigated developmental changes in the first few months 
of life have found higher absorbance at low and mid frequencies compared to adults 
but similar absorbance at high frequencies (Feeney & Sanford 2005; Keefe et al., 
1993; Werner et al., 2010).  Keefe et al. (1993) was the first to investigate the 
developmental effects of middle ear maturation on WBA measures.  They studied 
energy absorbance in 10 adults and 78 healthy infants aged 1 to 24 months across five 
age groups (1, 3, 6, 12 and 24 months) and found systematic changes in absorbance 
with increasing age.  Keefe et al. found that the middle ear compliance was lower and 
middle ear resistance higher in infants than in adults.  The researchers also found a 
significant effect of age below 1000 Hz with a decrease in absorbance from birth to 
about six months of age where WBA decreased by 30% with a smaller difference in 
the mid frequency range.  They attributed the age effect to power loss from flaccid 
canal wall motion apparent in newborns.  Werner et al. (2010) studied WBA in 174 
two to three month olds and 205 five to nine month olds. They found age related 
changes during infancy similar to that of Keefe et al. Werner et al. found that the 
absorbance was slightly higher in the left ear than the right ear. However, they did not 
find any gender differences.     
Sanford and Feeney (2008) reported power absorbance from 60 infants with 
20 each at 4, 12 and 27 weeks of age and found the results at ambient pressure 
condition to be consistent with Keefe et al. (1993).  Sanford and Feeney (2008) too 
found a 30% change in the mean energy absorbance for frequencies from 250 to 750 
Hz. The frequency region from 750 to 2000 Hz was reported to be a developmentally 
stable frequency range with few age related changes. Figure 1.4 compares WBA in 
infants at three age intervals across studies by Sanford and Feeney (2008) and Keefe 
et al (1993).  
In their study with five infants aged six weeks and three adults, Feeney and 
Sanford (2005) reported that significantly higher absorbance was observed at all 
frequencies for the infants compared to adults, and the difference was greatest in the 
low frequency region.  Contrary to the above findings, Hunter et al. (2008b) found no 
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significant age effect with respect to absorbance in their study population.  The 
investigators studied 159 ears from 81 children aged 3 days to 47 months and found 
no significant age effect across age groups from 250 to 8000 Hz except at 6000 Hz.  
Although some variability occurred across age groups, there was no apparent 
systematic effect and the 95 percent confidence intervals overlapped from birth to 
four years of age.  Merchant et al. (2010) studied 12 ears of seven healthy neonates 
and 19 ears of 11 one month old infants.  Except for a slight difference at 2000 Hz 
between neonates and one month olds, there was no difference in power absorbance 
between the two age groups and between males and females across all other 
frequencies.  There were small differences in some frequency bands between right and 
left ears.  Hunter et al. and Merchant et al. suggested that the reason they did not find 
developmental changes compared to other studies could be partly attributed to 
methodological differences including the age of subjects and differences in the 
equipment and probe tips.   
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Figure 1.4: Wideband absorbance of infants aged 1 to 6 months in studies by Sanford 
& Feeney (2008) and Keefe et al. (1993) 
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In a recent study, Shahnaz, Cai and Qi (2014) established normative WBA 
data in infants from birth to six months of age (Figure 1.5). Using a longitudinal 
paradigm, they also studied the time course and rate at which functional maturation of 
the middle ear occurs in 18 infants from birth through to six months of age.  They 
found that WBA decreased (closer to 0 at low frequencies (<400 Hz) and increased 
(closer to 1) at high frequencies (>2000 Hz) as a function of age. There was very little 
change in power absorbance from 600 to 1600 Hz across the first six months of life.  
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Figure 1.5 Mean absorbance as a function of frequency during six evaluations 
from birth to six months of age in a longitudinal study by Shahnaz et al. (2014) 
To sum up, investigators who have found developmental changes to WBA 
recommend the range of frequencies up to 2000 Hz as the frequency region of interest 
since infants have shown a significant difference in this frequency range (Hunter et 
al., 2010; Keefe et al., 1993; Sanford & Feeney, 2008).  Currently, normative data, 
especially for the first six months of life, has been limited, as the age range covered 
by several studies beyond the newborn period is restricted.  In addition, there has been 
no agreement regarding the developmental changes in WBA. This lack of agreement 
can partly be attributed to the methodological differences including the different age 
groups and equipment across the studies.  Due to significant developmental changes 
during early infancy, there is a need to include infants at various age intervals in order 
to more closely describe developmental effects on the outer and middle ear (Sanford 
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& Feeney, 2008). Age-graded norms are essential to the successful clinical application 
of WBA measures, especially in the period from newborn to one year of age (Hunter 
et al., 2013).  
1.9.2 Measuring WBA under tympanometric pressure conditions  
A more complicated procedure, known as wideband tympanometry (WBT), 
measures WBA as the pressure in the ear canal is varied.  In this procedure, clicks are 
presented to the ear canal and WBA is measured across the frequency range from 250 
to 8000 Hz when the ear canal pressure is varied from +200 to -300 daPa.  Figure 1.6 
shows the typical wideband tympanometric pattern with a three-dimensional 
representation of absorbance plotted as a function of pressure and frequency.   
 
 
 
Figure 1.6:  Wideband tympanometric plot from left ear of a 7-year-old child 
Research has shown WBT to be equally or more sensitive to middle ear 
dysfunction compared to WBA measured under ambient pressure conditions (Beers et 
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al., 2010; Ellison et al., 2012; Keefe et al., 2012; Keefe & Simmons, 2003; Margolis 
et al, 1999; Sanford et al., 2009).  Margolis et al (1999) obtained WBT results from 20 
adults and demonstrated that WBT pattern progressed in an orderly fashion as 
frequency increased from 2000 to 11000 Hz. They suggested that WBT can be a 
useful clinical measure since it is sensitive to middle ear dysfunction and 
demonstrates systematic variation across a wide frequency range.  
 The test performance of WBT during assessment of middle ear status in 
children and adults is reported to be either similar or higher than WBA at ambient 
pressure (Margolis et al., 1999; Keefe & Simmons, 2003; Keefe et al., 2012; Sanford, 
Hunter, Feeney & Nakajima, 2013). For instance, Margolis et al (1999) compared 
absorbance results obtained from a 10-year-old boy with recurrent OM under ambient 
pressure and pressurised conditions. Surprisingly, they found normal results obtained 
under ambient pressure, but abnormal WBT results. Keefe and Simmons (2003) 
evaluated the test performance of WAI under ambient and pressurised conditions and 
226 Hz tympanometry in predicting the presence of conductive hearing loss, based on 
an air-bone gap of ≥20 dB in 42 normal ears and 18 ears with conductive or mixed 
hearing loss. Results showed an AROC of 0.28 for 226 Hz tympanometry, 0.72 for 
ambient wideband absorbance and 0.94 for WBT.  
Keefe et al. (2012) evaluated the test performance of absorbance under 
ambient and pressurised conditions and 226 Hz tympanometry in terms of their ability 
to predict conductive hearing loss in 25 children (36 ears) aged 3.5 to 8.2 years with 
23 children (44 ears) aged 2.6 to 8.2 years serving as normal controls. They found that 
both absorbance tests accurately predicted the presence of conductive hearing loss in 
children, and each was a better predictor of conductive hearing loss than conventional 
226 Hz tympanometry. There was no significant difference between the accuracy of 
ambient and pressurised absorbance measures in detecting conductive hearing loss. 
Ears with conductive hearing loss had reduced absorbance at frequencies between 700 
and 8000 Hz.  
Although the effects of ear canal pressure on absorbance in adults (Margolis et 
al.,1999) and infants (Sanford & Feeney, 2008) are well understood, there is less 
understanding regarding the effects of introducing ear canal pressure in neonate and 
young infants (Feeney & Sanford, 2012). Neonatal studies have often measured WAI 
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under ambient pressure conditions (Keefe et al, 2000; Shahnaz, 2008; Sanford et al, 
2009; Hunter et al, 2010; Merchant et al, 2010; Prieve et al, 2013).  To date, only one 
study by Sanford et al. (2009) has investigated WBT in neonates. Sanford et al. (2009) 
evaluated test performance of ambient and tympanometric measures and 1000 Hz 
tympanometry in relation to outcomes of distortion product otoacoustic emission 
(DPOAE) in 455 neonate ears (375 passed, 80 referred). Sanford et al. measured log 
likelihood ratios of the WAI measures to indicate whether a response from an 
individual ear was from either the pass or refer group. The highest areas under the 
curves were 0.87 for ambient WAI test, and 0.84 for WBT compared with 0.75 for 
1000 Hz tympanometry 
Sanford and Feeney (2008) investigated WBT measurements at varying static 
ear canal pressures in 4-, 12- and 24- week-old infants and young adults and found 
developmental changes in WBT measures that varied as a function of frequency. 
There was as much as a 30% change in mean absorbance at frequencies from 250 to 
750 Hz with changes in static ear canal pressure from +200 to -200 daPa.  Minimal 
developmental differences in absorbance were observed at frequencies from 750 to 
2000 Hz with changes in ear canal pressure suggesting a developmentally stable 
frequency range. A high frequency effect between 2000 and 6000 Hz was observed 
only in 4-week old infants wherein negative pressures caused decreased absorbance 
and positive pressures caused increased absorbance.  Sanford and Feeney suggested 
that some of the age related effects of pressure on absorbance may be the result of 
more compliant ear canal walls or less rigid coupling of the ossicles which became 
more resistant to changes in pressure with age.   
In view of the potentially useful diagnostic information provided by WBT in 
the evaluation of middle ear status in children and adults, WBT could be explored as a 
technique specifically in neonates and young infants where there is a need for 
improved assessment techniques of middle ear function (Sanford et al., 2013).  
 
1.9.3 WBA findings in ears with conductive hearing loss and middle ear 
pathology. 
In the last decade, WBA has been used to assess middle ear pathology in 
children and adults.  WBA measurements have been reported in infants and children 
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with OME (Beers et al., 2010; Ellison et al., 2012; Hunter et al., 2008a; Jeng et al., 
1999; Margolis et al., 2000), as well as in adults with otosclerosis, ossicular 
discontinuity and perforation of the tympanic membrane (Allen et al., 2005; Feeney et 
al., 2003; Shahnaz et al., 2009), and in older children and adults with conductive 
hearing loss (Keefe et al., 2012; Keefe & Simmons, 2003; Piskorski et al., 1999).   
 
Keefe and Simmons (2003) studied the test performance of WBA and 226 Hz 
tympanometry in predicting the presence of conductive hearing loss based on an ABG 
of 20 dB or more.  Subjects included adults and children of age 10 years and older 
with 42 normal functioning ears and 18 ears with a conductive hearing loss.  They 
found that the absorbance from a conductive impaired ear differed markedly from that 
of a normal ear. The absorbance of a conductive impaired ear had lower values with 
increasing frequency compared to a normal ear. The absorbance value in a conductive 
loss ear rarely exceeded 0.4, while in a normal ear, the absorbance value was 
approximately 0.9 at the 3000 Hz region. Low absorbance was associated with low 
transfer of energy into the middle ear and, thus, was consistent with a conductive 
hearing loss. Comparing tests at a fixed specificity of 0.90, the sensitivity was 0.28 for 
the static admittance at 226 Hz and 0.72 for the ambient pressure WBA measure. 
Keefe and Simmons concluded that the ambient pressure WBA measure had sufficient 
accuracy to be utilised in hearing screening applications. This is in agreement with the 
findings of  Piskorski et al. (1999) who found that a multivariate analysis of 
admittance-absorbance responses yielded an output that successfully predicted the 
presence of conductive hearing losses with AROC values as large as 0.97.  When the 
multivariate test performance was assessed at a fixed sensitivity of 0.9, the specificity 
was as high as 0.94.     
 
In a sample of 97 children ranging from 3 days to 47 months, Hunter et al. 
(2008b) demonstrated a significant difference in WBA measures in ears clinically 
defined as having poor ear status (i.e., OME) that was determined by the combined 
test algorithm of otoscopy, tympanometry and DPOAE.  They found that the poor ears 
had decreased absorbance in the frequency range of 1000 to 4000 Hz compared to 
normal ears.  Jeng et al. (1999) studied three children with OME and reported that 
ears with OME showed dramatically less power absorption at all frequencies and 
close to zero absorption  below 1000 Hz.  Although, there was a substantial increase 
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in the power absorption above 1000 Hz, the peak absorption was still less than that of 
normal ears. The largest difference between the normal ears and ears with OME 
occurred in the region between 1000 to 2500 Hz.      
 
Hunter et al. (2008a) found that the average WBA in infants and children with 
cleft lip and palate was substantially lower than the normative sample between 1000 
and 4000 Hz.  The largest difference occurred at about 2000 Hz where the absorbance 
averaged 77% in healthy children, compared to 0% in children with cleft palate.  
Pneumatic otoscopy, conventional low frequency tympanometry and 1000 Hz 
tympanometry findings were abnormal, respectively in 58%, 67% and 73% of 34 ears 
from 17 children with cleft palate.  In contrast, OAE and WBA findings were 
abnormal in 88 and 82% of the ears, respectively.  The overall agreement between the 
OAE and 1000 Hz tympanometry results was 80%, while the overall agreement 
between the OAE and WBA results was 88% (Hunter et al., 2008a).  WBA, thus, 
holds promise as an effective tool in detecting middle ear problems in this population.  
 
 Ellison et al. (2012) compared the accuracy of WBA to the current clinical 
guidelines of using pneumatic otoscopy to diagnose MEE. WBA measures were 
obtained in 53 ears of 44 children prior to confirmation of MEE via myringotomy as 
the gold standard. These results were compared to an age matched normative group of 
59 ears of 44 healthy children serving as controls. The results showed that absorbance 
was reduced in ears with MEE compared to the control group especially between 800 
and 2000 Hz. Absorbance varied systematically with TM mobility based on data from 
pneumatic otoscopy. The authors concluded that absorbance was sensitive to middle 
ear stiffness and MEE and that WBA predictions of MEE are as accurate as those 
reported for pneumatic otoscopy. In comparison, Prieve et al. (2013) studied WBA, 
high frequency tympanometry using 678 and 1000 Hz tones, and air and bone 
conduction ABR in 84 ears from 70 infants with a median age of 10 weeks. They 
found that conductive hearing loss could be accurately detected using WBA, 678 Hz 
and 1000 Hz tympanometry. Keefe et al. (2013) studied WBA under ambient and 
pressurized conditions in 26 children without conductive hearing loss (control group) 
and 24 children with conductive hearing loss (experimental group). They found that 
absorbance was lower at frequencies above 700 Hz in the conductive hearing loss 
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group than the control group. WBA in both ambient and tympanometric tests were 
significantly better predictors of conductive hearing loss than 226 Hz tympanometry.  
In summary, the above studies have shown that WBA is well suited to assess 
conductive conditions in infants and children. Since the WBA is able to assess the 
conductive pathway (outer and middle ear) independent of the inner ear status, it 
could be utilised along with hearing screening tools (e.g., AABR) to differentiate 
conductive from sensorineural hearing loss in young infants.    
1.9.4 WBA in UNHS programs. 
As the WBA provides reliable information on middle ear function in young 
infants, it could be a useful tool in UNHS programs.  Keefe et al. (2003b) performed a 
retrospective analysis of DPOAE, TEOAE, ABR and WBA in 2766 ears. Analysis of 
results revealed that the high frequency absorbance was the most important factor in 
classifying DPOAE. The odds ratio for high frequency absorbance was 2.44 (95% CI 
2.09 – 2.86), suggesting that ears with reduced absorbance in the high frequencies had 
a higher likelihood for middle ear dysfunction. Keefe, Gorga, Neeley, Zhao and Vohr 
(2003a) further examined if WBA could be added to a screening battery to improve 
the prediction of sensorineural hearing loss as later assessed by behavioural 
audiometry at eight to 12 months of age. They found that WBA and OAE variables 
combined were better at predicting outcomes than OAE alone. This suggested that 
inclusion of WBA measures improved prediction of sensorineural hearing loss with 
DPOAE measurements. High frequency absorbance was the best predictor of middle 
ear function with an AROC of 0.86 in classifying normally hearing ears as having 
normal middle ear function and those that fail both tests as having middle ear 
dysfunction. Inclusion of WBA in to the model, revealed that of the 51 of 1027 ears 
that failed two stage DPOAE and ABR screening, 40 ears had middle ear dysfunction, 
thereby reducing false positives from 5% to 1.1%. Therefore, the researchers 
concluded that inclusion of WBA in addition to OAE could enhance the ability to 
predict hearing status and improve the accuracy of newborn hearing screening 
programs.  
 
Sanford et al. (2009) investigated WBA in 455 neonate ears in a UNHS 
program using DPOAE as a screening tool. They found that the 375 ears that passed 
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the DPOAE test had higher absorbance than the 80 ears that were referred, indicating 
that neonates who passed DPOAE had a more acoustically efficient conductive 
pathway.  Sanford et al. also found that WBA had better performance in classifying 
DPOAE outcomes than 1000 Hz tympanometry.  Using DPOAE as a reference 
standard, Sanford and colleagues found that the greatest AROC value was 0.87 for 
WBA and 0.75 for 1000 Hz tympanometry.  They concluded that WBA results in ears 
that were referred from UNHS were related to transient conditions affecting the sound 
conduction pathway and that WBA is sufficiently objective, quick, and feasible to 
consider implementing in conjunction with the UNHS program.  
 
Hunter et al. (2010) reported WBA data in a newborn hearing screening 
population and compared WBA test performance with 1000 Hz tympanometry for 
predicting DPOAE screening outcome in 324 infants.  Hunter et al. showed that WBA 
measured in a frequency region around 2000 Hz provided the best prediction of 
DPOAE outcomes and that WBA produced better prediction of DPOAE status than 
1000 Hz tympanometry.  The authors also observed that WBA improved significantly 
during the first four days after birth with normalization of middle ear function. They 
recommended that neonates with low absorbance scores during the first screen should 
be rescreened within a few hours to a few days, because most transient conductive 
conditions may resolve spontaneously.  If absorbance and OAE are not passed upon 
second screening, they suggested referral to an otologist for ear examination along 
with diagnostic testing. They further suggested that neonates who failed in both WBA 
and OAE should be referred to an otologist for ear examination along with diagnostic 
testing, while neonates who passed WBA but failed OAE should be referred 
immediately to an audiologist for diagnostic testing with threshold auditory brainstem 
response because of higher risk of permanent hearing loss.  
 
Although the above mentioned studies compared WBA with OAE results, 
OAE may not be an ideal reference standard because OAEs may be present despite 
minor middle ear dysfunction (Hunter et al., 2010; Kemp, 2002; Sanford et al., 2009). 
This may call for further WBA research using a stronger reference standard, such as a 
combination of diagnostic measures to separate healthy ears from ears with a 
conductive condition.  
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1.9.5 Reliability of WBA. 
As WBA is an emerging technology, its reliability needs to be ascertained 
before it can be used as a clinical tool with infants.  Studies evaluating test-retest 
reliability of WBA in infants have reported good reliability (Hunter et al., 2008a; 
Shahnaz et al., 2014; Vander Werff et al., 2007).  In the study by Vander Werff et al. 
(2007), test-retest reliability of the WBA measure obtained from an infant group (N = 
61) receiving outpatient hearing screenings (mean age = 7.6 weeks, SD=5.3) was 
compared to that obtained from another infant group (N = 66) receiving outpatient 
diagnostic assessments (mean age = 12.4 weeks, SD= 8.5 weeks).  Better test-retest 
reliability was reported for the diagnostic than for the screening group.  The 
difference in reliability was attributed to decreased noise in the testing environment 
for the diagnostic group. Hunter et al. (2008a), in their study of infants with 
unrepaired cleft lip and palate, found substantial reliability of repeat measures of 
WBA within the same test session even after removal and reinsertion of the probe tip.  
They also found that the reliability results were equivalent irrespective of the type of 
stimuli (broadband chirps and specific sine waves) used for the WBA measure.  
 
Despite its high test-retest reliability, a potential limitation of WBA appears to 
be the variability of WBA results. Hunter et al. (2008b) reported a high degree of 
variability in WBA in healthy ears and ears with OME.  They attributed the sources of 
variance to the internal noise in the ear canal, ambient noise in the test room, depth of 
insertion of the probe tip, probe seal and calibration of the probe.  In fact, several 
studies have highlighted the importance of a leak-proof seal in order to obtain 
accurate measurements and avoid variability in the results (Hunter et al., 2008a; Keefe 
et al., 2000; Vander Werff et al., 2007).   
 
1.10 Rationale for the Study  
1.10.1 Synopsis. 
False positive referrals due to outer and middle ear dysfunction continue to be 
an issue with the newborn hearing screening programs.  In order to reduce the false 
positive referrals, prioritise infants for testing and alleviate parental anxiety, a reliable 
and objective measure that assesses the outer and middle ear system of infants at the 
time of screening is warranted.  WBA holds promise as an objective tool for the 
assessment of conductive conditions in neonates and young infants. It has been 
    48 
recommended for use along with screening tools in UNHS programs. Before WBA 
can be used as a clinical tool with screening or diagnostic evaluation, normative data 
need to be developed and the test performance must be evaluated against stringent 
reference standards. Currently, there is limited research in the application of WBA to 
infants in Australia.  Further Australian studies using WBA in infants are required in 
view of the high prevalence of OM in Australian Aboriginal infants.  
 
1.10.2 Justification for conducting the present study. 
A review of the literature has identified some issues regarding the use of WBA 
with neonates and young infants. The present study seeks to address five of these 
issues.   First, although newborn hearing screening programs have been introduced in 
Australia for more than a decade, there are no reports on the false positive rates as 
well as prevalence of conductive hearing loss in the young infant population. It is 
important to determine the prevalence of conductive hearing loss in both Australian 
Aboriginal and non-Aboriginal infants referred from screening programs to determine 
if there is a need for an adjunct tool for middle ear assessment in this population.  
 
 Second, the WBA is reported to have advantage over other measures of 
middle ear assessment in infants (Keefe et al., 2000). Recent studies have shown that 
WBA measures perform better in classifying the DPOAE outcomes at birth than 1000 
Hz tympanometry (Hunter et al., 2010; Sanford et al., 2009).  Due to its ability to 
assess the outer and middle ear independent of the inner ear, it is also suggested as a 
feasible tool to be used in conjunction with UNHS programs (Keefe et al., 2003a; 
Sanford et al., 2009). To date, WBA has been described in infants who were assessed 
by DPOAEs only (Hunter et al., 2010; Merchant et al., 2010; Sanford et al., 2009). 
However, DPOAE may not identify minor or sub-clinical middle ear pathologies 
(Kemp, 2002) and hence may not be an ideal gold standard (Hunter et al., 2010; 
Sanford et al., 2009). While a single measure such as DPOAE or 1000 Hz 
tympanometry may not be sensitive to subtle middle ear dysfunction, a test battery 
may provide a robust measure of middle ear function to evaluate the WBA. 
Nevertheless, normative WBA data based on a set of clinical tests including TEOAEs 
and 1000 Hz tympanometry have not been investigated.  The present study will 
develop normative WBA measures in healthy neonates that pass a battery of tests that 
includes AABR, 1000 Hz tympanometry, acoustic stapedial reflex, TEOAE and 
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DPOAE. A strict gold standard would reduce the possibility of mild or sub-clinical 
middle ear conditions being included in the normative population.  
 
Third, the test performance of WBA in assessing the conductive pathway in 
neonates and young infants was found to be higher than that of 1000 Hz 
tympanometry (Hunter et al., 2010; Merchant et al., 2010; Sanford et al., 2009). 
However, the use of DPOAE as a reference standard did not yield optimal results. 
This represents a significant shortcoming in the evaluation of WBA, and limits its 
clinical applicability (Sangster, 2011). Since there is no easily accessible and accurate 
tool to detect conductive hearing loss during the neonatal screening period, an 
alternate, albeit less strict, reference standard would be a composite reference standard 
involving a battery of tests (Mazlan & Kei, 2012). Nevertheless, an important research 
question is to determine if the test performance of WBA varies with the choice of a 
single test (such as DPOAE or HFT) or composite test battery reference standard. The 
present study seeks to evaluate the test performance of WBA against seven reference 
standards consisting of single tests and composite test batteries including AABR, 
HFT, TEOAE and DPOAE in an attempt to determine whether WBA can provide a 
more effective alternate to either single tests or a combination of tests for determining 
the outer and middle ear status in neonates.  
 
Fourth, despite the high prevalence of OM in Aboriginal children, there is a 
lack of studies on assessing the function of their outer and middle ears at birth.  Early 
diagnosis and early intervention of middle ear disease are imperative. Surprisingly, 
there have been only three studies by Boswell and Nienhuys (1995, 1996) and 
Lehmann et al. (2008) that have reported otoscopy, 220 Hz tympanometry and 
TEOAE findings in Aboriginal and Caucasian neonates from birth to two years of 
age. Nevertheless, these studies have not studied neonates in their first few days of 
life. Additionally, otoscopy, 220 Hz tympanometry and TEOAE are not sensitive to 
detecting conductive conditions in neonates and young infants. To date, there have 
been no studies using 1000 Hz tympanometry or WBA with this young population.  
The present study is designed to study middle ear function using WBA along with 
other measures, such as OAE and 1000 Hz tympanometry, in both Aboriginal and 
Caucasian  neonates.   
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Fifth, if WBA is to be used as a valid clinical tool of outer and middle ear 
assessment in young infants, developmental variations of WBA need to be described. 
To date, there has been only one longitudinal study by Shahnaz et al. (2014) that has 
tracked the developmental WBA pattern during early infancy.  However, earlier 
studies have assessed infants across a wide age range. Hence, age-specific norms are 
not readily available.  In addition, the results of studies on the effect of age on WBA 
in the first few months of life have been equivocal (Hunter et al., 2008a; Keefe et al., 
1993; Merchant et al., 2010).  Thus, more research is needed to obtain age-dependent 
norms and determine the developmental trends of WBA at regular intervals during the 
first six months of life.  The present study will measure WBA in infants at birth and at 
1, 2, 4, and 6 months of age to track developmental changes during this fast growing 
period. 
 
1.11 Aims of the Current Investigation 
 The current investigation aimed to:  
(1) Evaluate the prevalence of conductive hearing loss and middle ear pathology in 
infants referred by a NHS program in Australia and compare the prevalence rates 
of conductive conditions in Aboriginal and non-Aboriginal infants (see chapter 
2).  
(2) Obtain normative WBA data in healthy neonates who pass a combination of tests 
including AABR, HFT, ASR, TEOAE and DPOAE (see chapter 3). 
(3) Compare test performance of WBA using individual measures such as AABR, 
HFT, TEOAE or DPOAE and a combination of tests (e.g., HFT+DPOAE) to 
determine whether WBA can provide an effective alternate to either single test or 
test battery (composite) reference standards for determining the outer and middle 
ear status in neonates (see chapter 4).  
(4) Compare WBA measures obtained from healthy Aboriginal neonates with that 
obtained from non-Aboriginal neonates (see chapter 5). 
(5)  Conduct a cross-sectional study on a sample of normal infants to determine the 
developmental trend of WBA results at birth and at 1, 2, 4 and 6 months of age 
(see chapter 6). 
 
To achieve these aims, the following studies were conducted: 
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(1) “Conductive hearing loss and middle ear pathology in young infants referred 
through newborn universal hearing screening program in Australia” (chapter 2).  
(2) “Normative wideband reflectance measures in healthy neonates” (chapter 3).  
(3) “Wideband absorbance outcomes in neonates: A comparison with high frequency 
tympanometry, automated auditory brainstem response, transient evoked and 
distortion product otoacoustic emissions’ (chapter 4).   
(4) “Wideband absorbance in Australian Aboriginal and Caucasian neonates” (chapter 
5).     
(5) “Wideband absorbance in young infants (0-6 months): A cross-sectional study” 
(chapter 6).  
 
1.12 Major Hypotheses of the Present Investigation 
This thesis contains four null hypotheses to be tested. They are: 
 
HO1: There will be no significant difference in the prevalence of conductive hearing 
loss between Aboriginal and Caucasian infants who are referred for diagnostic 
evaluation through a NHS program.  
HO2: There will be no significant difference in the test performance of WBA between 
single tests and test battery reference standards.   
HO3: There will be no significant difference in WBA results between Aboriginal and 
Caucasian neonates.  
HO4:   There will be no significant age effects on WBA results obtained from infants 
aged 0- to six months.  
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Chapter Two: Conductive Hearing Loss And Middle 
Ear Pathology In Young Infants Referred Through 
Newborn Universal Hearing Screening Program In 
Australia 
 
2.1 Background 
Although newborn hearing screening programs have been introduced in 
Australia across all states and territories, there is no data on the prevalence of 
conductive hearing loss in young infants.  Australian Aboriginal children have a high 
prevalence of conductive hearing loss and middle ear dysfunction that starts from a 
young age. However, there are no published studies that have documented the 
prevalence of conductive hearing loss and middle ear dysfunction in Australian and 
non-Aboriginal infants referred through newborn hearing screening.  
Chapter Two provides an account of the conductive disorders in infants 
referred through a newborn universal hearing screening program in Australia. A 
retrospective hospital chart review was conducted to analyse the diagnostic test results 
of infants referred through newborn hearing screening program in north Queensland. 
In this study, the prevalence of conductive hearing loss in Aboriginal and non-
Aboriginal infants are compared.  
Chapter Two of this thesis, entitled, “Conductive hearing loss and middle ear 
pathology in young infants referred through a newborn universal hearing screening 
program in Australia” has been published in the Journal of the American Academy of 
Audiology. This published article is inserted into this thesis with minor modifications. 
In particular, the formatting of section sub-headings has been modified from the 
original publication to match the thesis format.  
 
Aithal, S., Aithal, V., Kei, J., & Driscoll, C. (2012). Conductive hearing loss 
and middle ear pathology in young infants referred through a newborn universal 
hearing screening program in Australia. Journal of the American Academy of 
Audiology 23: 673-685. 
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2.2 Abstract  
Background: Although newborn hearing screening programs have been introduced in 
most states in Australia, the prevalence of conductive hearing loss and middle ear 
pathology in the infants referred through these programs is not known. 
Purpose: This study was designed to (1) evaluate the prevalence of conductive hearing 
loss and middle ear pathology in infants referred by a newborn hearing screening 
program in north Queensland, (2) compare prevalence rates of conductive hearing loss 
and middle ear pathology in indigenous and nonindigenous infants, and (3) review the 
outcomes of those infants diagnosed with conductive hearing loss and middle ear 
pathology. 
Research Design: Retrospective chart review of infants referred to the Audiology 
Department of The Townsville Hospital was conducted. 
Study Sample: Chart review of 234 infants referred for one or both ears from a 
newborn hearing screening program in north Queensland was conducted. A total of 
211 infants attended the diagnostic appointment. Review appointments to monitor 
hearing status were completed for 46 infants with middle ear pathology or conductive 
hearing loss. 
Data Collection and Analysis: Diagnosis of hearing impairment was made using an 
age-appropriate battery of audiological tests. Results were analysed for both initial 
and review appointments. 
Results: Mean age at initial diagnostic assessment was 47.5 days (SD 31.3). Of the 69 
infants with middle ear pathology during initial diagnostic assessment, 18 had middle 
ear pathology with normal hearing, 47 had conductive hearing loss, and 4 had mixed 
hearing loss. Prevalence of conductive hearing loss in the newborns was 2.97 per 
1,000 while prevalence of middle ear pathology (with or without conductive hearing 
loss) was 4.36 per 1,000. Indigenous Australians or Aboriginal and Torres Strait 
Islander (ATSI) infants had a significantly higher prevalence of conductive hearing 
loss and middle ear pathology than non-ATSI infants (35.19 and 44.45% vs 17.83 and 
28.66%, respectively). ATSI infants also showed poor resolution of conductive 
hearing loss over time with 66.67% of ATSI infants reviewed showing persistent 
conductive hearing loss compared to 17.86% of non-ATSI infants. Medical 
management of 17 infants with persistent conductive hearing loss included 
monitoring, antibiotic treatment, examination under anesthesia, and grommet 
insertion. 
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Conclusions: Conductive hearing loss was found to be a common diagnosis among 
infants referred through screening. ATSI infants had significantly higher rates of 
middle ear pathology and conductive hearing loss at birth and showed poor resolution 
of middle ear pathology over time compared to non-ATSI infants. Future research 
using a direct measure of middle ear function as an adjunct to the automated auditory 
brainstem response screening tool to distinguish conductive from sensorineural 
hearing loss may facilitate prioritization of infants for assessment, thus reducing 
parental anxiety and streamlining the management strategies for the respective types 
of hearing loss. 
 
 Key words: newborn hearing screening, middle ear pathology, conductive hearing 
loss, neonates, indigenous 
 
2.3 Introduction   
   Universal newborn hearing screening programs are becoming standard 
practice in Australia and internationally. Most often and, perhaps, rightly so, high 
priority is given to early identification and intervention of permanent hearing loss. 
However, congenital conductive hearing losses (which may be transient or long-
standing) are treated as false positive outcomes: a by-product of the screening 
program. 
 
  Conductive hearing loss due to middle ear pathology appears to be common in 
neonates as studies have reported conductive disorders to be roughly 30 times greater 
than that of inner ear pathologies in infants (Gorga et al, 2001; Allen et al, 2005).  
White et al (1993) reported that 17 of 1,000 well infants and 36 of 1,000 infants who 
had been in the newborn intensive care unit had conductive hearing loss. Boone et al 
(2005) have pointed out that otitis media with effusion may contribute up to 67% of 
the false positive newborn hearing screens.  Amniotic fluid contents aspirated into the 
middle ear have been reported to contribute to conductive hearing loss in neonates 
(deSa, 1977; Eavey, 1993; Northrop et al, 1999).   
 
  The only definitive tests for the presence of middle ear effusion (MEE) are 
myringotomy or imaging studies such as computed tomography; however, neither of 
these is practical or ethical for the evaluation of infants. Identification of MEE using 
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otoscopy is not a reliable method in neonates due to difficulties in visualising and 
interpreting the tympanic membrane (McLennan and Webb, 1957; Zarnoch and 
Balkany, 1978; Marchant et al, 1984; Eavey, 1993; Doyle et al, 1997; Rhodes et al., 
1999).  Although otomicroscopy is reported to improve the accuracy of diagnosing 
otitis media in children (Young et al, 2009; Lee, 2010), it needs to be performed by 
specialist otolaryngologists and often requires sedation or anaesthetisation of the 
child.  
 
  Apart from AC and BC ABR test, there are no clinically validated tests for 
diagnosing middle ear dysfunction in infants younger than 6 months (Hunter and 
Margolis, 1992; Keefe et al, 2003). Conventional 226 Hz tympanometry is not 
effective in detecting MEE in infants (Paradise et al, 1976; Rhodes et al, 1999). 
Instead, 1,000 Hz probe-tone tympanometry is recommended with infants under 6 mo 
of age since this higher frequency appears to be more sensitive than 226 and 600 Hz 
probe tones for detecting MEE in this age range (Paradise, 1976; Hunter and 
Margolis, 1992; McKinley et al, 1997; Kei et al, 2003; Margolis et al, 2003).  
However, a test battery approach is often used to diagnose middle ear dysfunction in 
infants younger than 6 mo. Studies have suggested the presence of strong transient 
evoked otoacoustic emissions (TEOAEs) in conjunction with 1,000 Hz tympanometry 
to be indicative of normal middle ear functioning (Sutton et al, 1996; Kei et al, 2003). 
Using a combination of otoscopy, acoustic reflex measurements and tympanometry in 
68 full term neonates, Roberts et al (1995) reported MEE to be present in all the 
babies in the first 3 hr of life. By the third day, MEE had resolved in 73% of ears by 
otoscopy, 88% by acoustic reflex measurements and 92% by tympanometry. Boone et 
al (2005) used a combination of otoscopy, auditory brainstem response (ABR) and 
otoacoustic emission (OAE) testing and found that MEE was identified in 64.5% of 
76 neonates referred for diagnostic evaluation following referral from newborn 
hearing screening. 
 
  An extraordinary high prevalence of ear disease and hearing impairment 
among Australian Aboriginal children has been well documented by several cross-
sectional studies (Clements, 1968; Dugdale et al, 1978; McCafferty et al, 1985; 
Foreman, 1987; Kelly and Weeks, 1991; Clarke, 1992; Nienhuys et al, 1994).  Several 
prospective otoscopic and audiological studies of young Aboriginal infants too have 
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shown a very high prevalence of otitis media ranging from 67 to 95% by 12 mo of age 
(Douglas and Powers, 1989; Rebgetz et al, 1989; Boswell et al, 1993; Boswell and 
Nienhuys, 1995). Despite this high prevalence of ear disease, there is only one 
audiological study (Boswell et al, 1993) and a handful of microbiological studies 
(Leach et al, 1994; Morris et al, 2009) that document the natural history of MEE and 
conductive hearing loss from birth in Aboriginal infants. 
 
  While statistical data on congenital sensorineural hearing loss in Australian 
newborns are available (Upfold and Ispey, 1982; Davis et al, 1997; Mehl and 
Thomson, 1998; Bailey et al, 2002; Australian Hearing, 2005),   there are no 
published studies on the prevalence and natural history of conductive hearing loss in 
neonates despite the introduction of newborn hearing screening programs across the 
country. The state of Queensland in Australia offers hearing screening using 
automated ABR (AABR) for all newborns. This program, called Healthy Hearing, 
began as a pilot project in three tertiary hospitals in October 2004 and has now 
become a state-wide program that covers all tertiary and regional hospitals and home 
births. Despite the successful rollout of the program across the state, there are, as yet, 
no published data on the prevalence and course of conductive hearing loss and middle 
ear pathology in infants referred for diagnostic assessment through this program. 
 
  The objectives of the present study were to (i) evaluate the prevalence of 
conductive hearing loss and middle ear pathology in infants referred by a newborn 
hearing screening program in north Queensland, Australia (ii) compare prevalence 
rates of conductive hearing loss and middle ear pathology in indigenous and non-
indigenous infants and (iii) review the outcomes of those infants diagnosed with 
conductive hearing loss and middle ear pathology. 
 
2.4 Method 
2.4.1 Subjects 
  Under the Healthy Hearing Program, a total of 15,824 infants were screened 
during the period from August 2004 to March 2009. Of these infants, 1,836 (11.6%) 
were indigenous Australians or Aboriginal and Torres Strait Islanders (ATSI), 13,830 
(87.40%) were nonindigenous Australians or non-ATSI and 158 (1.0%) were of 
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unknown ethnic background. The mean age of infants at the time of screening was 
23.9 days (SD = 23.64, range = 0.96 days).  
 
  The Audiology Department at the Townsville Hospital serves as a tertiary 
referral centre for the diagnostic assessment of infants referred through newborn 
hearing screening in north Queensland. A total of 234 infants (63 ATSI and 171 non-
ATSI) who did not pass the two tier AABR screening in either one or both ears were 
referred for diagnostic audiology assessment between August 2004 and March 2009. 
A retrospective hospital chart review of the medical records was performed by an 
experienced paediatric audiologist for these 234 infants. This study is a part of a major 
project on identification of middle ear pathology in infants for which chart review was 
performed as part of a quality assessment audit of the state-wide hearing screening 
program. Ethical clearance was obtained from the Townsville Health Service District 
Institutional Ethics Committee.  
 
2.4.2 Procedure 
2.4.2.1 Initial diagnostic assessment. 
  Figure 2.1 depicts the flow chart for diagnostic and review audiology 
assessments as per the Healthy Hearing program protocol (Keogh and Beahan, 2009).  
A battery of audiological tests as per the program protocol was administered by an 
experienced paediatric audiologist in a quiet non-sound treated room. The minimum 
test battery included 1,000 Hz probe-tone tympanometry, TEOAEs and click-evoked 
ABR audiometry. Other audiological tests that were not part of the minimum test 
battery were not routinely performed but were administered as required to obtain 
further information on the type and degree of hearing loss. The ambient noise level as 
measured using a sound level meter (SdB 01) ranged from 33 to 45 dB A.  
 
The infant was considered to have functionally normal hearing with normal 
middle ear function if results of all the assessments (tympanometry, TEOAEs, and 
click ABR) were normal in both ears and was subsequently discharged from the 
program.   If an infant was found to have hearing loss or middle ear pathology with 
normal hearing in one or both ears, another appointment was organised within 7 to 10 
days to confirm the findings. In addition to the minimum test battery described above, 
auditory steady state response (ASSR), 1,000 Hz tone burst ABR and bone 
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conduction ABR were performed as required. Following the confirmation of hearing 
loss, infants with sensorineural and mixed hearing loss were referred for 
amplification, medical investigation and early intervention services.   
 
2.4.2.2 Review Assessment. 
 Infants diagnosed with middle ear pathology and normal hearing, or with 
conductive hearing loss or indeterminate hearing loss were referred for review 
assessment in 6-8 weeks’ time. This study did not follow the outcomes of those with 
indeterminate hearing loss. During this review, each infant underwent a test battery of 
1,000 Hz or 226 Hz tympanometry depending on the age, TEOAEs, and click ABR. If 
hearing loss was found, further assessments using 1,000 Hz tone burst ABR, ASSR, 
bone conduction ABR and/or visual reinforcement audiometry (VRA) were 
performed. The same paediatric audiologist carried out both initial and review 
assessments using the following diagnostic tests. 
 
2.4.3 Diagnostic tests 
2.4.3.1. Tympanometry. 
  Tympanometry was performed using a GSI Tympstar middle ear analyser. 
Tympanograms were obtained using a 1,000 Hz probe tone with the pressure varying 
from 200 daPa to -400 daPa. The pass criteria were repeatable single or notched 
admittance peaks with compliance ≥ 0.3 mmho and middle ear pressure around 0 
daPa (Keogh and Beahan, 2009).   Additionally, a 226 Hz probe tone was used when 
the infants were 6 mo of age or older. The pass criteria were a type A tympanogram as 
per Jerger’s (1970) classification system, with middle ear compliance ≥ 0.3 ml and 
middle ear pressure between +50 and -150 daPa in both ears (Alaerts et al, 2007).   
 
2.4.3.2 Transient Evoked Otoacoustic Emissions (TEOAEs). 
A Biologic Scout (v.3.45) was used to measure TEOAEs. The signal consisted 
of wide band clicks of 80 µs duration, at a target amplitude of 80 dB peak Sound 
Pressure Level (pkSPL). The pass criteria included reproducibility of at least 70%, 
and a difference between the amplitude of the emission and the associated noise floor 
of at least 6 dB in at least three out of four frequency bands (1,500, 2,000, 3,000 and 
4,000) including 1,500 and 4,000 Hz in both ears (Kemp et al, 1990; Amedee, 1995).   
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Figure 2.1: Flow chart for diagnostic and review audiology  
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2.4.3.3 Click-evoked Air conduction ABR  
Single channel click ABR recordings were obtained from both ears in sleeping 
infants using Biologic auditory evoked potentials Navigator Pro System (v.6.2.0). 
Rarefaction pulses of 100 µs were delivered at a rate of 27.1/s through insert 
earphones. Stimuli were presented in descending steps from 80 dB normalised hearing 
level (nHL) to below response threshold with a maximum of 2,000 stimuli per 
response. A stimulus level of 70 dB was chosen in some instances when the baby was 
disturbed by the 80 dB signal level. Thresholds were tracked using latency of wave V 
in both ears. A minimum of two replications of 2,000 trials each was obtained at 50 
dB and below. Additional replications were obtained when necessary to confirm the 
presence of response.  Pass criteria included repeatable wave V at normal latencies at 
30 dBnHL, normal intensity-latency function from 80 to 30 dBnHL and normal 
interpeak latencies at 80 dBnHL (Keogh and Beahan, 2009). 
 
2.4.3.4 1,000 Hz Tone Burst ABR. 
   Tone burst ABR was performed using the Biologic auditory evoked potentials 
(v.6.2.0). The response determination criteria were the same as described for click 
ABR. The 1,000 Hz tone bursts with rarefaction polarity were delivered at a rate of 
27.7/s through insert earphones. The Blackman gated signals, with a 2 ms rise/fall 
time and total signal duration of 6 msec, were delivered to the ear. Pass criteria 
included repeatable wave V at 30 dBnHL in both ears (Keogh and Beahan, 2009).  
 
2.4.3.5 Bone conduction ABR. 
   Bone conduction ABR was performed using a Biologic auditory evoked 
potentials (v.6.2.0). Broadband clicks with alternating polarity were presented at a rate 
of 33.1/s through a Radioear B70A oscillator held on the temporal bone in a 
superoposterior auricular position (Yang and Stuart, 1990).  Response determination 
was similar to click ABR. The criterion for normal bone conduction ABR was a 
repeatable ABR trace at an intensity of 15 dBnHL (Stuart et al, 1990; Cone-Wesson, 
1995). 
 
2.4.3.6 Auditory Steady State Response (ASSR). 
   ASSR evaluation was performed using the Multiple Auditory Steady State 
Response (MASTER; v.2.04.i00) from Biologic Systems (John and Picton, 2000). 
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Stimuli consisted of sine waves at carrier frequencies of 500, 1,000, 2,000 and 4,000 
Hz with 100% amplitude modulation and 20% frequency modulation. Up to a level of 
80 dB HL, all of the four frequencies were presented simultaneously to each ear. Once 
the stimulus level exceeded 80 dB HL, the instrument permitted presentation of only 
one frequency, one ear at a time, in order to avoid damage due to high intensity. 
Modulation frequencies were 82, 87, 91 and 96 Hz for the left ear and 84, 89, 94 and 
99 Hz for the right ear (John and Picton, 2000).  Air conducted stimuli were presented 
through insert ear phones while bone conducted stimuli were presented via a Radioear 
B-71 bone oscillator held in position with a headband fastened with Velcro. The 
signals were presented using 10 dB steps down to 30 dB HL for both air and bone 
conducted stimuli. Pass criteria for both air and bone conducted ASSR was a response 
at 30 dB HL from 500 to 4000 Hz with a significance level of p<.05. 
 
2.4.3.7 Visual reinforcement audiometry (VRA). 
 For children older than 7 mo of age, behavioural assessment of hearing was 
performed with VRA in the sound field using an Interacoustics AC40 clinical 
audiometer. Testing was conducted in a sound-treated test booth with a single room 
set up.  VRA thresholds or minimum response levels (MRLs) were determined for 
warble tones in the frequency range of 500 to 4,000 Hz presented through 
loudspeakers kept at 1 m distance and at an angle of 450 from the child’s ears. A 10 
dB step size (20 down, 10 up) was chosen to allow for quick convergence on VRA 
threshold or MRL (Widen et al, 2000). For the purpose of this study, normal hearing 
was defined as MRLs of 30 dB SPL at 500 Hz and 25 dB SPL from 1,000 to 4,000 Hz 
(Keogh and Beahan, 2009).  
 
2.4.3.8 Bone conduction VRA. 
 Bone conduction VRA was performed when the sound field MRLs were 
above normal levels. Warble tones were presented at 1,000 to 4,000 Hz via a bone 
conductor placed on the mastoid. Normal bone conduction results were defined as 
MRLs of 15 dB from 100 to 4,000 Hz (Vander Werff et al, 2009).   
 
2.4.4 Conductive hearing loss and middle ear pathology 
 Hearing sensitivity can vary widely in the presence of middle ear pathology. 
In the current study, the term “middle ear pathology” includes infants with middle ear 
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pathology with normal hearing and infants with conductive or mixed hearing loss. The 
following sections describe algorithms for determining middle ear pathology with 
normal hearing and conductive hearing loss.  
 
2.4.4.1 Algorithm to determine middle ear pathology with normal hearing. 
  Hearing was considered to be functionally normal in the presence of middle 
ear dysfunction if (1) high frequency tympanogram showed flat-type tympanogram 
with no change in admittance or (2) 226 Hz tympanogram showed flat B-type 
tympanogram with no change in admittance along with (3) wave V present up to 
30dBnHL with click ABR and/or (4) wave V present down to 30 dBnHL with 1,000 
Hz tone burst ABR and/or (5) free field VRA thresholds of 30 dB SPL at 500 Hz and 
25 dB SPL at 1,000 to 4,000 Hz and/or (6) response present down to 30 dB HL from 
500 to 4,000 Hz with ASSR and (7) TEOAEs not present >6 dB signal-to-noise ratio 
(SNR) in at least three of four frequency bands.  
 
2.4.4.2 Algorithm to determine middle ear pathology with conductive  
hearing loss.  
  Using results from the test battery, conductive hearing loss due to middle ear 
pathology was considered to be present if (1) high frequency tympanogram showed 
flat-type tympanogram with no recordable middle ear pressure or compliance, or (2) 
226 Hz tympanogram showed flat B-type tympanogram with no change in admittance 
along with (3) TEOAEs not present at >6 dB SNR in at least three of four  frequency 
bands including 1,500 and 4,000 Hz and (4) Wave V present above 30 dBnHL with 
prolonged or normal latencies with Click ABR and (5) Wave V present above 30 
dBnHL with 1,000 Hz tone burst ABR and/or (6) VRA thresholds above 25 dB SPL 
in any of the frequencies between 1,000 and 4,000 Hz and above 30 dB SPL at 500 
Hz and/or (7) responses above 30 dB HL in any of the frequencies between 500 and 
4,000 Hz with ASSR and (8) normal bone conduction ABR/ASSR/VRA. 
 
2.4.5 Classification of hearing loss 
 The Healthy Hearing program has adopted an operational definition of normal 
hearing to correspond to an ABR threshold of 30 dBnHL. While there are no standard 
methods of classifying the severity of hearing loss based on ABR thresholds, the 
present study adopted the conservative approach of the Healthy Hearing program in 
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classifying severity based on the average of click and 1000 Hz air conducted ABR 
thresholds. This procedure was similar to the classification of hearing thresholds 
based on pure tone evaluation as given by Jerger and Jerger (1980). Worse ear was 
used to calculate the degree of hearing loss. Average air conducted thresholds up to 40 
dBnHL were classified as mild, 41-55 dB nHL as moderate, 56-70 dBnHL as 
moderately severe, 71-85 dBnHL as severe and above 85 dBnHL as profound (Jerger 
and Jerger, 1980).  
 
2.5 RESULTS 
2.5.1 Initial assessment outcomes 
  Of the 234 infants (140 males, 94 females) referred for diagnostic audiology 
assessment, 63 (26.9%) were ATSI and 171 (73.1%) were non-ATSI.  A total of 211 
infants (128 males, 83 females) attended the initial diagnostic audiology assessment at 
the Audiology department. Of these, 54 infants (25.6%) were ATSI and 157 (74.4%) 
were non-ATSI. The remaining 23 infants (12 males, 11 females) were either referred 
elsewhere or failed to attend the appointment. Of the 23 infants who did not attend the 
initial diagnostic appointment, 9 were ATSI and 14 were non-ATSI. The difference 
between the nonattendance rates of ATSI and non-ATSI infants (14.29% and 8.19% 
respectively) was not significant (χ2= 1.305, p>.05). 
 
  The mean age of infants at the time of first diagnostic assessment was 47.5 
days (SD = 31.30, range = 2-121 days).  The mean time difference between screening 
and first diagnostic assessment was 24.4 days (SD = 22.69, range = 0-117 days).  
Delays in performing the initial diagnostic assessment were due to infants not being 
medically ready for audiological assessment, parents having difficulty travelling long 
distances with young infants and other children, family circumstances including the 
partner’s availability to accompany mother and infant, or families missing earlier 
appointments.  
 
  Figure 2.2 shows the audiological outcomes for infants at the first 
appointment, as determined by the algorithm described earlier in “Methods”. Of the 
211 infants who attended the appointment, 99 (46.92%) had normal hearing with 
normal middle ear functioning in both ears. No gender difference was seen in these 99 
infants (χ2= 0.691, p>.05). Eighteen (8.53%) infants had middle ear pathology with 
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normal hearing, 47 (22.27%) had middle ear pathology with conductive hearing loss, 
26 (12.32%) had sensorineural hearing loss and four (1.90%) had mixed hearing loss. 
Type of hearing loss could not be determined in 17 (8.06%) infants during the initial 
assessment.  
 
2.5.1.1 Conductive hearing loss. 
 Prevalence of conductive hearing loss was 2.97 per 1000 (47 of 15,824 babies 
screened) while prevalence of sensorineural hearing loss was 1.64 per 1,000 (26 of  
15, 824). Prevalence of conductive hearing loss was 1.8 times that of sensorineural 
hearing loss in the study cohort.  
 
 One infant had unilateral permanent conductive hearing loss with congenital 
atresia. Of the remaining  46 infants with conductive hearing loss with no congenital 
ear anomalies, 24 infants had unilateral and 22 bilateral conductive hearing loss. 
Twenty-four infants had a mild degree of loss (17 unilateral and 7 bilateral), 18 had a 
moderate degree (5 unilateral and 13 bilateral) and 4 had a moderately severe degree 
of loss (2 unilateral and 2 bilateral).  
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Figure 2.2: Audiological outcomes at the first diagnostic assessment for 211 infants 
(54 ATSI and 157 non-ATSI)   
 
   During the initial diagnostic assessment, 29.63% (16 of 54) of ATSI infants 
and 52.87% (83 of 157) of non-ATSI infants passed all the tests and had normal 
hearing with normal middle ear function in both ears. The difference between the two 
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groups was statistically significant (χ2= 7.803, p=.0042). The prevalence of 
conductive hearing loss was twice as high in ATSI infants (19 of  54, 35.19%) 
compared to non-ATSI infants (28  of 157, 17.83%). ATSI infants had a significantly 
higher prevalence of conductive hearing loss than non-ATSI infants (χ2= 6.020, 
0=0.0141). There was no significant difference between ATSI and non-ATSI infants 
in terms of prevalence of sensorineural hearing loss (χ2=0.028, p>.05), mixed hearing 
loss (χ2=0.367, p>.05) and indeterminate hearing loss (χ2=1.552, p>.05) (Table 2.1). 
There was no significant gender difference in rates of conductive loss between males 
(30 of 128, 23.44%) and females (17 of  83, 20.48%) (χ2=0.112, p>.05). 
 
2.5.1.2 .Middle ear pathology.  
   As defined earlier, middle ear pathology included middle ear pathology with 
normal hearing and hearing loss. As shown in Figure 2.2, 18 infants had middle ear 
pathology with normal hearing, 47 infants had conductive hearing loss and four had 
mixed hearing loss during initial diagnostic assessment. Hence, a total of 69 infants 
out of 211 infants (29.5%) referred had middle ear pathology. The prevalence of 
middle ear pathology in neonates was 4.36 per 1,000 (69 of 15824) which was 2.7 
times that of sensorineural hearing los (1.64 of 1,000).  
 
Table 2.1: Comparison of audiological outcomes of ATSI (n=54) and non-ATSI  
 (n=157) infants at first diagnostic appointment 
 Total ATSI, n (%) nonATSI, n (%) z  
Value 
Significance, p 
Normal hearing  99 16 (29.63) 83 (52.87) 2.794  <.05 
Middle ear pathology 
with normal hearing 
18 5 (9.26) 13 (8.28) -0.06 >.05 
Conductive loss 47 19 (35.19) 28 (17.83) 2.455 <.05  
Sensorineural loss 26 7 (12.96) 19 (12.10) -0.074 >.05 
mixed loss 4 0  (0) 4  (2.55) 0.607 >.05 
indeterminate loss 17 7 (12.96) 10 (6.37) 1.245 >.05 
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   Thirty-three infants had unilateral and 36 infants had bilateral middle ear 
pathology during initial assessment. There was no significant gender difference in the 
prevalence of middle ear pathology between males (45 of 128, 35.16%) and females 
(24 of 83, 28.92%) (χ2=0.891, p>.05). A total of 44.45% (24 of 54) of ATSI and 
28.66% (45 of 171) of non-ATSI infants had middle ear pathology with normal 
hearing or with conductive or mixed hearing loss (Table 2.1). ATSI infants had 
significantly higher prevalence of middle ear pathology compared to non-ATSI 
infants (χ2=3.859, p=.0495).  
 
2.5.2 Outcomes of review assessment  
2.5.2.1 Outcomes for infants with conductive hearing loss 
The mean time interval between the first and review assessments was 88.31 
days (SD = 44.14, range = 23-182 days). Figure 2.3 shows the audiological outcomes 
of infants with conductive hearing loss at review assessment. Of the 47 infants with 
conductive hearing loss, one infant with congenital atresia was referred for ear, nose , 
and throat (ENT) consultation. The remaining 46 were scheduled for an audiology 
review in 6-8 wk. Among the infants scheduled for review, 19 were ATSI and 27 
were non-ATSI. However, only 34 (34 of 46, 73.91%) infants (22 males, 12 females) 
attended the review. Of these 34 infants, 16 were ATSI and 18 were non-ATSI. Ten 
(three ATSI and seven non-ATSI infants) were either referred elsewhere or failed to 
attend the follow-up and a further two non-ATSI infants were not ready for testing at 
the time and, hence, were unavailable for review. Although the nonattendance rate 
appeared to be higher among the non-ATSI (9 of 27, 33.33%) than ATSI (3 of 19, 
15.79%) infants, the difference was not statistically significant (χ2=0.987, p>.05).  
 
 During review, a total of 16 infants (47.06%, 11 males, five females) had 
normal hearing with normal middle ear function, 17 (50%, 11 males, six females) had 
conductive hearing loss and one female ATSI infant (2.94%) had an indeterminate 
finding. No significant gender effect was noted for infants with normal hearing 
(χ2=0.011, p>.05) or for those with conductive hearing loss (χ2=0.000, p>.05). 
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 Figure 2.3: Review outcomes for ATSI (n=16) and non-ATSI (n=18) infants 
diagnosed with conductive hearing loss at first diagnostic assessment 
 
 
  Of the 17 infants with persistent conductive hearing loss, seven demonstrated 
unilateral and eight bilateral conductive hearing loss. Two infants had conductive 
hearing loss in the better ear as evaluated by VRA. Eight infants (four unilateral, two 
bilateral and two in the better ear) had a mild degree, seven (two unilateral and five 
bilateral) had a moderate and two (one unilateral and one bilateral) had a moderately 
severe degree of conductive hearing loss. 
 
 During review, 16 (three ATSI and 13 non-ATSI) infants had normal hearing 
with normal middle ear function in both ears. This accounted for 18.75% (3 of 16) of 
ATSI and 72.22% (13 of 18) of non-ATSI infants with normal hearing and this 
difference between the two groups of infants was statistically significant (χ2=7.694, 
p= .0055). Of the total 17 infants with conductive hearing loss, 12 were ATSI and five 
were non-ATSI.  This accounted for 75% (12 of 16) of ATSI and 27.78% (5 of 18) of 
non-ATSI infants having persistent conductive hearing loss during review. This 
difference in prevalence of conductive hearing loss between the two groups of infants 
was statistically significant (χ2=5.785, p= .0162) (Table 2.2). 
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Table 2.2: Comparison of review outcomes of ATSI (n=16) and non-ATSI (n=18)  
 infants diagnosed with conductive hearing loss at initial assessment 
 Total ATSI              
n (%) 
nonATSI 
n (%) 
z Value Significance, p 
Normal hearing 16 3 (18.75) 13 (72.22) 2.774 <.05 
Conductive loss 17 12 (75) 5 (27.78) 2.405 <.05 
indeterminate loss 1 1 (6.25) 0 (0) 0.06 >.05 
ATSI = Aboriginal and Torres Strait Islander 
 
   Figure 2.4 shows comparison of outcomes of first assessment with review 
assessment. Sixteen infants (with conductive hearing loss at initial assessment) were 
found to have normal hearing during review, suggesting that conductive hearing loss 
(47.06%) infants. Unilateral conductive hearing loss had resolved in 10 infants and 
bilateral conductive loss in six infants. Seventeen of the 34 infants continued to show 
conductive hearing loss, suggesting that they had persistent hearing loss even after an 
average of 135 days. 
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 Figure 2.4:  Audiological outcomes of infants with conductive hearing loss during  
      initial and review assessments   
 
The 17 infants (five non-ATSI and 12 ATSI) with conductive hearing loss 
constituted 8.06% (17 of 211) of the infants referred for diagnostic assessment. These 
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17 infants were referred for further management by ENT specialists and were 
considered for medical management including grommets, examination under 
anaesthesia, medication, and monitoring.  
 
2.5.2.2 Outcomes for infants with middle ear pathology  
Of the 64 infants with middle ear pathology scheduled for review, a total of 46 
infants (30 males, 16 females) attended the review. Of the 46 infants, 18 were ATSI 
and 28 were non-ATSI. Nineteen infants had normal hearing with normal middle ear 
function, six had middle ear pathology with normal hearing and 17 had conductive 
hearing loss and hearing status could not be determined in four infants. Thus, a total 
of 23 infants had middle ear pathology during the review (10 infants unilateral, 13  
bilateral). There was no gender difference in terms of middle ear pathology between 
males (17 of 30, 56.67%) and females (nine of 16, 56.25%) (χ2=0.001, p>0.05). 
 
Of the 19 infants with normal hearing and normal middle ear functioning, four  
(four of 18, 22.22%) were ATSI and 15 (15 of 28, 53.57%) were non-ATSI (Figure 
2.5). A significantly higher proportion of non-ATSI infants demonstrated normal 
hearing with normal middle ear functioning during review (χ2=4.441, p= .0351). Of 
the 23 infants with middle ear pathology, 13 (13 of 18, 72.22%) were ATSI and 10 
(10 of 28, 35.71%) were non-ATSI. ATSI infants had a significantly higher rate of 
middle ear pathology at review than non-ATSI infants (χ2=4.472, p= .0345) (Table 
2.3).  
Table 2.3: Comparison of review outcomes of ATSI (n=18) and non-ATSI 
(n=28)  infants diagnosed with middle ear pathology at initial assessment  
 Total ATSI,             
n (%) 
nonATSI         
n (%) 
 zValue Significance, p 
Normal hearing  19 4 (22.22) 15 (53.57) 1.801 <.05 
Middle ear 
pathology with 
normal hearing 
6 1 (5.56) 5 (17.86) 0.76 >.05 
Conductive loss 17 12 (66.67) 5 (17.86) 3.034 <.05  
indeterminate 
loss 
4 1           
(5.56) 
3 (10.71) 0.069 >.05 
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Figure 2.5: Review outcomes of ATSI (n=18) and non-ATSI (n=28) infants diagnosed 
    with middle ear pathology at first diagnostic assessment  
 
2.6 Discussion 
One of the aims of the study was to evaluate the prevalence of conductive 
hearing loss and middle ear pathology in infants referred through the Healthy Hearing 
screening program in north Queensland.  Using a battery of audiological tests, 
conductive hearing loss was found to be a common diagnosis among infants referred 
through screening.  Prevalence of conductive hearing loss was found to be 2.97 per 
1,000 during initial diagnostic assessment which was 1.8 times that for sensorineural 
hearing loss (1.64/1000). This agrees very well with findings of Boone et al (2005) 
who also found prevalence of conductive hearing loss to be 1.8 times that of 
sensorineural hearing loss in infants referred through an American newborn hearing 
screening program.  
 
   However, the reported figures vary for prevalence of conductive hearing loss 
in infants. White et al (1993) have reported that 17 of 1,000 well babies and 36 of 
1,000 babies in newborn intensive care units had conductive hearing loss. Orlando 
and Prieve (1998) and Gorga et al (2001) reported that conductive hearing losses due 
to congenital middle ear effusion or more permanent external and middle ear 
problems occur at a rate 30 times greater than sensorineural hearing losses in young 
infants. The present study found that 22.27% of infants who were seen following 
failure of AABR hearing screening were diagnosed to have conductive hearing loss. 
    71 
This variation in prevalence figures across studies could be attributed to differences in 
the screening methods used in the hearing screening programs. In the present study, 
the infants were screening using AABR, while the other studies cited have used either 
OAE or a combination of OAE and AABR. It is well known that external and middle 
ear abnormalities can have a significant effect on the OAE screening results, but not 
on AABR screening results (Northrop et al, 1999). Although the nature of middle ear 
pathology was not investigated using methods such as amniocentosis in any of these 
studies, it can be expected that the amniotic fluid retained in the middle ear cavity 
would be the most likely causative factor (Boone et al, 2005). 
 
   The second goal of the study was to compare the prevalence of conductive 
hearing loss and middle ear pathology between ATSI and non-ATSI infants. 
Nonattendance rates were not significantly different between ATSI and non-ATSI 
infants during both initial and review assessments, and hence, did not influence the 
results in any particular group. A significantly higher proportion of non-ATSI infants 
showed normal hearing with normal middle ear function at both initial and review 
assessment (Tables 2.1-2.3). ATSI infants had a higher prevalence of middle ear 
pathology and conductive hearing loss than non-ATSI infants both at initial diagnostic 
as well as at review assessments. During initial assessment, the prevalence of 
conductive hearing loss in ATSI infants (35.19%) was nearly twice that of non-ATSI 
infants (17.83%). During review, conductive hearing loss was found to persist in 75% 
of ATSI infants compared to 27.78% of non-ATSI infants. This indicates that ATSI 
infants demonstrated poorer resolution of conductive hearing loss than non-ATSI 
infants. Thus, the middle ear function of ATSI infants appears to differ from non-
ATSI infants from early infancy. These findings are consistent with the earlier reports 
of high rates of middle ear pathology in ATSI infants. For example, Boswell and 
Nienhuys (1995) found that 95% of 22 6- to 8- wk-old Aboriginal infants had otitis 
media with effusion compared to 30% among non-Aboriginal infants. In a cross-
sectional study of Aboriginal infants, Foreman (1987) found the prevalence of 
perforation was 11% at age of 0-6 mo and 43% at 7-12 mo. However, longitudinal 
studies that document the natural history of MEE and conductive hearing loss in 
young ATSI infants are very scarce. In the first longitudinal audiological and 
otoscopic study of 17 infants in the first year of life, Boswell and Nienhuys (1996) 
reported that Aboriginal infants had middle ear aeration and normal hearing within 2 
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wk of birth. During follow-up over a period of 12 mo, 90% of non-Aboriginal infants 
and 0% of Aboriginal infants had normal middle ears during repeated observations. 
Longitudinal microbiological studies have shown early bacterial colonisation with 
multiple bacterial types resulting in prolonged carriage and Eustachian tube damage to 
be the main reason for persistent otitis media in Aboriginal children (Leach et al, 
1994; Morris et al, 2009). Other contributing factors include overcrowding, poor 
hygiene, and lowered resistance from nutritional and genetic causes (Scrimshaw et al, 
1968; Canty et al, 1975; Kavanagh, 1986; Leach et al, 1994; Runcie and Bailie, 2000; 
Leach and Morris, 2001; Smith-Vaughan et al, 2001; Morris et al, 2009; Jacoby et al, 
2008). However, there are no longitudinal studies that link these environmental 
factors to early onset and persistent otitis media from early infancy in these children. 
There is, thus, a need for well controlled longitudinal studies to document the natural 
history of MEE along with hearing status in Australian Aboriginal infants.  
    
There is also limited longitudinal research to determine the course of neonatal 
MEE and its relation to chronic MEE in the general population. In humans, although 
the resorption of mesenchyme from the middle ear cleft is reported to be complete by 
the eighth foetal month, it can vary up to the thirteenth postnatal month (Guggenheim 
et al, 1956; Buch and Jorgensen, 1964; Arey, 1968) with some children retaining large 
amounts of mesenchyme until the onset of puberty (Takahara et al, 1986). Temporal 
bone studies have shown that persistent amniotic fluid cellular content can spread to 
various middle ear compartments and cause extensive histopathological changes due 
to foreign body giant cell reaction, the severity of which is related to the amount of 
amniotic cellular content (Piza et al, 1989; Northrop et al, 1999; Palva, Northrop & 
Ramsay, 1999).   There was also a linear relationship between increasing age and 
organised reaction of the middle ear mucosa with the spectrum of middle ear 
pathology ranging from minimal to formation of reactive polyps and extensive 
fibrosis (Bacsik, 1977; Palva et al, 2001).  Massive granulation tissue with numerous 
pseudocysts and secretions trapped to many attic compartments, together with the 
hyperplastic mucosa with secretory elements are postulated to lower the resistance of 
the middle ear to viral or bacterial infection, thereby predisposing these infants with 
persistent effusion to otitis media (Northrop et al, 1999; Ramsay et al, 2001).  
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  A handful of studies have found that newborns with persistent MEE were 
more likely to develop chronic MEE. Doyle et al (2004) found that 58% of 14 infants 
with persistent neonatal MEE at 30-48 hr of life developed chronic otitis media with 
effusion during the first year of life compared to 20% of 15 infants who had no MEE 
in the first 2 days of life. In a study of 238 infants, Pereira, Azevedo, and Testa  
(2010) found that 57% of 16 infants who failed their hearing screening in the first 
month of life due to conductive pathology had otitis media in the first year of life 
compared to 23% of 9 infants who passed their hearing screening. Boswell et al 
(1993) noted that once middle ear disease started within the first 8 wk of life and was 
established in Australian Aboriginal infants, it was persistent despite treatment. It 
remains to be seen whether this persistent MEE and resulting damage to middle ear 
tissues in young infants could be predisposing their ear for further infections, thereby 
rendering them “otitis prone”.  There are currently no well-defined, longitudinal 
studies that have monitored the resolution of middle ear fluid from birth to the first 
few months of life. Further longitudinal studies are needed to study the natural history 
and resolution of MEE with or without hearing loss in early infancy in both ATSI and 
non-ATSI infants to determine if MEE is a precursor for later persistent middle ear 
infections.  
 
 The third aim of the present study was to review the outcomes of the infants 
diagnosed with middle ear pathology. The results showed that middle ear pathology 
had resolved in 41.30% (19 of 46) of infants seen at review. This figure is much lower 
than the 65% resolution of MEE reported by Boone et al (2005).  However, this 
difference could be due to results not being available for 18 infants due to loss to 
follow up, transfer, incomplete results or infants not ready for review. 
 
   The fact that 17 infants had persistent conductive hearing loss even at an 
average age of 135 days suggests that middle ear pathology is likely to persist beyond 
the first few weeks of life. This is consistent with temporal bone studies that have 
reported presence of mesenchyme in the middle ear cleft up to 13 mo of age 
(Guggenheim et al, 1956; Kasemsuwan et al 1996; Jaisinghani et al, 1999). However, 
these results need to be substantiated using audiological and radiological studies in 
live infants. While the natural history of treated or untreated MEE in older infants and 
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children is well documented (Rosenfeld et al, 2004), there are no longitudinal studies 
that have investigated the resolution of MEE in children in the first 12 mo of life.  
 
  Of the 23 infants with middle ear pathology during review, 17 with conductive 
hearing loss were referred for medical management including grommets insertion, 
medication and follow up appointments.  The remaining six infants were advised 
audiological review to monitor their middle ear status. These management strategies 
are in line with the most commonly recommended treatments for MEE in older 
children including watchful waiting for a certain amount of time, oral antibiotics and 
surgical drainage with or without placement of ventilation tubes (Rosenfeld et al, 
2004; Boone et al, 2005).  
 
 A number of factors could have affected the results of the present study. First, 
the study only assessed those infants who failed the AABR screen. It is possible that 
some infants with middle ear pathology with or without slight to mild hearing loss 
could have passed the screening. Unlike OAE screening, external and middle ear 
abnormalities do not have a significant effect on the results of AABR screening (El-
Refaie et al, 1996; Northrop et al, 1999). Second, a number of infants were lost to 
follow up in both the initial and review assessment sessions. Hence the prevalence for 
middle ear pathology and conductive hearing loss could have been under- or over-
estimated. Third, the present study did not consider the review outcomes of the infants 
diagnosed with mixed hearing loss or indeterminate hearing loss during the initial 
assessment. Inclusion of these infants may have influenced the prevalence rates of 
conductive hearing loss and middle ear pathology in the present study.  
 
  Although the main aim of neonatal hearing screening programs is the 
identification of congenital permanent hearing loss, the presence of middle ear 
pathology can prolong the diagnosis of permanent hearing loss. Hence, an accurate 
and non-invasive tool is needed at the time of screening to distinguish middle ear 
pathology from sensorineural hearing losses.  Not only may this streamline the 
management strategies for the respective types of hearing loss, but it may also 
facilitate prioritisation of infants for follow-up appointments and reduce parental 
anxiety. To this end, future research with multi-frequency tympanometry, sweep 
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frequency tympanometry, acoustic reflex or wide band reflectance used as an adjunct 
to the AABR screening tool would be beneficial.  
 
In summary, middle ear pathology with or without conductive hearing loss 
was found to be a common cause of referral from the newborn hearing screening 
program in north Queensland.  The prevalence of conductive hearing loss was 2.97 
per 1,000 while prevalence of middle ear pathology was 4.36 per 1,000. Australian 
indigenous infants had higher prevalence rates of conductive hearing loss and middle 
ear pathology than their non-indigenous counterparts. Indigenous infants also showed 
poor resolution of middle ear pathology with time. The present study found that 
8.06% of the referred infants had persistent conductive hearing loss exceeding 3 mo 
and required medical management for their condition including follow up 
appointments, antibiotic treatment and grommet insertion.  Future research utilising a 
direct measure of middle ear function as an adjunct to the AABR screening tool to 
distinguish between middle ear pathology from sensorineural hearing loss may 
facilitate prioritisation of infants for assessment, reduce parental anxiety and 
streamline the management strategies for respective types of hearing loss.   
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Chapter Three: Normative Wideband Absorbance 
Measures In Healthy Neonates 
 
3.1 Background 
Normative data on WBA has been developed in neonates using DPOAE, a 
screening tool, as a reference standard for middle ear status (Sanford et al., 2009; 
Hunter et al., 2010). For ethical reasons, myringotomy is not justified to determine 
middle ear status in asymptomatic neonates. Passing DPOAE is not an ideal reference 
standard because DPOAE can be present in some ears with middle ear dysfunction.  
In the absence of a single gold standard to assess middle ear dysfunction in neonates, 
Mazlan and Kei (2012) recommended the use of a battery of tests to determine middle 
ear status in this population. A battery of tests may provide a robust measure of 
middle ear function without resorting to invasive procedures such as myringotomy.  
 
Normative data for WBA was developed in neonates who passed a battery of 
tests that included automated auditory brain response, high frequency tympanometry, 
acoustic stapedial reflex, transient evoked otoacoustic emissions and DPOAE. The 
normative data developed in the present study and comparison of the results with 
other normative WBA studies in neonates are presented in Chapter Three of this 
thesis.  
 
Chapter Three of this thesis, entitled, “Normative wideband absorbance 
measures in healthy neonates”, is based on the article published in International 
Journal of Paediatric Otorhinolaryngology.  This published article is inserted into this 
thesis with some modifications. For example, the results of the study are presented in 
terms of absorbance rather than reflectance. This modification is necessary to ensure 
consistency of the measure (absorbance) throughout the thesis. Additionally, the 
formatting of section sub-headings has been modified from the original publication to 
match the thesis format. The referencing format of the article is retained as per the 
International Journal of Paediatric Otorhinolaryngology journal format. 
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Aithal, S., Kei, J., Driscoll, C., & Khan, A. (2013). Normative wideband 
reflectance measures in healthy neonates. International Journal of Paediatric 
Otolaryngology 77: 29-35.  
 
 3.2 Abstract  
Objective: Presently, normative wideband reflectance data are available for neonates 
who have passed a distortion product otoacoustic emission test. However, passing the 
distortion product otoacoustic emission test alone does not ensure normal middle ear 
function. The objective of this study was to establish normative wideband reflectance 
data in healthy neonates with normal middle ear function, as justified by passing a 
battery of tests. 
Method: Wideband reflectance was measured in 66 infants (mean age = 46.0 h, SD = 
21.0, range = 13.3–116.5 h) who passed a test battery that included high frequency 
(1000 Hz) tympanometry, acoustic stapedial reflex, transient evoked otoacoustic 
emissions and distortion product otoacoustic emissions. 
Results: The analysis of variance (ANOVA) results showed significant variations of 
reflectance across the frequencies. There was no significant difference between ears 
and genders. The median reflectance reached a minimum of 0.21–0.24 at 1–2 kHz, but 
increased to 0.45–0.59 below 1 kHz and 0.24–0.52 above 2 kHz. 
Conclusions: The normative reflectance data established in the present study were in 
agreement with, but marginally smaller than, those of previous normative studies, 
except for the Keefe et al. (2000) study. While the use of a test battery approach to 
ensure normal middle ear function in neonates has resulted in slightly reduced 
reflectance across most frequencies when compared to studies that have used only 
otoacoustic emissions, further research is needed to accurately determine the middle 
ear status of neonates using test performance measures. 
 
Keywords wideband absorbance, neonates; normative. 
 
3.3 Introduction 
    Determination of middle ear function is an important aspect of diagnostic 
assessment in infants and young children. The standard tools used to determine the 
middle ear status in older children are neither efficient nor accurate in evaluating 
neonates. Myringotomy, which is the gold standard to determine middle ear fluid, is 
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neither ethical nor justified with neonates in a screening context. Both otoscopy and 
pneumatic otoscopy are not effective in neonates due to difficulties in visualising the 
tympanic membrane [1-4]. Conventional 226 Hz tympanometry has been found to be 
inaccurate in assessing infants younger than six months of age due to differences in 
acoustical and anatomical properties between adults and young infants [5-11]. Several 
studies have recommended high frequency (1000 Hz) tympanometry (HFT) for the 
assessment of middle ear function in infants less than six months of age [6, 10-12].  
Nonetheless, recent studies [13, 14] that have compared the test performance of HFT 
and wideband absorbance (WBA) with  distortion product otoacoustic emissions 
(DPOAE) in newborns found that the WBA test predicted DPOAE outcomes more 
accurately than the HFT. 
 
    The WBA test measures the power absorbance at ambient pressure using a 
wideband stimulus such as a click or chirp which covers a frequency range from 0.2 
to 8 kHz. Power absorbance (1-power reflectance) is defined as the ratio of absorbed 
energy to incident energy [15] and ranges from 1 (representing total absorbance of 
sound into the middle ear) to 0 (representing complete reflectance of sound by the 
tympanic membrane). Several studies have shown that, at all ages, power absorbance 
is the lowest at frequencies below 1kHz  and above 4 kHz and highest in the 
frequency region between 1 and 4 kHz, which corresponds to the most effective 
frequency region of the middle ear transfer function [13, 16-18].  
 
 The WBA test has been shown to be useful in the assessment of middle ear 
function in neonates [13-14, 19-23] and is, therefore, recommended as an adjunct tool 
with newborn hearing screening programs. For instance, Keefe et al. [20] 
demonstrated that inclusion of the WBA test in newborn hearing screening programs 
decreased the false positive rates from 5% to 1%, thus, suggesting that information on 
middle ear status improves the ability to predict hearing status.  Sanford et al. [13] 
measured WBA in 455 healthy, full-term newborn infant ears that passed their 
DPOAE screening within 24 h of birth and compared the findings with 80 ears that 
were referred. They found that the referred ears had lower energy absorbance between 
0.4 and 2.5 kHz when compared with those that passed the DPOAE test. In a study of 
127 infants in screening and diagnostic test conditions, Vander Werff et al. [22] also 
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found that infants who failed DPOAE screening had lower absorbance in the range 
from 0.63 to 2 kHz than infants who passed the screening.  
 
 Despite its potential regarding the assessment of middle ear function in 
infants, there are limited normative WBA data for this population. Keefe et al. [24] 
reported the first set of normative WBA data in 2081 neonates. However, this study 
did not include any measure to determine the middle ear status of the neonates.  It is 
only in recent years that studies have reported WBA results in healthy neonates with 
normal middle ear function as determined by a pass result in either DPOAE [13, 14, 
21, 22] or transient evoked otoacoustic emissions (TEOAE) testing [25]. In a study of 
324 newborns, Hunter et al. [14] described normative WBA regions for predicting 
DPOAE status in newborns. Hunter et al. [14] also proposed the use of absorbance 
area indices wherein the absorbance values are averaged over a specified frequency 
range (e.g., 1-2 kHz, 1-4 kHz, and 2-6 kHz). They found that area indices at 2 kHz or 
involving 2 kHz, successfully differentiated between ears that passed or referred on 
the DPOAE test, with areas under the ROC curve of 0.93 and 0.90, respectively. 
Merchant et al. [21] described normative absorbance and transmittance measurements 
on 12 ears from seven newborns that passed DPOAE screening. They found that the 
mean power absorbance was minimum (0.4) at 500 Hz and increased with frequency 
until 2 kHz where it reached a maximum of 0.82 and then decreased with frequency 
above 2 kHz.  
 
   As can be seen from the above studies, the DPOAE is often used as the 
reference standard to determine normal middle ear function in infants. However, the 
DPOAE alone may not accurately identify minor or sub-clinical middle ear 
pathologies [26] and, hence, may not serve as an ideal reference standard [13, 14]. 
Similarly, other tests such as HFT, acoustic stapedial reflex (ASR) or TEOAE in 
isolation are not effective measures of middle ear function in neonates. For example, 
there are unresolved issues for interpreting HFT results. To date, there are no 
universally agreed methods for interpreting HFT results, nor is there agreement 
regarding the test parameter or combination of parameters that are most sensitive to 
middle ear dysfunction in neonates [27]. Although normative ASR data is now 
available for neonates [28, 29], the ASR test alone cannot determine middle ear status 
as the presence or absence of ASR is dependent on several factors such as hearing 
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sensitivity and auditory function up to the brainstem region. Finally, TEOAEs alone 
are not perfect as a reference standard because TEOAEs can be recorded in some ears 
with middle ear dysfunction [30, 31].  
 
  In the absence of a single test for accurately identifying middle ear 
dysfunction in neonates, Mazlan and Kei [32] suggested that the use of a battery of 
tests including TEOAE, HFT and ASR tests may be an accurate measure for detecting 
middle ear dysfunction in young infants. Whilst a single measure such as HFT or 
DPOAE may not be sensitive to subtle middle ear dysfunction, a battery of tests may 
provide a robust measure of middle ear function for the evaluation of WBA in 
neonates. Such a battery may also provide the best reference standard available for 
newborns without resorting to invasive procedures such as myringotomy. To date, 
there are no WBA studies that have used a combination of tests as a reference 
standard to determine middle ear status in healthy neonates. The objective of this 
study was to describe normative WBA measures in healthy neonates who passed all 
tests in a reference standard battery that included AABR, HFT, ASR, TEOAE and 
DPOAE tests.  
 
3.4 Method 
 
3.4.1 Participants  
  A total of 195 (107 males, 88 females) healthy neonates were enrolled in the 
study. Only 66 neonates (35 males, 31 females) who passed all tests in the test battery 
in one or both ears were selected for the study. A total of 23 neonates passed the test 
battery in the right ear only, 21 passed in the left ear only and 22 neonates passed in 
both ears. When a neonate passed the test battery in both ears, either the right or left 
ear was chosen randomly for inclusion in the data analysis. Altogether, 66 ears (32 
right and 34 left ears) that passed all the tests in the test protocol were included in the 
study.  
 
 Mean gestational age of the neonates was 38.7 weeks (SD = 5.01, range = 36-
42 weeks). Thirty-four neonates (51.5%) were born via spontaneous vaginal delivery, 
six (9.1%) via assisted vaginal delivery, 24 (36.4%) via caesarean delivery and 
information was not available for two neonates (3%). Mean birth weight was 3534.9 g 
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(SD= 468.7, Range = 2290-4640 g). Fifty-five neonates (83.3%) were breast-fed, five 
(7.6%) were bottle-fed and information was not available for six (9.1%) neonates. 
Mean age of the neonates at the time of testing was 46.0 h (SD= 20.9, Range = 13.3-
116.5 h). Fifty-five neonates (83.3%) were asleep during testing, while four (6.1%) 
were awake but quiet, three (4.5%) were awake and restless, one (1.5%) was being 
fed and information was not available for three (4.5%) neonates.  
 
3.4.2 Test battery 
  Tympanometry was performed using a GN Otometrics Otoflex acoustic 
immittance device with a 1000 Hz probe tone. During the test, the admittance (Y) was 
measured as the pressure was changed from +200 to -400 daPa at a rate of 400 daPa/s. 
A visual classification system was used to classify the tympanometric results. The 
pass criterion was a single positively peaked tympanogram with middle ear pressure 
between 50 and -150 daPa [33-35].  
 
  ASR was measured using the same Otoflex instrument. ASR responses were 
recorded at the tympanometric peak pressure for a 2 kHz tone presented ipsilaterally 
in the presence of a 1000Hz probe tone. The stimulus tone was presented for 1 s at an 
intensity level starting at 70 dB HL using a manual threshold search mode. A change 
in admittance exceeding 0.04 mmho was considered as an ASR response [29]. A pass 
was awarded if an ASR was present up to 90 dB HL [28].   
 
   TEOAE was performed using a Biologic Navigator Plus. The signal consisted 
of wide band clicks of 80 µs duration, at a target amplitude of 80dBpkSPL. The pass 
criteria included reproducibility of at least 70% and a difference between the 
amplitude of the emissions and the associated noise floor of at least 3 dB at 2, 3 and 4 
kHz [22, 34].   
 
  DPOAE was performed using the same Biologic device. DPOAEs were 
measured in response to pairs of primary tones with F2 set at 1.5, 2, 3, 4, 6 and 8 kHz. 
The F2/F1 ratio was 1.2 for each primary pair. The level of F1 was 65 dBSPL and F2 
was 55 dBSPL. Pass criteria included if the noise level was less than 0 dBSPL and the 
difference between the amplitude of the emission and associated noise floor was at 
least 6 dB in at least three out of four frequencies from 2 to 6 kHz [13, 14].   
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  WBA was performed using a prototype research system developed by 
Interacoustics. The Reflwin computerised system consisted of a Windows-based 
computer, a 24 bit resolution sound card, a pressure pump and controller system 
contained in an acoustic immittance instrument (AT235), and custom software for 
stimulus generation and data acquisition. Calibration was performed every day [36] to 
determine the source reflectance and incident sound pressure associated with the 
probe and its transducers based on acoustic measurements in four rigid walled 
cylindrical calibration tubes.  
 
  Ambient WBA measurements were obtained by recording acoustic response to 
clicks, presented at 55 dB SPL and at a rate of one click per 46 ms, to a neonate’s ear. 
Responses from a total of 16 clicks were averaged for each measurement and 
reflectance was calculated for each response. The WBA response consisted of 16 data 
points (at 1/3 octave frequencies from 0.25 to 8 kHz). A visual display with high 
absorbance at frequencies below 1 kHz served as an on-screen prompt that alerted the 
tester if there was a probe leak. A visual prompt also alerted the tester if the noise 
level was high. The data acquisition was very quick and the typical test time was less 
than 10 s.  
 
3.4.3 Procedure 
 Ethical approval for the study was obtained from the Townsville Health 
Service District Institutional Ethics Committee and the University of Queensland 
Behavioural and Social Science Ethical Review Committee. Parents of healthy 
neonates at the maternity ward of Townsville Hospital were informed of the study by 
the nurses prior to the hearing screening of neonates. A consent form, approved by the 
Institutional ethics committees, was used to obtain written parental permission.  
 
  All measurements were performed in a quiet room in the well baby nursery. 
Hearing screening using AABR was always performed first by trained nursing staff. 
This was necessary so as not to interfere with the state-wide universal newborn 
hearing screening and to ensure functionally normal hearing. The AABR screening 
was done using the ALGO3 with a presentation level of 35 dBnHL. All the neonates 
included in the study passed the AABR screen in both ears. Following the AABR 
    89 
screen, an audiologist performed the HFT, ASR, TEOAE and DPOAE tests, in no 
particular order and with the most accessible ear first. Only the ears that passed all the 
four tests were considered for inclusion in the study. The neonates were usually seen 
after feeding while in natural sleep or in an awake but quiet state. In a sleeping or co-
operative neonate, the entire testing took an average of 20 min for both ears. In a 
wakeful or unsettled neonate, the testing time was 30 to 45 min depending on the 
activity state.  
 
 3.5 Results 
A mixed model of analysis of variance (ANOVA) was applied to the data to 
evaluate the effects of gender, ear and frequency on absorbance. In this model, both 
gender and ear served as between-subject factors, and frequency (16 levels) as a 
within-subject factor. The Greenhouse and Geisser (G-G) approach [37] was used to 
compensate for the violation of compound symmetry and sphericity.  The ANOVA 
results, shown in Table 3.1, revealed that there was a significant main effect for 
frequency [F(78, 242) = 78.336, p < 0.001]. The effects of ear, gender and their 
interactions with frequency were not significant (p > 0.05).  To further investigate the 
frequency effect, multiple pairwise comparison tests with Bonferroni adjustment were 
performed on the absorbance data. Significant differences were found in 85 out of 120 
paired comparisons (Table 3.2), showing large variations in absorbance across the 
frequencies.   The absorbance was significantly different between 0.25-0.8 k Hz and 
1-2.5 kHz regions, 0.25-0.8 kHz and 5-8 kHz regions, and 1-2.5 kHz and 3-4 kHz 
regions.  The absorbance did not vary significantly between 0.25-0.8 kHz and 3-4 kHz 
and between 1-2.5 kHz and 6-8 kHz.   
 
Table 3.1: ANOVA results for wideband absorbance obtained from 66 neonates. 
 F value df P 
value 
Observed 
Power 
Frequency 78.336 78, 242 0.000 1.00 
Ear 0.001 1, 62 0.980 0.05 
Gender 2.176 1, 62 0.145 0.31 
Ear × Gender 0.003 1, 62 0.959 0.05 
Frequency × Ear 0.269 4, 242 0.894 0.11 
Frequency × Gender 1.428 4, 242 0.236 0.44 
Frequency × Ear × Gender 1.055 4, 242 0.379 0.33 
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  In view of the insignificant ear and gender effects, the absorbance data were 
pooled across the ears and genders. Adjacent frequencies that did not differ 
significantly from each other were averaged to obtain absorbance area indices (AAIs). 
Table 3.3 shows the absorbance values for the 0, 5th, 10th, 50th, 90th, 95th and 100th 
percentiles at the individual frequencies and various AAIs for the neonates in the 
present study. The normative range for absorbance was defined as the region between 
the 10th and 90th percentiles [14]. Figure 3.1 shows the trend of the median and 
normative range of absorbance for individual frequencies. This trend reveals two 
minima of median absorbance of 0.41 and 0.48 at 0.5 and 4 kHz, respectively. The 
median absorbance attained maximum value of 0.79 at 1.5 kHz and 0.76 at 6 kHz.    
 
The inter-quartile range (between the 25th and 75th percentiles) and the 
normative range (between the 10th and 90th percentiles) of absorbance are given in 
Table 3.4. The inter-quartile ranges of the absorbance at 2 kHz and above were 
generally lower than those at frequencies below 2 kHz. The inter-quartile range varied 
from 0.88 at 0.5 kHz to 0.51 at 8 kHz. The normative range varied from 0.82 at 0.3 
kHz to 0.31 at 8 kHz.  A general trend of decreasing normative range of absorbance 
with frequency was observed.  
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Figure 3.1: Median and normative range of absorbance for 66 neonates.  
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Table 3.2: Significance of difference between various absorbance area indices (Bonferroni correction applied) 
 
                                                                     Frequency (kHz) 
Freq-
uency 
(kHz) 0.3 0.4 0.5 0.6 0.8 1 1.25 1.5 2 2.5 3 4 5 6 8 
0.25 0.603 0.000 0.000 0.000 ns 0.000 0.000 0.000 0.000 ns ns 0.013 0.000 0.000 Ns 
0.3  0.000 0.000 0.000 ns 0.000 0.000 0.000 0.000 ns ns ns 0.000 0.000 0.005 
0.4   0.000 ns 0.000 0.000 0.000 0.000 0.000 0.000 ns ns 0.000 0.000 0.000 
0.5    0.000 0.000 0.000 0.000 0.000 0.000 0.0000 0.000 ns 0.000 0.000 0.000 
0.6     0.000 0.000 0.000 0.000 0.000 0.00 ns ns 0.000 0.000 0.000 
0.8      0.000 0.000 0.000 0.000 ns ns ns 0.000 0.000 0.005 
1       0.000 0.000 ns ns 0.000 0.000 Ns Ns ns 
1.25        ns ns 0.000 0.000 0.000 0.000 Ns ns 
1.5         0.014 0.000 0.000 0.000 0.000 Ns ns 
2          0.000 0.000 0.000 0.015 Ns ns 
2.5           0.000 0.000 ns 0.000 ns 
3            ns 0.000 0.000 0.000 
4             0.000 0.000 0.000 
5              0.004 Ns 
6               Ns 
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Figure 3.2 shows the variation of median absorbance with frequency for three 
earlier studies, in comparison to the present study. The findings of the present study 
are in agreement with those of the Shahnaz  [25] and Hunter et al’s [14] studies. 
However, the absorbance in the 1-4 kHz region in the present study was larger than 
those reported by Shahnaz [25] and Hunter et al. [14]. In comparison, the absorbance 
values reported by Keefe et al. [24] were larger than those obtained in the present 
study.  
 
Table 3.3: Absorbance and absorbance area index (AAI) values for various percentiles 
(0, 5, 10, 25, 50, 75, 90, 95 and 100) for the infants with normal middle ear function 
as determined by a pass in all tests including HFT, ASR, TEOAE and DPOAE  
                                                 Percentiles Frequency 
(kHz) 0 5 10 25 50 75 90 95 100 
0.25 0.20 0.29 0.44 0.48 0.55 0.63 0.68 0.72 0.76 
0.31 0.33 0.35 0.38 0.45 0.53 0.58 0.66 0.70 0.75 
0.40 0.22 0.25 0.31 0.37 0.44 0.51 0.57 0.64 0.69 
0.5 0.15 0.23 0.28 0.34 0.41 0.46 0.55 0.58 0.63 
0.63 0.18 0.29 0.33 0.38 0.44 0.51 0.57 0.61 0.62 
0.80 0.22 0.32 0.41 0.44 0.52 0.58 0.64 0.70 0.73 
1 0.26 0.39 0.47 0.56 0.67 0.75 0.82 0.89 0.93 
1.25 0.31 0.48 0.59 0.68 0.76 0.85 0.91 0.94 0.96 
1.50 0.50 0.56 0.62 0.69 0.79 0.87 0.93 0.94 0.98 
2 0.49 0.51 0.57 0.63 0.77 0.85 0.90 0.93 0.99 
2.5 0.25 0.32 0.38 0.47 0.59 0.69 0.79 0.86 0.89 
3 0.23 0.25 0.29 0.39 0.52 0.60 0.66 0.77 0.86 
4 0.08 0.19 0.27 0.36 0.48 0.59 0.63 0.67 0.83 
5 0.03 0.36 0.44 0.57 0.69 0.77 0.83 0.88 0.94 
6 0.31 0.43 0.50 0.66 0.76 0.90 0.96 0.97 0.99 
8 0.10 0.25 0.27 0.42 0.74 0.91 0.96 0.98 0.99 
  
                  
 
         
 .25-.31 0.29 0.33 0.40 0.47 0.54 0.60 0.66 0.69 0.75 
.4-.8 0.19 0.28 0.34 0.41 0.45 0.50 0.59 0.61 0.62 
1 0.26 0.39 0.47 0.56 0.67 0.75 0.82 0.89 0.93 
1.25-2 0.49 0.57 0.62 0.70 0.77 0.84 0.87 0.90 0.94 
2.5 0.25 0.32 0.38 0.47 0.59 0.69 0.79 0.86 0.89 
 3-4 0.17 0.24 0.29 0.39 0.50 0.60 0.63 0.70 0.85 
 5-8 0.30 0.42 0.47 0.60 0.72 0.82 0.85 0.90 0.92 
 
 
  Table 3.5 compares the absorbance for various AAI of the present study with 
the Hunter et al. [14] study. While the results between the two studies are comparable, 
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the absorbance values of the present study were generally larger than those of the 
Hunter et al. study.   
 
Table 3.4:  Inter-quartile range  and normative range (between 10th and 90th 
percentiles) of absorbance at various individual frequencies and AAIs 
Frequency 
(kHz) 
Inter-
quartile 
range 
Normative 
range   
     0.25 0.16 0.25 
0.30 0.13 0.28 
0.40 0.14 0.27 
0.5 0.12 0.27 
0.60 0.12 0.23 
0.80 0.14 0.23 
1 0.19 0.36 
1.25 0.17 0.32 
1.50 0.18 0.31 
2 0.22 0.33 
2.5 0.22 0.41 
3 0.21 0.37 
4 0.23 0.36 
5 0.20 0.39 
6 0.24 0.46 
8 0.49 0.69 
  
    
  .25-.31 0.13 0.26 
.4-.8 0.09 0.25 
1.00 0.19 0.36 
1.25-2 0.14 0.25 
2.50 0.22 0.41 
 3-4 0.20 0.34 
 5-8 0.22 0.39 
 
  
 
Table 3.5: Comparison of absorbance results between the present and Hunter et al.’s 
(2010) studies for various AAI.  
 
      0th Percentile     10th percentile      90th Percentile    100th percentile 
Frequency 
(Hz) 
Hunter 
etal. 
2010 
Present 
study 
Hunter 
etal. 
2010 
Present 
study 
Hunter 
etal. 
2010 
Present 
study 
Hunter 
etal. 
2010 
Present 
study 
0.2-6 K 15.5 25.1 40.1 41.7 71.2 74.1 83.1 83.6 
1-2K 17.7 28.9 47 56 82.8 89.2 93.2 96.2 
1-4K 15.6 31.3 40.7 45.3 72.3 80.7 87 91.9 
1-6K 13.9 27.3 40.3 45.7 74.7 82.6 85.1 92.8 
2-4K 12.5 26.4 34.9 37.5 71 74.5 86.2 89.3 
2-6K 11.5 23.2 35.8 40.6 74.6 79.4 88.5 91.5 
4-6K 4.8 14.1 34.9 40.1 81.8 80.3 92.8 91.8 
2K 15.5 49.3 44 56.9 89.9 90.2 98.5 98.6 
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Figure 3.2: Comparison of median wideband absorbance in neonates across four 
studies   
   Figures 3.3 and 3.4 illustrate how normative absorbance data developed in this 
study can be used in clinics to determine the middle ear status of neonates.  A normal 
middle ear would have absorbance that falls within the normative range while an ear 
with middle ear pathology would have absorbance outside the normative range (i.e., 
below the 10th percentile).  
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Figure 3.3: WBA from right ear of a 76-hour-old female neonate who passed the test 
battery 
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Figure 3.4: WBA from left ear of a 42-hour-old female neonate who failed the test 
battery   
 
3.6 Discussion 
The present study provided normative WBA measures in healthy neonates 
who passed the HFT, ASR, TEOAE and DPOAE tests. WBA measures were obtained 
for individual frequencies from 0.25 to 8 kHz as well as AAIs that were averaged over 
different frequency regions (Table 3.3). The requirement that all neonates should pass 
all tests (HFT, ASR, TEOAE and DPOAE) may constitute a new reference standard 
for evaluating middle ear function in neonates. Previous studies [13, 14, 21, 22] had 
used a pass in DPOAE or TEOAE as the reference standard for normal middle ear 
function. Since passing OAE alone does not rule out minor middle ear dysfunction, a 
pass with a combination of tests was considered to provide a more stringent measure 
for normal middle ear function. It was reasoned that this stringent criteria may serve 
as a robust measure of middle ear function in neonates and provide the best reference 
standard available for newborns without resorting to invasive procedures such as 
myringotomy [32].  This stringent reference standard was established as it provides 
the best measure of middle ear function without resorting to invasive procedures.    
 
  There was no significant difference in absorbance between right and left ears 
at any of the frequencies in the present study. This finding agrees with that reported 
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by Hunter et al. [14] and Shahnaz [25].  On the contrary, Keefe et al. [24] found that 
at frequencies below 1.4 kHz, the left ear response had smaller absorbance than that 
of the right ear, whereas at frequencies above 1.4 kHz, the left ear response had larger 
absorbance than the right ear response. Keefe et al [24] attributed this difference 
between the ears to a relative (acoustic) stiffening of the left ear, with a resonance 
frequency in the neighbourhood of 1-1.4 kHz. Similarly, Merchant et al. [21] found 
small, albeit significant, differences between the mean measurements of the left and 
right ears. They reported that the right ear had larger absorbance than the left ear for 
the 0.5-1 kHz frequency range, while the left ear had larger absorbance than the right 
ear for the 1-4 kHz frequency range. Therefore, ear difference for absorbance 
measurements in neonates appears to be equivocal.   
 
  The present study did not find any gender difference for absorbance at any of 
the frequencies studied. This concurs with the findings of Hunter et al. [14] and 
Merchant et al. [21] who did not find a significant difference in absorbance between 
males and females. Conversely, Keefe et al. [24] found that at frequencies below 2 
kHz, the absorbance in the male ear was smaller than that in the female ear. There was 
no gender difference at frequencies above 2 kHz.  Keefe et al. [24] suggested that 
male ear is less stiff than female ears. The lack of agreement on gender differences 
between studies could be partially accounted for by the study sample. While the 
present study and studies by Hunter et al.[14] and Merchant et al.[21] included 
healthy neonates with normal middle ear function as measured against a reference 
standard, Keefe et al. [24] included neonates with risk factors (such as cleft lip and 
palate, and craniofacial anomalies) and used no measures to evaluate middle ear 
function.   
 
Several studies have shown that, at all ages, absorbance is the lowest at 
frequencies below 1kHz Hz and above 4 kHz and highest in the frequency region 
between 1 and 4 kHz [13, 16-18, 21].  The present study is in agreement with these 
findings as the absorbance was high at 1.25-2 kHz and small at 0.3-0.8 kHz and 3-4 
kHz. There was no significant difference in absorbance between the 1.25-2 kHz and 
6-8 kHz regions. However, both inter-quartile and normative ranges were higher for 
frequencies above 2 kHz compared with frequencies below 2 kHz.  The 6-8 kHz 
region had the highest inter-quartile and normative ranges. Due to this large variation, 
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the normative absorbance findings at these high frequencies may not provide useful 
clinical information to separate ears with and without middle ear disorders.    
 
  Although there was a considerable variation in absorbance with frequency, the 
diagnostic significance of each of the frequencies in the evaluation of middle ear 
pathology is yet to be determined. This process would involve evaluation of 
individual frequencies between 0.25 and 8 kHz. An alternate method would be to 
evaluate the AAIs obtained by grouping adjacent frequencies with similar absorbance.  
This method of AAI estimation, which involves fewer measurement variables, 
facilitates prompt and accurate interpretation of absorbance findings. Hunter et al. 
[14] and the present study have proposed two different sets of AAIs during the 
development of normative data. However, further research is needed to compare these 
AAIs with those obtained from neonates with middle ear pathology in order to 
evaluate their diagnostic significance. 
 
        The findings of the present study compare favourably with those of previous 
studies (Fig 3.2) [14, 25]. However, the present study showed slightly larger 
absorbance, especially from 1 to 2.5 kHz, when compared with these studies. The 
median values for Merchant et al. [21] and Sanford et al. [13] studies were not 
available for direct comparison with the present study. However, Merchant et al. [21] 
compared normative absorbance data for their neonatal subjects with other normative 
studies [13, 21, 24, 25].  The findings of the present study were also similar to those 
reported by Merchant et al. [21] but higher than those reported by Sanford et al. [13]. 
The differences in absorbance could be attributed to methodological differences 
among these studies.  First, the reference standard used to determine the middle ear 
status was different. The present study used a test battery consisting of HFT, ASR, 
TEOAEs and DPOAEs to assess middle ear function. In contrast, other researchers 
have used either DPOAEs [13, 14, 21] or TEOAEs [25] as a reference standard to 
determine normal middle ear function. The use of a test battery approach would have 
ruled out minor middle ear dysfunction and considered only ears with normal middle 
ear function. The exclusion of subtle middle ear pathology possibly facilitates 
increased absorbance, as evident in the present study.  
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  Second, the age of the study population differed across the studies. An age 
effect on WBA findings has been reported for infants in the first three months of life 
[17, 23]. Inclusion of NICU infants in their study sample increased the age at the time 
of testing in the studies by Shahnaz [25] and Keefe et al [24]. The present study and 
studies by Hunter et al. [14] and Sanford et al. [13] studied healthy neonates in the 
first few days of life. However, the average age of neonates at the time of testing in 
the present study was 46 h compared to 29 h in the study by Hunter et al [14] and 25.5 
h in the study by Sanford et al. [13]. This could have contributed to the higher median 
absorbance for frequencies from 1 to 2.5 kHz in the present study compared to these 
studies [13, 14]. This observation also agrees with the findings of other studies [13, 
21] that have noted increased absorbance on day 2 than day 1 due to the clearing of 
external and middle ear factors with age.  
 
     Third, the instruments used were different across the studies. The present 
study, Sanford et al. [13] and Keefe et al. [24] used Reflwin developed by 
Interacoustics A/S in Denmark, while Hunter et al. [14], Merchant et al. [21] and 
Shahnaz [25] used the Mimosa reflectance system. Different ear tips and calibration 
methods used between the two systems could have contributed to the observed 
differences between the studies [21, 22, 38]. 
  
Last, the method of ensuring a tight probe fit differed across the studies. The 
absorbance response is sensitive to the quality of probe fit which, in turn, affects the 
energy being reflected or absorbed. For example, the present study and the study by 
Hunter et al. [14] used a visual display of results during data acquisition, and the 
pattern of results of both studies concur with each other as well as with other studies 
on neonates and young neonates [21, 22, 25]. In contrast, Keefe et al. [24] used 
negative equivalent volume to verify the seal only during the recording of results.  
Using this method, Keefe et al. [24] reported that 13% of neonates in their study had 
poor acoustic seal. The relatively high absorbance at and below 1 kHz in their study 
also suggests poor acoustic seal in some ears. Therefore, probe fit should be checked 
during data acquisition using either visual display of results or equivalent volume to 
determine adequate seal. However, as Keefe et al. [24] suggest, there is a need for 
further experiments to compare the criterion for probe fit with the results obtained by 
an independent reference standard to check whether or not a leak is present.  
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3.6.1 Clinical application 
  The present study has provided normative WBA data by employing a very 
stringent reference standard to determine middle ear function. This stringent reference 
standard has ensured normal middle ear function and an efficient conductive 
mechanism as evidenced by increased absorbance in comparison to studies that have 
used only OAEs to determine normal middle ear status. Such a stringent reference 
standard can be used to compare ears with and without middle ear dysfunction to 
establish the sensitivity, specificity and efficacy of absorbance measurements in ears 
of neonates. 
 
  The results from the present study could be useful during assessment of 
middle ear function in neonates. Figures 3.3 and 3.4 show two case studies where this 
normative data can be applied. Figure 3.3 shows the absorbance values from a 76-h-
old female neonate who passed the test battery. These absorbance values are within 
the normative range, suggesting normal middle ear function. Figure 3.4 shows the 
WBA from a 42-h-old female neonate who failed the test battery. Here, the 
absorbance values are below the normative range, suggesting middle ear dysfunction.  
 
  The present study defined the normative range as the range between the 10th 
and 90th percentiles. Further studies using test performance of WBA in ears with and 
without middle ear dysfunction are needed to determine whether this normative range 
is best suited for neonates. Additionally, this study used a test battery approach to 
ensure normal middle ear function. Among the tests in the battery, HFT, TEOAE and 
DPOAE require measurement at a single level and are easy to perform. On the 
contrary, ASR measurement involves presentation at various levels and the loud 
signal may disturb a well settled baby. Therefore, further research using test 
performance measures is necessary to determine the minimum test battery that should 
be used for the assessment of middle ear function in neonates.  
 
3.6.2 Limitations of the study 
  Although normative data were obtained from healthy neonates who passed a 
battery of tests, a number of factors could have adversely affected the test results. 
First, the pass criteria were very stringent and, hence, only about one third (66 /195) 
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of neonates passed the test battery in one or both ears. The remaining two thirds of 
neonates either did not pass or had missing data with one or more tests in one or both 
ears. The ASR test was the most difficult to perform and, most often, the neonates 
either failed the ASR test or the ASR test could not be completed as the neonate was 
unsettled. Second, the activity state of the neonates affected the measurement of 
WBA. In a well settled neonate, the test could be completed within 10 s. However, if 
the neonate was unsettled or being fed, the high physiologic noise generated by the 
neonate would invalidate the WBA results. This factor was controlled by measuring 
WBA when the neonate was well settled. Third, it was not always possible to get a 
tight probe seal in the neonates. In some circumstances, the probe had to be removed 
and reinserted more than once to obtain a good seal during the test.  This process had 
the potential to disturb the well settled neonate.  A visual display of the probe seal was 
checked with every neonate to ensure that there was no reduced reflectance in the 
frequencies below 1000 Hz due to leakage.  
 
 
3.6.3 Summary 
  In conclusion, the present study provided normative wideband absorbance data 
in healthy neonates who passed HFT, ASR, TEOAE and DPOAE. The results of this 
study showed higher absorbance and more efficient middle ear transfer function 
compared to other studies that have obtained normative WBA using only OAEs as the 
reference standard.  The normative data obtained in this study can be applied 
clinically to assess middle ear function in neonates. Further research using test 
performance measures is needed to determine the best combination of tests required to 
establish a reference standard.  
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Chapter Four: Wideband Absorbance Outcomes In 
Newborns: A Comparison With High Frequency 
Tympanometry, Automated Brainstem Response, 
Transient Evoked And Distortion Product 
Otoacoustic Emissions. 
 
4.1 Background 
Determination of true status of the outer and middle ear is very difficult with 
neonates and young infants. Apart from air and bone conduction tone burst ABR (AC 
& BC TB ABR) threshold measures, there is no gold standard for evaluating the 
function of the conductive pathway in this population. However, AC and BC TB ABR 
measures are time consuming and not commonly used in newborn hearing screening 
programs. In previous studies of wideband absorbance (WBA), distortion product 
otoacoustic emissions (DPOAE) have been used as a reference standard. Since 
DPOAE cannot reliably identify the true outer and middle ear conditions, the 
conclusions that can be drawn regarding the diagnostic accuracy of WBA are limited.  
Use of DPOAE as a reference standard in the evaluation of diagnostic accuracy of 
WBA is a serious shortcoming and limits the clinical applicability of WBA.  
 
This study compared the test performance of WBA against four single test and 
three composite test (or test battery) reference standards. The aim was to determine 
whether WBA can provide a more effective alternate to either individual tests or a 
combination of tests for determining the outer and middle ear status.  The results of 
this study are presented in Chapter Four of this thesis.  
 
Chapter Four of this thesis, entitled, “Wideband absorbance outcomes in 
newborns: A comparison with high frequency tympanometry, automated brainstem 
response, transient evoked and distortion product otoacoustic emissions” is based on 
an article submitted for publication in Ear and Hearing. While this manuscript is 
inserted as a chapter in this thesis, the formatting of section sub-headings and 
numbering of tables and figures have been modified from the original publication to 
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match the thesis format. The referencing of the article is retained as per the Ear and 
Hearing journal format.   
Aithal, S., Kei, J., Driscoll C., & Khan, A. Wideband absorbance outcomes in 
newborns: A comparison with high frequency tympanometry, automated 
brainstem response, transient evoked and distortion product otoacoustic 
emissions.   Article submitted to Ear and Hearing.  
 
4.2 Abstract  
 Objectives: The purpose of this study was to evaluate the test performance of 
wideband absorbance (WBA) in terms of its ability to predict the outer and middle ear 
status as determined by nine reference standards.    
Design: Automated auditory brainstem response (AABR), high frequency (1000 Hz) 
tympanometry (HFT), transient evoked otoacoustic emission (TEOAE) and distortion 
product otoacoustic emission (DPOAE) tests were performed on 298 ears (144 right, 
154 left) of 192 (108 males, 84 females) neonates with a mean age of 43.7 hours (SD 
= 21.3, range = 8.3 to 152.2 hours). WBA was measured from 0.25 to 8 kHz using 
clicks under ambient pressure conditions. Test performance of WBA was assessed in 
terms of its ability to identify conductive conditions in neonates when compared with 
nine reference standards (including four single tests and five test batteries) using the 
receiver operating characteristic (ROC) analysis.   
Results: The test performance of WBA against the test battery reference standards 
was better than that against single test reference standards (AABR, HFT, TEOAE and 
DPOAE). The area under the ROC curve reached a high value of 0.78 for 
HFT+TEOAE+DPOAE and AABR+TEOAE+DPOAE reference standards. Within 
the ears that passed each of the reference standards, there were no significant 
differences in WBA. However, for the ears that failed each of the test standards, there 
were significant differences in WBA. The region between 1 and 4 kHz provided the 
best discriminability to evaluate the conductive status compared to other frequencies.   
Conclusions: WBA is a desirable measure of conductive conditions in newborns due 
to its superior test performance in classifying ears that passed or were referred, using 
the above composite standards’ (HFT+TEOAE+DPOAE and 
AABR+TEOAE+DPOAE) test outcomes as the surrogate gold standard compared to 
single test standards.  
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4.3 Introduction 
 
Assessment of outer and middle ear function is important in differentiating a 
transient conductive condition from a sensorineural condition. Conventional 
tympanometry, a standard test of middle ear function used with children and adults, 
has limited application with neonates. Tympanometry using a 226-Hz probe tone has 
been found to be insensitive to conductive conditions in newborns (Paradise et al. 
1976; Marchant et al. 1984; Hunter & Margolis 1992; Kei et al. 2003). Although high 
frequency tympanometry (HFT) using a 1-kHz probe tone is recommended for use 
with young infants (Kei et al. 2003; Margolis et al. 2003; Baldwin 2006; Alaerts et al. 
2007), there are no universally agreed methods for interpreting results (Kei & Mazlan 
2012).   
 
Auditory brainstem response (ABR) is currently considered as the gold 
standard measure for assessing the auditory function of infants referred from newborn 
hearing screening. A combination of air conduction (AC) and bone conduction (BC) 
ABR for tone burst stimuli has been shown to be useful in determining the type and 
degree of hearing loss (Prieve et al. 2013).  However, Stapells (2011) reported that 
many clinicians do not routinely obtain ABR results for bone conduction stimuli after 
finding elevated AC thresholds. Instead, they rely on immittance results for 
determining the middle ear status.   Stapells also reported that when BC testing is 
performed, the results are not used to calculate the air-bone gap but are primarily used 
to indicate whether BC thresholds are normal or elevated.  
 
An alternate method of outer and middle ear assessment is wideband acoustic 
immittance (WAI) which includes measures such as wideband reflectance (WBR) and  
wideband absorbance (WBA). WBR is defined as the ratio of reflected power to 
incident power (Voss & Allen 1994).  WBA, defined as 1-WBR, represents the 
proportion of sound energy absorbed by the middle ear using a wideband stimulus 
(such as a click or chirp) which covers a frequency range from 0.2 to 8 kHz. WBA 
varies from 1.0 meaning that all the energy is absorbed by the middle ear to 0.0 
meaning that all energy is reflected from the middle ear (Feeney & Sanford 2012). In 
the present paper, the findings of all studies will be discussed in terms of WBA for 
ease of comparison with the present study.  
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Studies have shown WBA to be sensitive to various conductive disorders in 
children (Jeng et al. 1999; Piskorski et al. 1999; Keefe & Simmons 2003; Beers et al. 
2010; Keefe et al. 2012) and adults (Feeney et al. 2003; Keefe & Simmons 2003; 
Allen et al. 2005).  WBA is also reported to be useful in the neonatal population 
(Keefe et al. 2003; Vander Werff et al. 2007; Sanford et al. 2009; Hunter et al. 2010).  
More importantly, Keefe et al. (2003) demonstrated that inclusion of WBA test in 
universal newborn hearing screening (UNHS) programs decreased the false positive 
rates from 5% to 1%, thus, suggesting that information on outer and middle ear status 
improves the ability to predict hearing status.  Consequently, WBA is recommended 
as an adjunct tool in UNHS programs (Vander Werff et al. 2007; Sanford et al. 2009; 
Hunter et al. 2010; Merchant et al. 2010; Werner et al. 2010; Feeney & Sanford 
2012).  
 
In addition, WBA has been found to predict distortion product otoacoustic 
emission (DPOAE) outcomes more accurately than HFT (Sanford et al. 2009; Hunter 
et al. 2010).  Sanford et al. (2009) investigated test performance of WBA and HFT in 
terms of their ability to predict DPOAE outcomes in 455 neonate ears. They reported 
an area under the receiving operating characteristic curve (AROC) of 0.87 for WBA 
and 0.75 for HFT. Similarly, Hunter et al. (2010) studied the test performance of 
WBA and HFT to predict DPOAE outcomes in 324 neonates and reported an AROC 
of 0.90 for WBA at 2 kHz, 0.82 for WBA at 1 kHz and 0.72 for HFT.  
 
Although WBA has been reported to be useful in predicting outer and middle 
ear status in neonates, evaluating its test performance is challenging. Even though air 
and bone conduction (AC and BC) tone burst ABR may be regarded as a surrogate 
gold standard for detecting conductive conditions, this threshold ABR measure 
requires long testing time to complete and is done as a diagnostic measure at some 
point later in time rather than during the hearing screening period. Furthermore, as 
Sangster (2011) suggests, most studies circumvent this issue by using DPOAE as the 
reference standard because it is already used in screening programs and it indirectly 
gives information on the forward and reverse transmission of sound through the 
middle ear. However, DPOAE may not accurately identify minor or sub-clinical 
conductive pathologies (Kemp 2002) and DPOAE outcomes are affected by 
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physiologic and ambient noise. Hence, it may not serve as an ideal reference standard 
(Sanford et al., 2009; Hunter et al., 2010).  This represents a significant shortcoming 
in the evaluation of WBA, and limits its clinical applicability (Sangster 2011).  
 
A strict gold standard to determine middle ear effusion would be 
myringotomy. Since ethical considerations prohibit surgical procedures in non-
symptomatic neonates, myringotomy cannot be used to determine the test 
performance of WBA.  In light of this limitation, an alternate, albeit less strict, 
reference standard based on the outcomes of a battery of tests, may be used instead 
(Mazlan & Kei 2012). Aithal et al. (2013) developed normative WBA data on 
neonates using a test battery consisting of automated auditory brainstem response 
(AABR), HFT, acoustic stapedial reflex (ASR), transient evoked otoacoustic emission 
(TEOAE) and DPOAE tests as a reference standard to determine the outer and middle 
ear status. They suggested that this composite reference standard provided the best 
measure of outer and middle ear function without resorting to invasive procedures. 
Nevertheless, an important clinical question is how WBA compares with various 
individual tests (such as TEOAE and HFT) or composite of tests in terms of 
predicting test outcomes in the neonatal population.   
 
The aim of the study was to evaluate the test performance of WBA against 
nine reference standards consisting of four single tests and five test batteries in an 
attempt to determine whether WBA can provide a more effective alternate to either 
individual tests or a combination of tests for determining the outer and middle ear 
status in neonates.    
 
4.4 Method 
The present study enrolled 192 healthy neonates born at the maternity unit of 
The Townsville Hospital. The Townsville Health Service District Institutional Ethics 
Committee and the University of Queensland Behavioural and Social Sciences Ethical 
Review Committees approved the study.  Written consent was obtained from the 
parents during their hospital stay.     
 
4.4.1 Subjects and test environment  
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In total, 192 (108 males, 84 females) healthy neonates were recruited for the 
present study. Of these infants, 154 were Caucasian, 31 were Aboriginal, 5 were 
Asian and 2 were African. None of the infants included in the present study 
participated in the Aithal et al. (2013) study. Mean age of the neonates at the time of 
testing was 43.7 hours (SD= 21.3, range = 8.3 to 152.2 hours). Only three neonates 
were more than 100 hours old. Mean gestational age of the neonates was 39.2 weeks 
(SD = 1.2, range = 36-42 weeks). Mean birth weight was 3476.9 g (SD= 460.9, range 
= 2290-5000 g).   
 
All measurements were performed in a quiet room in the maternity unit. 
Nursing staff performed AABR screen while an experienced audiologist performed 
the other tests. AABR screen was always performed first followed by HFT, TEOAE, 
DPOAE and WBA tests, in no particular order. The order of testing depended on the 
activity state of the neonate and how feasible it was to obtain a good seal for 
performing the test. The most accessible ear was tested first and the second ear was 
tested if the neonate was well settled and there was adequate time for testing.   
 
4.4.2 Procedure  
4.4.2.1 Automated auditory brainstem response: The AABR screening was 
done using the Natus ALGO3. Click stimuli were presented at a level of 35 dB nHL to 
both ears via ear muffins. A pass or refer for each ear was automatically displayed on 
the screen.   
 
4.4.2.2 High frequency tympanometry: HFT was performed using a Madsen 
Otoflex 100 acoustic immittance device with a 1-kHz probe tone. The pressure was 
changed from +200 to -400 daPa at a rate of 400 daPa/sec and admittance (Y) 
tympanograms were obtained. The pass criterion was a single positively peaked 
tympanogram with peak compensated static admittance (+200 daPa tail to peak) of 
more than 0.2 mmho (Mazlan et al. 2009). 
 
4.4.2.3 Transient evoked otoacoustic emissions: TEOAEs were obtained 
using a Biologic Navigator Plus. The signal consisted of wideband clicks of 80 µs 
duration, at a targeted amplitude of 80 dB pkSPL. The pass criteria included 
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reproducibility of at least 70% and a signal-to-noise ratio (SNR) of at least 3 dB at 2, 
3, and 4 kHz (Kei et al. 2003; Vander Werff et al. 2007). 
  
 
4.4.2.4 Distortion product otoacoustic emissions: DPOAEs were obtained 
using the same Biologic device as the TEOAEs. DPOAEs were measured in response 
to stimulation using pairs of primary tones (F1, F2) with F2 frequency set at 2, 3, 4, 
and 6 kHz with a frequency ratio (F2/F1) of 1.2 and fixed levels of 65 and 55 dB SPL 
for F1 and F2, respectively. Pass criteria included (i) the noise level less than 0 dB 
SPL and (ii) the SNR to be a minimum of 6 dB in at least three out of four F2 
frequencies (Sanford et al. 2009; Hunter et al. 2010) and (iii) a DPOAE magnitude 
with a level of at least -6 dB SPL (Sanford et al. 2009; Merchant et al. 2010). 
 
4.4.2.5 Wideband absorbance: WBA was measured using a prototype 
research system developed by Interacoustics A/S (Denmark). The Reflwin 
computerised system consisted of a Windows-based computer, a 24-bit resolution 
sound card, a pressure pump and controller system contained in an acoustic 
immittance instrument (AT235), and custom software (version 3.2.1) for stimulus 
generation and data acquisition. Calibration was performed every day prior to data 
collection. Keefe and Simmons (2003) provide a detailed description of the 
calibration process for WBA.  Calibration of the Reflwin system was based on the 
analysis of wave characteristics within two rigid walled cylindrical calibration tubes 
232.3 and 5.6 cm in length.  A calibration was accepted as long as the root-mean-
squared reflectance error (∆R) did not exceed 0.009 and the loss parameter χ was in 
the range from 1 to 1.09 (Keefe & Simmons 2003; Sanford et al. 2009).  
 
WBA measurements at ambient pressure were obtained by recording acoustic 
responses to clicks, presented at 55 dB SPL and at a rate of one click per 46 msec to 
the neonate’s ear. Responses from a total of 16 clicks were averaged for each 
measurement and WBA was calculated for each averaged response. A visual display 
with high absorbance at frequencies below 1 kHz served as an on-screen prompt that 
alerted the tester if there was a probe leak. Absorbance of 0.7 or more at each of the 
six one-third octave frequencies between 0.25 and 0.8 kHz (0.25, 0.3, 0.4, 0.5, 0.6 and 
0.8 kHz) was considered high and was suggestive of a probe leak. When this 
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happened, the probe was removed and re-inserted to ensure that an adequate seal was 
obtained for another WBA measure. The typical test time for the WBA test was less 
than 10 seconds for a quiet neonate.  
 
4.4.3 Reference standards and pass/fail classification 
Presently, there is no unanimous agreement on which reference standard 
should be used to determine the test performance of WBA. For instance, Sanford et al. 
(2009) and Hunter et al. (2010) have used DPOAE while Vander Werff et al. (2007), 
Shahnaz (2008) and Silva et al. (2013) have used TEOAE to determine the status of 
the middle ear. Although Norton et al. (2000) have found the performance of TEOAE 
and DPOAE to be similar in a UNHS program, the inclusion of both TEOAE and 
DPOAE as reference standards would be useful because the mechanisms involved in 
generating otoacoustic emissions by the two procedures are different and the two 
procedures demonstrate different susceptibility to noise, resulting in different test 
outcomes in the individuals (Costa et al 2009; Rhoades et al. 1998; Shi et al. 2000). In 
the present study, nine reference standards were established using the AABR, HFT, 
TEOAE and DPOAE tests or their combinations for the determination of test 
performance of WBA. These reference standards are presented in Table 1.  The reason 
for including a combination of tests as reference standards was the assumption that 
neonates who passed a battery of tests involving HFT, TEOAE and DPOAE were 
more likely to have a normal conductive pathway (outer and middle ear) than those 
who passed a single test (Aithal et al. 2013).  
Table 4.1 Single test/test battery reference standards adopted in the present study 
Reference Standard 
Automated auditory brainstem response  (AABR) 
High frequency tympanometry  (HFT) 
Transient evoked otoacoustic emissions  (TEOAE) 
Distortion product otoacoustic emissions  (DPOAE) 
HFT + TEOAE 
HFT + DPOAE  
TEOAE+DPOAE 
HFT + TEOAE + DPOAE 
AABR+TEOAE+DPOAE 
    113 
The pass criteria for single tests were determined as described earlier in this 
section. A strict parallel test protocol (Turner et al. 1999) was used with the test 
battery reference standards. With this criteria, the ear with a pass in all the tests in a 
particular test battery was included in the ‘pass’ condition for that reference standard.  
For instance, with the HFT+TEOAE reference standard, only ears with a pass in both 
HFT and TEOAE tests were included in the pass condition for that test battery while 
the results of the other individual tests were not considered. Likewise, the test 
protocol for neonates who failed in a test battery reference standard was also a strict 
parallel protocol wherein an ear with a fail in those tests in the test battery was 
included in the ‘fail’ condition for that reference standard. For example, with the 
HFT+TEOAE+DPOAE reference standard, only the ears with a fail in all three 
individual tests (HFT, TEOAE and DPOAE) were included in the fail condition for 
that reference standard. 
 
Table 2 shows different reference standard tests/test batteries with the number 
of ears that passed or failed against each reference standard. Only the ears that either 
passed or failed individual tests, or all tests in the case of test batteries, were included 
for analysis. With the strict test protocol, the ears that passed some but not all the tests 
were not included for analysis. Only one test battery that included AABR was 
considered for analysis. This is because, only 10 out of 298 ears included in the study 
failed AABR. When AABR was included along with other tests in the test batteries, 
the number of ears that failed the respective test battery was further reduced.  For 
instance, only four ears failed (243 passed) AABR+HFT and AABR+DPOAE, nine 
ears failed (268 passed) AABR+TEOAE and only two ears failed (200 passed) 
AABR+HFT+TEOAE+DPOAE reference tests. Nevertheless, only results for 
AABR+TEOAE+DPOAE are provided for comparison against other reference test 
standards. 
 
The pass/fail classification for the WBA measure was more complicated than 
that of other tests because of the large number of frequencies measured. In the present 
study, WBA was measured at 16 single frequencies from 0.25 to 8 kHz in one-third 
octave intervals. Using the same equipment but different subjects, Aithal et al. (2013) 
developed normative WBA data at the 16 frequencies for newborns using a pass in a 
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test battery consisting of AABR, HFT, ASR, TEOAE and DPOAE as a reference 
standard. They suggested that this reference standard provided the best measure of  
outer and middle ear function without resorting to an invasive surgical procedure such 
as myringotomy. The normative range of WBA at each frequency, as described by 
Aithal et al. (2013), was used to determine pass/fail criteria for the neonates.  WBA 
values at and above the 10th percentile of the normative data were considered as a 
pass, whereas values below the 10th percentile were considered as a fail. WBA data 
was available for all the 298 ears included in the study. Table 3 shows the number of 
ears that passed or failed WBA.  
 
 
Table 4.2  Number of ears that passed or failed in nine reference standards 
Reference standard Number of 
ears that 
passed  
Number of 
ears that 
failed  
Total number 
of ears 
AABR  288 10 298 
HFT 186 89 275 
TEOAE 206 88 294 
DPOAE 218 57 275 
HFT + TEOAE 147 45 192 
HFT + DPOAE 
TEOAE+DPOAE 
150 
235 
27 
52 
177 
        183 
HFT + TEOAE + DPOAE 
AABR+TEOAE+DPOAE 
134 
183 
21 
8 
155 
191 
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Table 4.3 Number of ears that passed or failed WBA at various frequencies    
Frequency 
(kHz) 
Pass Fail 
0.25 242 56 
0.3 266 32 
0.4 261 37 
0.5 258 40 
0.6 268 30 
0.8 259 39 
1 257 41 
1.25 253 45 
1.5 253 45 
2 256 42 
2.5 257 41 
3 269 29 
4 253 45 
5 244 54 
6 258 40 
8 257 41 
 
4.4.4 Statistical Analysis   
To compare WBA among the nine reference standards, an analysis of variance 
(ANOVA) was performed with WBA as the dependent variable, and frequency (16 
levels) and reference standard as independent variables. An alpha level of 0.05 was 
used for all analyses.  Post hoc analysis using Bonferroni correction was performed to 
examine the effect of reference standard on WBA. ANOVA was also performed to 
determine the significance of difference between pass and fail conditions for each 
reference standard.  
 
Receiver operating characteristic (ROC) curves, showing test sensitivity 
against one minus test specificity, are a standard procedure to evaluate the test 
performance of a diagnostic test. They show to what extent two distributions (e.g., 
pass and fail) overlap. The further apart the distributions, the greater will be the area 
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under the ROC curve (AROC), which is an overall indication of the diagnostic 
accuracy of a ROC curve (Zhou et al. 2002). An AROC value of 1 indicates that the 
test measure reliably distinguishes between two mutually exclusive distributions, for 
instance, ‘normal’ and ‘disease’ conditions. On the other hand, an AROC value of 0.5 
indicates that the predictor is no better than chance to determine the conditions (Zhou 
et al. 2002). Test performance for all the nine reference standards was determined 
using SPSS software (version 20). Additionally, AROC was determined for various 
absorbance area indices (0.25-0.3, 0.4-0.8, 1, 1.25-2, 2.5, 3-4 and 4-8 kHz) as 
described by Aithal et al. (2013). Statistical significance of difference between the 
AROCs was determined as suggested by Hanley and McNeil (1982).  
 
4.5 Results 
Figure 4.1 displays the results for median WBA for the ‘pass’ condition for the 
nine reference standards along with the normative range (10th to 90th percentile) 
provided by Aithal et al (2013). The median WBA from 0.25 to 8 kHz was similar 
across all reference standard pass conditions with two maxima occurring at 1.5 and 6 
kHz. The WBA ranged between 0.40 and 0.76 across all reference standard pass 
conditions. The WBA for all reference standards was within the normative range 
provided by Aithal et al. (2013). 
 
An ANOVA with repeated measures was applied to the data with WBA as the 
dependent variable, and frequency and reference standard as independent variables. 
The results revealed a significant frequency effect [F(8, 13925) = 7.31, p = 0.00]. 
However, the difference in WBA across reference standards did not reach significance 
[F(66, 13925) = 0.97, p = 0.55].  There was no significant interaction between 
frequency and reference standard [F(8, 1686) = 1.89, p = 0.06].  Further analysis of 
the frequency effect was not conducted since WBA pattern across the frequency range 
was similar to that reported by earlier normative studies, wherein absorbance was 
highest in the frequency region between 1 and 4 kHz and lowest at frequencies below 
1 kHz and above 4 kHz (Keefe et al. 1993; Sanford et al. 2009; Hunter et al. 2010; 
Merchant et al. 2010; Aithal et al. 2013).   
 
    117 
0.25 0.4 0.6 1 1.5 2.5 4 6
Frequency (kHz)
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
A
bs
o
rb
an
ce
 
AABR
HFT
TEOAE
DPOAE
HFT+TEOAE
HFT+DPOAE
TEOAE+DPOAE
HFT+TEOAE+DPOAE
AABR+TEOAE+DPAOE
10th percentile Aithal et al. 2013
90th percentile Aithal et al. 2013
 
Figure 4.1: Median absorbance obtained from ears that passed various reference 
standards plotted against frequency in comparison to the normative range obtained by 
Aithal et al (2013).  
 
Figure 4.2 illustrates the standard deviation (SD) of WBA across nine 
reference standards for the pass condition.  Across all reference standards, SD was the 
least (0.12-0.17) between 0.25 and 0.8 kHz, medium (0.16-0.23) between 1 and 3 kHz 
and highest (0.26-0.28) at 8 kHz. There was a general trend for SD to increase with 
frequency from 0.8 to 8 kHz.  
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Figure 4.2: Standard deviation of absorbance for ears that passed various reference 
standards  
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Median WBA data across nine reference standards for the pass condition in 
the present study were compared with normative data provided by Shahnaz (2008), 
Sanford et al. (2009), Hunter et al. (2010), Merchant et al. (2010) and Aithal et al. 
(2013). As illustrated in Figure 4.3, apart from the difference in magnitude of WBA, 
the pattern of WBA was similar across the present study and other studies in that 
WBA was high between 1 and 4 kHz and reduced below 1 kHz and above 4 kHz.  
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Figure 4.3: Median absorbance obtained from ears that passed various reference 
standards plotted against frequency in comparison to five published studies 
 
Median WBA values for the ‘fail’ condition for the nine reference standards 
are displayed in Figure 4.4. The normative region (10th and 90th percentiles) described 
by Aithal et al. (2013) is also plotted in this figure for comparison. Apart from the 
median WBA pattern for the HFT reference standard which showed a large peak at 
1.5 kHz, the traces corresponding to the other reference standards were relatively flat 
across the entire frequency range with minor peaks and troughs from 1 to 8 kHz. The 
median WBA values for all, except the HFT, reference standards were below the 10th 
percentile values obtained by Aithal et al. (2013).  
 
Figure 4.5 illustrates the standard deviation (SD) of WBA across nine 
reference standards for the fail condition.  While there was a general trend for SD to 
increase with increasing frequency, the SD values for the fail condition were generally 
greater than those for the pass condition (Figure 4.2).  
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Figure 4.4: Median absorbance obtained from ears that failed various reference 
standards plotted against frequency in comparison to the normative range obtained by 
Aithal et al (2013).  
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Table 4.4  Results of a post hoc analysis using multiple comparisons with Bonferroni correction comparing wideband absorbance averaged 
across all frequencies between reference standards for ears that failed each of the reference standards.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                   * - denotes significant difference with p < 0.05 
 
 
 
 
 
 
 
 HFT TEOAE DPOAE 
HFT+             
TEOAE 
HFT+               
DPOAE 
TEOAE+ 
DPOAE 
HFT+                
TEOAE+        
DPOAE 
AABR+ 
TEOAE+ 
DPOAE 
AABR  0.36 0.75 1.00 0.64 0.35 0.98 0.29 0.92 
HFT    0.22 0.06 0.01* 0.00* 0.00* 0.08 0.34 
TEOAE      0.53  0.14 0.03* 0.02* 0.50 0.67 
DPOAE        0.41 0.25 0.09 0.96 0.90 
HFT+ 
TEOAE         
 0.45 0.33 0.44 0.76 
HFT+     
DPOAE           
 0.79 0.14 0.45 
TEOAE+ 
DPOAE           
  0.10  0.39 
HFT+ 
TEOAE+ 
DPOAE           
    0.92 
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Figure 4.5: Standard deviation of absorbance for ears that failed various 
reference standards 
 
The WBA results obtained from ears that failed in the reference standards 
were analysed using an ANOVA with repeated measures with WBA as the dependent 
variable, and frequency and reference standard as independent variables. The results 
revealed a significant effect for frequency [F(7, 2756) = 17.23, p = 0.00] and 
reference standard [F(8, 388) = 3.82, p = 0.03]. The interaction between frequency 
and reference standard [F(56, 2756) = 0.88, p = 0.72] was not significant. A post hoc 
analysis using multiple comparisons with Bonferroni correction was performed to 
analyse the effect of reference standards. As seen in Table 4.4, the results revealed 
significant difference in WBA averaged across all frequencies between HFT and three 
test battery reference standards (HFT+TEOAE, HFT+DPOAE and 
TEOAE+DPOAE), and between TEOAE and two test battery reference standards 
(HFT+DPOAE and TEOAE+DPOAE). However, there were no significant 
differences in WBA between the other reference standards.      
 
To ascertain if WBA obtained from ears that failed in each reference standard 
vary with frequency, a post hoc analysis using multiple comparisons with Bonferroni 
correction was applied to the data. The results showed no significant difference in 
WBA across frequencies for AABR, HFT, HFT+DPOAE, HFT+TEOAE+DPOAE 
and AABR+TEOAE+DPOAE tests, indicating a relatively flat response pattern for 
these reference standards.  WBA was significantly different between 0.6 kHz and 
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0.25, 1.5, and 5 kHz for the TEOAE+DPOAE test battery, and between 0.25 and 0.6 
kHz only for the HFT+TEOAE test battery. For the TEOAE test, WBA was 
significantly different between 0.25 and 0.6 kHz, between 0.5 and 1.25 kHz, and 
between 3 kHz and 1.5, 2.5, 4 and 5 kHz. For the DPOAE test, WBA was 
significantly different between 1.25 and 0.3, 0.4 and 0.5 kHz, between 2 kHz and 0.3, 
0.4, 0.5, 0.6, and between 3 and 8 kHz, indicating significant variations in the WBA 
response.     
 
As seen from Figures 4.1 and 4.4, the median WBA for the fail condition was 
generally lower than that for the pass condition for each reference standard. Table 4.5 
demonstrates the significance of the difference in WBA between the pass and fail 
condition for each reference standard. For all reference standards, WBA condition 
was significantly different from 0.8 to 2.5 kHz across the two conditions. A close 
examination of results revealed that WBA for pass condition was significantly 
different from the WBA for fail condition across all frequencies between 0.25 and 8 
kHz for the test battery reference standards except for TEOAE+DPOAE and 
AABR+TEOAE+DPOAE.  
 
An AROC was computed to determine the test performance of WBA against 
each reference standard. The results for the nine reference standards are shown in 
Table 4.6.  In general, across all the reference standards, AROC was the highest at 
1.25 kHz. For instance, the AROC at 1.25 kHz was the highest for, 
HFT+TEOAE+DPOAE (0.78) AABR+TEOAE+DPOAE (0.78) and HFT+DPOAE 
(0.77). In comparison, AROC for other reference standards ranged between 0.57 and 
0.73 at 1.25 kHz. Hunter et al. (2010) found that 2 kHz was the best absorbance 
frequency for discriminating DPOAE pass from DPOAE refer conditions. The results 
from Table 4.6 show that the AROC of WBA at 2 kHz against TEOAE at 2 kHz was 
0.63 and against DPOAE at 2 kHz was 0.63. 
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Table 4.5: Significance of difference in WBA between the pass and fail conditions for nine reference standards.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* - denotes significant difference with p < 0.05 
Frequency 
(kHz) AABR HFT TEOAE DPOAE 
HFT+               
TEOAE 
HFT+               
DPOAE 
TEOAE+ 
DPOAE 
HFT+                
TEOAE+        
DPOAE 
AABR+ 
TEOAE+ 
DPOAE 
0.25 0.03* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 
0.3 0.25 0.01* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.02* 
0.4 0.93 0.04* 0.07 0.42 0.00* 0.00* 0.17 0.00* 0.53 
0.5 0.96 0.04* 0.24 0.99 0.00* 0.02* 0.58 0.01* 0.71 
0.6 0.40 0.02* 0.02* 0.25 0.00* 0.00* 0.06 0.03* 0.21 
0.8 0.07* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.01* 
1 0.01* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 
1.25 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 
1.5 0.00* 0.01* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 
2 0.00* 0.03* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 
2.5 0.00* 0.01* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 
3 0.16 0.06 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.20 
4 0.77 0.06 0.01* 0.02* 0.00* 0.00* 0.00* 0.00* 0.90 
5 0.39 0.02* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.34 
6 0.29 0.01* 0.00* 0.00* 0.00* 0.00* 0.00* 0.00* 0.12 
8 0.32 0.04* 0.01* 0.01* 0.00* 0.00* 0.00* 0.00* 0.04* 
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Figures 4.6 and 4.7 illustrate examples of ROC curves for WBA across 16 
one-third octave frequencies for an individual test (DPOAE) and test battery 
(HFT+TEOAE+DPOAE) reference standards, respectively. These figures 
demonstrate higher AROC for WBA against test battery reference standard compared 
to DPOAE reference standard across all 16 frequencies.  
 
 Figure 4.6: ROC curves for WBA against DPOAE reference standard 
 
 
 
Figure 4.7: ROC curves for WBA against HFT+TEOAE+DPOAE reference standard 
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To determine whether the AROC was significantly different from 0.5 at each 
of the 16 frequencies for all reference standards, a statistical test as described by 
Hanley and McNeil (1982) was applied. As illustrated in Table 4.6, the AROC was 
significantly different from 0.5 in the frequency range between 1 and 6 kHz and 
between 0.25 and 0.3 kHz for all the reference standards except HFT, AABR and 
AABR+TEOAE+DPOAE tests.  
 
Furthermore, WBA was also determined for various absorbance area indices 
(AAIs) as described by Aithal et al (2013). Table 4.7 illustrates the AROC for seven 
AAIs for each reference standard.  As seen in Table 4.7, the AROC for WBA was 
significantly different from 0.5 across all AAIs for the HFT+TEOAE test battery.  
The AROC for WBA was significantly different from 0.5 for the 1.25-2 kHz AAI for 
all reference standards except for the HFT. Interestingly, the AROCs for WBA at 
1.25-2 kHz for these reference standards attained maximum values when compared to 
other AAIs.  
 
In addition, significance of difference between AROCs for WBA against 
different reference standards was determined for each AAI using Hanley and 
McNeil’s (1982) method. There were no significant differences in AROCs between 
any two reference standards for the AAI of 0.25-0.3, 0.4-0.8, 2.5, and 3-4 kHz (p > 
0.05).  At 1 kHz AAI, there was a significant difference in AROC for WBA between 
HFT and HFT+DPOAE (p =  0.01), and between HFT and HFT+TEOAE+DPOAE (p 
= 0.02) reference standards. At 1.25-2 kHz AAI, AROC for WBA against HFT was 
significantly lower than that for TEOAE (p = 0.01), DPOAE (p = 0.01), 
HFT+TEOAE (p = 0.01), HFT+DPOAE (p = 0.00), TEOAE+DPOAE (p = 0.00) and 
HFT+TEOAE+DPOAE (p = 0.00).   At 5-8 kHz AAI, the AROC for WBA against 
HFT was significantly different from WBA against that for HFT+DPOAE (p = 0.04) 
and HFT+TEOAE+DPOAE (p = 0.01) reference standards. AROC for WBA against 
TEOAE was also significantly different from that for HFT+DPOAE (p = 0.02) and 
HFT+TEOAE+DPAOE (p = 0.01) reference standards. There was no significant 
difference between WBA for AABR and other eight reference standards.    
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     Table 4.6 Test performance of wideband absorbance as judged by area under the receiver operating  
    characteristic curves against nine reference standards  
Frequency 
(Hz) 
AABR HFT TEOAE DPOAE HFT + 
TEOAE 
HFT + 
DPOAE 
TEOAE+ 
DPOAE 
HFT + 
TEOAE+ 
DPOAE 
AABR 
+TEOAE 
+DPOAE 
0.25k 0.61 0.58* 0.62* 0.64* 0.69* 0.74* 0.64* 0.70* 0.69 
0.3k 0.54 0.55 0.58* 0.58 0.63* 0.65* 0.59* 0.65* 0.59 
0.4k 0.54 0.54 0.58 0.55 0.61* 0.62 0.57 0.62 0.58 
0.5k 0.53 0.54 0.56 0.55 0.59 0.61 0.55 0.59 0.57 
0.6k 0.55 0.53 0.55 0.54 0.57 0.58 0.54 0.57 0.59 
0.8k 0.54 0.55 0.59* 0.57 0.62* 0.63* 0.59* 0.63 0.58 
1k 0.69* 0.57 0.62* 0.65* 0.67* 0.74* 0.65* 0.75* 0.72* 
1.25k 0.73* 0.57 0.66* 0.67* 0.71* 0.77* 0.68* 0.78* 0.78* 
1.5k 0.68 0.57 0.64* 0.66* 0.67* 0.72* 0.69* 0.78* 0.71* 
2k 0.69* 0.55 0.63* 0.63* 0.64* 0.68* 0.68* 0.71* 0.72 
2.5k 0.64 0.56 0.62* 0.63* 0.66* 0.70* 0.69* 0.70* 0.65 
3k 0.55 0.54 0.55 0.56 0.60* 0.60 0.57 0.62 0.53 
4k 0.53 0.57 0.61* 0.61* 0.67* 0.69* 0.61* 0.69* 0.51 
5k 0.56 0.58* 0.62* 0.62* 0.68* 0.72* 0.68* 0.75* 0.57 
6k 0.53 0.58* 0.58* 0.61* 0.66* 0.67* 0.61* 0.77* 0.58 
8k 0.53 0.57 0.54 0.54 0.60* 0.60 0.56 0.68* 0.56 
* indicates that AROC is significantly different from 0.5 with p < 0.05. 
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         Table 4.7: Area under the operating curve (AROC) for WBA against nine reference standards for various absorbance  
        area indices   
 Reference standard 
Absorbance  
Area Index 
AABR HFT TEOAE DPOAE HFT+ 
TEOAE 
HFT+ 
DPOAE 
TEOAE+ 
DPOAE 
HFT+ 
TEOAE+ 
DPOAE 
AABR+ 
TEOAE+ 
DPOAE 
0.25-0.3 
kHz 
0.60 0.59 0.62* 0.63* 0.68* 0.71* 0.65* 0.69* 0.70 
0.4-0.8 kHz 0.50 0.54 0.56 0.54 0.60* 0.61 0.55 0.57 0.54 
1 kHz 0.69* 0.57 0.62* 0.65* 0.67* 0.74* 0.65* 0.75* 0.72* 
1.25-2 kHz 0.71* 0.56 0.69* 0.71* 0.70* 0.77* 0.74* 0.81* 0.74* 
2.5 kHz 0.64 0.56 0.62* 0.63* 0.64* 0.68* 0.68* 0.71* 0.72 
3-4 kHz 0.57 0.55 0.59* 0.66* 0.63* 0.66* 0.62* 0.58* 0.66 
5-8 kHz 0.53 0.58* 0.56 0.62* 0.62* 0.72* 0.62* 0.76* 0.59 
           * - denotes difference was significant < 0.05 
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4.6 Discussion   
4.6.1 Test performance of WBA   
The aim of the present study was to evaluate the test performance of WBA 
against various reference standards to determine how WBA compares with single tests 
(AABR, HFT, TEOAE and DPOAE) and a battery of tests (HFT+TEOAE, 
HFT+DPOAE, TEOAE+DPOAE, HFT+TEOAE+DPOAE and 
AABR+TEOAE+DPOAE) in terms of the accuracy of predicting test outcomes in the 
neonatal population.  As demonstrated in Tables 6 and 7, the AROC of WBA for the 
test battery reference standards were, in general, higher than that for single tests. The 
HFT+DPOAE and HFT+TEOAE+DPOAE test battery reference standards had higher 
test performance than that of other test batteries.  WBA for HFT reference standard 
was significantly lower than WBA for all test battery reference standards between 1 
and 2 kHz, and between 5 and 8 kHz. The WBA for the TEOAE reference standard 
was also significantly lower than the WBA for HFT+DPOAE and 
HFT+TEOAE+DPOAE reference standards between 5 and 8 kHz.  
 
In general, the test performance of WBA against the three test battery 
reference standards as indicated by AROC values attaining the highest value at 1.25 
kHz wherein the AROC measured against the HFT+TEOAE+DPOAE 
AABR+TEOAE+DPOAE reference standards was 0.78, while that against the 
HFT+DPOAE reference standard was 0.77. Better performance with test battery  
reference standards was expected because a combination of several component tests 
has been reported to provide a better perspective on any disease condition than any of 
the individual tests alone (Baughman et al. 2008; Naaktgeboren et al. 2013). The high 
test performance of WBA against the best possible composite reference standard 
(HFT+TEOAE+DPOAE) available in the present study suggests that WBA can 
differentiate ears with normal conductive pathway from those with a conductive 
condition in newborns.   
 
In comparison, the test performance of WBA against single tests was low with 
AROC ranging from 0.57 to 0.73 at 1.25 kHz. The low performance of WBA against 
the single test reference standards may indicate that a single test per se may not 
accurately diagnose conductive conditions in neonates. There are at least four possible 
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reasons to account for this phenomenon. First, the pass criteria for a single test may 
not be optimal for diagnosing conductive conditions. For instance, only single peaked 
tympanograms were included for a pass in HFT while double peaks and multiple 
peaks were considered a fail. The interpretation of HFT findings has not been 
unanimously agreed upon. For instance, Kei et al. (2003) and Margolis et al. (2003) 
reported single peaked tympanograms to be indicative of normal middle ear function 
while Swanepoel et al. (2007) suggested that double-peaked tympanograms were also 
indicative of normal middle ear transmission because strong TEOAEs were obtained 
from these ears. Similarly, AABR is not sensitive to slight and mild conductive 
hearing losses (Stapells, 2011). Furthermore, the pass criteria for TEOAE of 
reproducibility of at least 70% and a SNR of at least 3 dB at 2, 3 and 4 kHz may not 
be optimal for detecting conductive conditions, especially when the pass criteria did 
not assess frequencies below 2 kHz where the effect of middle ear disorder may be 
more significant. Second, apart from AC and BC TB ABR measures, there is no gold 
standard for detecting conductive conditions in newborns. The tests employed in the 
present study are not specially designed for detecting conductive hearing losses. For 
example, a refer result in AABR, DPOAE and TEOAE tests may also indicate the 
presence of a sensorineural hearing loss. Furthermore, a pass result in AABR does not 
rule out slight/mild hearing losses (Stapells, 2011). Likewise, a pass in a TEOAE test 
cannot completely rule out middle ear dysfunction in children (Driscoll et al. 2001). 
Although Driscoll et al. (2001) reported these findings for six-year-old children, the 
results of the present study suggest that it may hold for the neonatal population as 
well. Third, the findings of some tests are affected by environmental and/or 
physiologic noise, resulting in false positive outcomes. In particular, physiologic noise 
in neonates could confound TEOAE and DPOAE results (Driscoll et al. 1999). The 
AABR test is susceptible to myogenic noise from neonates, resulting in false positive 
responses (Herrman et al. 1995). Fourth, the single tests could not reliably provide 
adequate clinical information for detecting conductive conditions. HFT findings are 
derived from a stimulus of a single frequency (1 kHz) which may provide limited 
information on the acoustic-mechanical properties of the outer and middle ear. The 
AABR test does not provide frequency-specific information on the function of the 
outer and middle ear.  
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The test performance for WBA against DPOAE in the present study was lower 
than that reported in other studies. For instance, Sanford et al. (2009) investigated test 
performance of WBA in terms of its ability to predict DPOAE outcomes in 455 
neonate ears and reported an AROC of 0.87 for WBA. Similarly, Hunter et al. (2010) 
studied the test performance of WBA to predict DPOAE outcomes in 324 neonates 
and reported an AROC of 0.90 for WBA at 2 kHz and 0.82 for WBA at 1 kHz.  In 
comparison, the present study found the AROC for different reference standards to 
range between 0.53 and 0.78.  In addition, the AROC of WBA at a fixed frequency 
was 0.63 against TEOAE at 2 kHz and 0.63 against DPOAE at 2 kHz (Table 6).   
 
The difference in AROC between the previous studies and the present study 
can be attributed to a plethora of factors including differences in equipment, test 
environment, sample size and participant characteristics such as ethnicity and age.  In 
fact, the ethnicity of subjects in the present study differs from earlier WBA test 
performance studies due to inclusion of Aboriginal infants in the study. Previous 
studies have shown that Australian Aboriginal infants have a higher prevalence of 
middle ear dysfunction (Aithal et al. 2012; Boswell & Nienhuys 1995, 1996; 
Lehmann et al. 2008). Recently, Aithal et al. (In press) found that Aboriginal neonates 
had lower WBA than their Caucasian counterparts. Further research is needed to 
determine the test performance of WBA in the Aboriginal neonatal population. 
 
 
The test performance of WBA may vary depending on the time of testing 
during the postnatal period. Due to the possible presence of vernix and/or 
mesenchyme in the outer and middle ear at birth, the referral rate of neonates in tests 
such as DPOAE, WBA and HFT may vary depending on the time of assessment 
(White et al. 1993; Roberts et al. 1995; Sanford et al. 2009; Hunter et al. 2010).  
Previous studies showed that due to transient outer/middle ear factors, the referral rate 
during newborn hearing screening is high in the first 24 hours of life (Hunter et al. 
2010; Roberts et al. 1995; White et al. 1993). The mean age of the neonates at the 
time of testing in the present study was 43.7 hours while it was 25.5 hours and 29 
hours with Sanford et al. (2009) and Hunter et al. (2010) studies, respectively. Sanford 
et al. (2009) using DPOAE as reference standard found a difference in test 
performance of WBA between one- and two-day-old neonates. One-day-old neonates 
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had an AROC of 0.87, while two-day-old neonates had an AROC of 0.74. The AROC 
of two-day-old neonates in Sanford et al.’s study is similar to the AROC found in the 
present study.  In view of resolution of outer/middle ear conditions in the first few 
days of life, it is very important to consider the time of assessment after birth as a 
contributing factor in making comparisons of test performance of outer/middle ear 
measures in neonates.   
 
 4.6.2 Comparison of WBA across frequency regions     
The WBA for all reference standards for the pass condition was within the 
normative range described by Aithal et al. (2013) across all of the frequencies 
between 0.25 and 8 kHz. Frequency distribution of WBA for the pass condition across 
all reference standards was in agreement with the earlier normative WBA studies in 
neonates (Hunter et al., 2010; Merchant et al., 2010; Sanford et al., 2009; Shahnaz, 
2008). The absorbance was high between 1.25 and 2 kHz and low below 1 kHz and 
above 4 kHz. In contrast, the WBA in ears that failed various reference standards was 
relatively flat with small variations across the frequency range. With the exception of 
the HFT test, the WBA for all of the other reference standards was below the 
normative range across the entire frequency spectrum.  
 
Median WBA for the fail condition was lower than that for the pass condition 
across all frequencies for all reference standards. There was a significant difference in 
WBA between pass and fail conditions across most of the frequencies for all reference 
standards except for the AABR test. This agrees with the findings of previous reports 
that ears with middle ear dysfunction have significantly lower absorbance compared 
to ears with normal middle ear function in neonates and young infants (Hunter et al., 
2008, 2010; Sanford et al., 2009; Vander Werff et al., 2007; Shahnaz, 2008).  
 
For all reference standards except HFT, AABR and AABR+TEOAE+DPOAE, 
the AROC for WBA in the frequency region between 1 and 2.5 kHz significantly 
differed from 0.5, indicating that this frequency region provided greatest 
discriminability between neonates who passed or failed these reference standards 
(Tables 6 and 7). Additionally, except for AABR, the WBA in the AAI from 1 to 2.5 
kHz was significantly lower for single tests compared to test battery reference 
standards. This result confirms the findings of the studies that reported 1 to 2.5 kHz to 
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be the best frequency region to evaluate middle ear function in neonates. For example, 
Hunter et al. (2010) found that at 2 kHz and frequency regions involving 2 kHz (1 to 2 
kHz and 1 to 4 kHz), WBA provided the greatest discriminability between the ears 
with a DPOAE pass or refer result. In another study, Sanford et al. (2009) found that 
the DPOAE refer ears had lower absorbance than DPOAE pass ears, with the best 
separation of WBA results between 1.4 and 2.5 kHz. 
 
Similar to the findings of Sanford et al. (2009) and Hunter et al. (2010), the 
AROC values were lower at the frequencies between 0.25 and 0.8 kHz for all 
reference standards than at higher frequencies. Despite the low AROC values, AROC 
was significantly greater than 0.5 at 0.25 and or 0.3 kHz for the test battery reference 
standards. This finding may suggest that the test performance of WBA evaluated 
against these reference standards was good enough to identify conductive conditions 
which affect the hearing of neonates particularly at these frequencies. However, this 
conclusion should be interpreted with caution because WBA at low frequencies may 
be affected by having an inadequate probe seal during testing (Hunter et al. 2010).   
 
Regarding the high frequencies, the AROC for WBA was significantly different 
from 0.5 between 4 and 6 kHz for all the reference standards except AABR and 
AABR+TEOAE+DPOAE tests. While this finding indicates the usefulness of WBA 
at these high frequencies, Aithal et al. (2013) cautioned that these frequencies may not 
be the best for diagnostic purposes because of the large normative range of WBA in 
this frequency region. Sanford et al. (2009) also found that there was more overlap in 
WBA above 4 kHz than 1 to 2 kHz between the neonates who passed or failed the 
DPOAE test. Additionally, the variation of WBA was high in the frequencies between 
4 and 8 kHz in both pass and fail conditions (Figures 4.2 and 4.5).  Hence, the 4 to 8 
kHz range may not be useful for identification of middle ear pathology.  
 
4.6.3 WBA measured across the reference standards   
  The present study also compared WBA across the reference standards under both 
pass and fail conditions. ANOVA results for the pass condition showed that there was 
no significant difference in WBA across different reference standards. An 
examination of the median WBA values showed similar WBA results across all 
reference standards (Figure 1). These median WBA results are in good agreement 
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with the normative WBA data obtained by Aithal et al. (2013) and Sanford et al. 
(2009). Increased absorbance for all references standards in the 1 to 4 kHz range 
compared to other frequencies was also in agreement with previous normative studies 
in neonates (Hunter et al., 2010; Merchant et al., 2010; Sanford et al., 2009; Shahnaz, 
2008) 
    
 In comparison, the WBA measured in ears that failed the respective reference 
standards showed a relatively flat pattern across the entire frequency range with minor 
peaks and troughs from 1 to 8 kHz (Figure 4.4).  The best reference standard was  
HFT+TEOAE+DPOAE which gave the lowest WBA values across all frequencies for 
ears that failed this reference standard. On the contrary, the worst reference standard 
was HFT which gave the highest WBA across the frequencies. It can be deduced from 
these results that some of the 89 ears that failed in the HFT test could have an 
unobstructed conductive pathway (Table 2). In other words, HFT resulted in high 
false positive referrals. This could be due to inclusion of ears with double or multiple 
peaked tympanograms for the fail condition. Swanepoel et al. (2007) consider ears 
with double peaked tympanograms as having normal middle ear function. 
Consequently, improvements in modifying the pass/fail criteria and standardizing the 
methods for interpreting HFT results are warranted.  
 
Similarly, the test performance of AABR and AABR+TEOAE+DPOAE tests 
was lower compared to other reference standards. Since AABR is not sensitive to 
slight to mild conductive conditions (Stapells, 2011), many ears with middle ear 
dysfunction could have passed the AABR. In the present study, large numbers of ears 
failed HFT, TEOAE and DPOAE but passed AABR. Lesser numbers of ears that 
failed AABR or AABR test batteries compared to the ones that passed could have 
resulted in poor performance for these reference standards.  Thus, AABR also resulted 
in high false positive referrals. Due to this reason, an adjunct test to middle ear 
function along with AABR screening is highly desirable.   
 
In view of the above findings, while acknowledging the limitations of single 
test reference standards, the use of two or more tests as a reference standard during 
evaluation of test performance of WBA is recommended. Individual tests such as 
AABR, HFT or OAEs are not adequate to determine the middle ear status in a 
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screening context. This recommendation is also supported by the high test 
performance of WBA based on the test battery reference standards (HFT+TEOAE, 
HFT+DPOAE and HFT+TEOAE+DPOAE) and the low WBA values in ears that 
failed in these reference standards.     
 
4.6.4 Clinical application of WBA  
The finding that the test performance of WBA was high against a combination 
of tests compared to single tests of middle ear function suggests that WBA is a valid 
measure of outer and middle ear function. Due to its high accuracy, validity and brief 
testing time, WBA shows great promise as an adjunct test for middle ear assessment 
in newborn hearing screening programs.  The WBA test could be very useful in 
prioritising neonates for further diagnostic evaluation.   
 
In addition to screening, WBA can be used to accurately identify conductive 
conditions and, hence, can be employed as a diagnostic tool during the neonatal 
period. Moreover, during assessment of middle ear function, WBA could be used as a 
single clinical tool with high test performance which is as good as, if not better than, 
that of the test battery reference standards.  In view of these properties, WBA has 
advantages over other tests in a clinical setting. First, objective WBA pass/fail criteria 
have been established using normative regions to determine middle ear status. On the 
contrary, there is no consensus on the criteria for pass/fail HFT or TEOAE tests. 
Second, WBA can be used as a single test in lieu of multiple tests such as HFT and 
OAE to determine the middle ear status in neonates. This can reduce testing time, 
especially when infants are not well settled for long periods. Third, the WBA test does 
not cause discomfort to infants because it can be conducted without the need to 
pressurize the ear canal as in HFT testing.  
 
4.6.5 Strengths And Limitations  
Earlier studies have compared the test performance of WBA against either 
DPOAE (Sanford et al. 2009; Hunter et al. 2010) or a combination of TEOAE and 
DPOAE tests (Keefe et al. 2003). This is the first study that has compared WBA 
against nine reference standards involving either single tests or a combination of tests 
in neonates.     
 
    135 
One of the limitations of the present study is the use of a strict parallel 
protocol for determination of pass/fail status with test battery reference standards. 
This strict protocol had excluded the ears that passed one test but failed the others in a 
test battery reference standard. This reduced the sample size and, consequently, 
reduced the power of the statistical analyses employed in the present study.  
 
Another limitation is that administration of the multiple tests using different 
probes might disturb the neonate, resulting in the neonate being unsettled. Calming 
the neonate was necessary at the expense of increasing test duration. However, if the 
neonate remained unsettled, the tests had to be aborted. Further research is 
recommended using equipment that allows all tests (e.g., DPOAE, TEOAE, HFT and 
WBA) to be performed using a single probe. 
 
Furthermore, the results of the study could have been influenced by the 
pass/fail criteria of some tests. For instance, the pass criterion for HFT was a single 
positive peak with static admittance ≥ 0.2 mmho, while double or multiple peaks were 
considered a fail. Similarly, the TEOAE criterion of at least a 3 dB SNR in three 
frequency regions might be too lenient. However, we performed a post hoc analysis to 
compare the AROC of WBA against the TEOAE reference standard between using 
the present criteria and using the criteria of ≥ 3 dB at 1.5 kHz and ≥ 6 dB from 2 to 4 
kHz adopted by Shahnaz (2008). Interestingly, there was no significant difference in 
AROC at any frequency between the two TEOAE criteria. In particular, the AROC 
values of WBA at 2 kHz against TEOAE using the present criteria and the Shahnaz’s 
(2008) criteria were 0.63 and 0.62, respectively, with no significant difference 
between them (p > 0.05). 
 
Finally, it was difficult to evaluate outer/middle ear function in neonates. 
AABR was performed for all infants in the present study. A pass in AABR with a fail 
in the other tests such as TEOAE, DPOAE and HFT may suggest a slight conductive 
condition. Conversely, a fail in AABR per se may suggest a significant conductive 
and/or sensorineural hearing loss in excess of 35-40 dB HL (Stapells 2011). Even if 
test battery reference standards were used to evaluate outer/middle ear function, a pass 
in these standards cannot definitively rule out slight conductive condition in neonates. 
At the very best, WBA as well as the best performing HFT+TEOAE+DPOAE 
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reference standard may only serve as a surrogate gold standard for evaluating 
outer/middle ear function in newborns.  
 
4.6.6 Summary 
The test performance of WBA against test battery reference standards was 
superior to that against single test reference standards. The AROC was greater for all 
reference standards between 1 and 4 kHz than at other frequencies, indicating the 
importance of measuring WBA at these frequencies for the neonatal population. In 
particular, the AROC reached its maximum value of 0.78 at 1.25 kHz for comparison 
with the HFT+TEOAE+DPOAE and AABR+TEOAE+DPOAE test battery reference 
standards. Due to its high performance in classifying ears with conductive loss as 
determined by the best performing surrogate gold standards (HFT+TEOAE+DPOAE 
and AABR+TEOAE+DPOAE), WBA is a desirable measure of conductive conditions 
in newborns. Consequently, as a valid test of conductive conditions, WBA can be 
used in both screening and diagnostic evaluations in neonates.  
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Chapter Five: Wideband Absorbance In 
Australian Aboriginal And Caucasian 
Neonates 
 
5.1 Background  
 
As shown in Chapter 2, the prevalence of conductive hearing loss was twice as 
high in Aboriginal infants (35.19%) compared to non-Aboriginal infants (17.83%). 
The main cause of conductive hearing loss was otitis media. Although otitis media has 
been reported to begin early in infancy in Aboriginal children, systematic 
investigation in evaluating the function of the middle ear at birth is scarce.  In recent 
years, wideband absorbance (WBA) has been shown to be an objective tool in the 
assessment of middle ear status in neonates. This study compared the status of the 
conductive mechanism of Aboriginal and Caucasian neonates using WBA.  Results 
comparing WBA between Aboriginal and Caucasian neonates are presented in the 
Chapter Five of this thesis. 
 
Chapter Five of this thesis, entitled, “Wideband absorbance in Australian 
Aboriginal and Caucasian neonates”, is based on the article accepted for publication 
in the Journal of the American Academy of Audiology. This article is inserted into this 
thesis with minor modifications. Only the formatting of section sub-headings and 
numbering of tables and figures have been modified from the original publication to 
match the thesis format. The referencing format of the article is retained as per the 
Journal of the American Academy of Audiology format.  
 
Aithal, S., Kei, J., & Driscoll, C. Wideband absorbance in Australian Aboriginal 
and Caucasian neonates. Article accepted for publication in Special Issue of the 
Journal of the American Academy of Audiology 
 
 
 
 
 
 
    144 
5.2 Abstract  
 
Background  Despite the high prevalence of otitis media in Australian Aboriginal 
infants and children, the conductive mechanism of the outer and middle ear of 
Aboriginal neonates remains unclear. Differences in characteristics of the conductive 
pathway (outer and middle ear) between Aboriginal and Caucasian neonates have not 
been systematically investigated using wideband acoustic immittance (WAI) 
measures.   
Purpose The objective of this study was to compare wideband absorbance (WBA) in 
Australian Aboriginal and Caucasian neonates who passed or failed a screening test 
battery containing high frequency tympanometry and distortion product otoacoustic 
emissions.    
Research Design A cross-sectional study design was used. The mean WBA as a 
function of frequency was compared between Aboriginal and non-Aboriginal 
neonates who passed or failed the test battery.  
Study sample A total of 59 ears from 32 Aboriginal neonates (mean age = 51.9 hours, 
SD = 18.2, Range = 22 to 86 hours) and 281 ears from 158 Caucasian neonates (mean 
age = 42.4 hours, SD = 23.0, Range = 8.1 to 152 hours) who passed or failed 1000-Hz 
tympanometry and distortion product otoacoustic emissions were included in the 
study.     
Data collection and analysis WBA results were analysed using descriptive statistics 
and t-tests with Bonferroni adjustments. An analysis of variance with repeated 
measures was applied to the data. 
Results Aboriginal and Caucasian neonates had almost identical pass rates of 61% as 
determined by the test battery. Despite the apparently equal pass rates, the mean WBA 
of Aboriginal neonates who passed the test battery were significantly lower than that 
of their Caucasian counterparts at frequencies between 0.4 and 2 kHz. Mean WBA of 
Aboriginal neonates who failed the test battery were significantly lower than that of 
their Caucasian counterparts who also failed the test battery at frequencies between 
1.5 and 3 kHz.  Both Aboriginal and Caucasian neonates who failed the test battery 
had significantly lower WBA than their counterparts who passed the test battery.   
Conclusion  This study provided convincing evidence that Aboriginal neonates had 
significantly lower WBA than their Caucasian counterparts, although both groups had 
equal pass rates as determined by the test battery. While the two ethnic groups showed 
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significant differences in WBA, the factors contributing to such differences remain 
undetermined. Further research is warranted to determine the factors which may 
account for the difference in WBA between the two ethnic groups.  
 
Key words Aboriginal, conductive pathway, middle ear, neonate, wideband 
absorbance 
 
Abbreviations:  
                           AABR – Automated auditory brainstem response 
                          ANOVA – Analysis of variance  
                           DPOAE – Distortion product otoacoustic emission  
                           HFT – High frequency tympanometry 
     OM – Otitis media 
     TEOAE – Transient evoked otoacoustic emission 
     WAI – Wideband acoustic immittance 
     WBA – Wideband absorbance 
                           WBR – Wideband reflectance 
 
Key words Aboriginal, conductive pathway, middle ear, neonate, wideband 
absorbance 
 
5.3 Introduction  
Wideband acoustic immittance (WAI) has been found to be useful for 
detecting conductive conditions in infant ears (Keefe et al., 2003; Vander Werff et al., 
2007; Hunter et al., 2008; Sanford et al., 2009; Hunter et al., 2010; Feeney and 
Sanford, 2012). Of the WAI measures, wideband power reflectance (WBR) has been 
the most frequently assessed measure in infants. Due to better test performance of 
WBR compared to 1000-Hz tympanometry in predicting outcomes of distortion 
product otoacoustic emission (DPOAE) testing, WBR is recommended to be used as 
an adjunct tool in newborn hearing screening programs (Sanford et al., 2009; Hunter 
et al., 2010). 
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While ear and gender differences in WBR have been well investigated in 
neonates (Keefe et al., 2000; Shahnaz, 2008; Hunter et al., 2010; Merchant et al., 
2010), there are no studies that have investigated ethnic differences in WBR for this 
age group. In contrast, earlier studies with children and adults have shown significant 
differences in WBR across different ethnic groups. For instance, Shahnaz and Bork 
(2006) found significant difference in WBR between Caucasian and Chinese adults.  
They also found a significant interaction between ethnicity and frequency, with the 
Chinese group demonstrating significantly lower WBR at higher frequencies and 
higher WBR at lower frequencies than their Caucasian counterparts. Beers et al. 
(2010) studied WBR in Caucasian and Chinese children aged five to seven years. 
While they reported no significant main effect of ethnicity, they found a significant 
ethnicity by frequency interaction with the Chinese children having lower WBR 
values over the mid-frequency range. Apart from the ethnic differences in WBR 
between Caucasian and Chinese children and adults, there have been no other WBR 
studies on ethnic differences in other populations.  
 
In Australia, there is a high prevalence of otitis media (OM) in Aboriginal 
infants (Rebgetz et al., 1989; Boswell and Nienhuys, 1995; Douglas and Powers, 
1989; Foreman et al., 1992). The higher incidence of OM in Aboriginal than 
Caucasian infants might suggest that ethnic differences in middle ear characteristics 
could exist between these two groups. However, there is limited research on 
comparison of the function of the conductive pathway (outer and middle ear) between 
Aboriginal and Caucasian infants at birth. In a longitudinal study of 22 Aboriginal 
infants, Boswell and Nienhuys (1995) showed that 95% of these infants had OM 
within six to eight weeks after birth. They also reported that once middle ear disease 
started early in life, it became persistent despite treatment.  Aithal et al. (2012) studied 
211 infants (54 Aboriginal, 157 Caucasian) referred through a newborn hearing 
screening program and found the prevalence of conductive hearing loss to be 
significantly higher in Aboriginal infants (35.19 %) compared to Caucasian infants 
(17.8%). Prevalence of middle ear pathology was also higher in Aboriginal infants 
(44.4%) compared to Caucasian infants (28.7%). Aboriginal infants also showed poor 
resolution of conductive hearing loss over time with 66.7% of Aboriginal infants 
reviewed showing persistent conductive hearing loss (defined as conductive hearing 
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loss present during both initial diagnostic evaluation and subsequent review) 
compared to 17.9% of Caucasian infants.  
 
To date, there has been only one longitudinal study of ear health in Aboriginal 
and Caucasian infants.  Lehmann et al. (2008) monitored middle ear function in 100 
Aboriginal and 180 Caucasian infants from birth to 2 years of age using transient 
evoked otoacoustic emissions (TEOAEs), tympanometry and otoscopic examination 
by an otolaryngologist. They found that TEOAEs were present in 90% (46/51) of 
Aboriginal and 99% (120/121) of Caucasian neonates aged less than one month. They 
also found that TEOAEs were present in 62% (21/34) Aboriginal and 93% (108/116) 
Caucasian infants aged 1-2 months. Aboriginal infants who failed TEOAEs at age 1-2 
months were 2.6 times more likely to develop OM subsequently than those who 
passed. In comparison, a failed TEOAE outcome could not predict subsequent OM in 
Caucasian infants aged 1-2 months.  
 
With the exception of the study by Aithal et al. (2012) who used a 
combination of high frequency (1000 Hz) tympanometry (HFT), TEOAE and auditory 
brainstem response (ABR) tests, all other studies have used otoscopy and/or 226-Hz 
tympanometry and TEOAE to compare auditory function in Aboriginal and Caucasian 
infants. However, both otoscopy and 226-Hz tympanometry have been found to be 
unreliable in evaluating middle ear function in young infants (McLennan and Webb, 
1957; Jaffe et al., 1970; Cavanaugh, 1987; Holte et al., 1990; Williams et al., 1995; 
Mckinley et al., 1997).  In order to describe the association between middle ear 
function and age of onset of ear diseases, it is necessary to document the status of the 
conductive mechanism at birth in Aboriginal infants using an efficient assessment 
tool.  To date, there have been no studies that have investigated differences between 
Aboriginal and Caucasian neonates using WAI measures.   
 
The objective of the present study was to compare wideband absorbance 
(WBA, one minus power reflectance) at ambient pressure between Australian 
Aboriginal and Caucasian neonates who passed or failed a test battery containing HFT 
and DPOAE screening tests.   WBA is used in the present study rather than wideband 
power reflectance because absorbance is generally greater in normal ears than ears 
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with otitis media, similar to the traditional single-frequency admittance measures 
familiar to clinicians.  
 
5.4 Method  
 
5.4.1 Subjects  
Aboriginal and Caucasian neonates were recruited from the Townsville 
Hospital in the tropical region of Queensland, Australia. Not all infants born at the 
Townsville Hospital were available for the study as consenting and data collection 
were limited to specific times of the day due to varying working rosters of research 
staff in the project. Ethical approval for the study was obtained from the Townsville 
Health Service District Institutional Ethics Committee and the University of 
Queensland Behavioural and Social Sciences Ethical Review Committee. Written 
consent was obtained from parents. All participants were born full-term with no 
medical complications.  
 
A total of 195 neonates that included 32 Aboriginal (19 males, 13 females) 
and 163 Caucasian neonates (88 males, 75 females) were recruited for the study. Of 
the 195 neonates, one ear of an Aboriginal neonate and six ears of Caucasian neonates 
that did not pass automated auditory brainstem response (AABR) screening were 
excluded from the study. Furthermore WBA test could not be completed in 43 
neonates (four Aboriginal, 32 Caucasian) because either the equipment was not 
available or the neonates were very restless. Hence, a total of 59 ears (30 right, 29 
left) of Aboriginal and 281 ears (134 right, 147 left) of Caucasian neonates were 
included for analysis.  
 
5.4.2 Equipment  
HFT was performed with a 1000-Hz probe tone using a GN Otometrics 
Otoflex acoustic immittance device. Admittance was measured as the pressure was 
varied from +200 to -400 daPa at a rate of 400 daPa/sec. A visual system was used to 
classify the tympanometric results. The pass criterion was a single positively peaked 
tympanogram with tympanometric peak pressure occurring between 50 and -150 daPa 
(Kei et al., 2003; Margolis et al., 2003; Alaerts et al., 2007).  
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The DPOAE screen was performed using a Biologic Navigator Plus device. 
DPOAEs were measured in response to pairs of primary tones with F2 set at 1.5, 2, 3, 
4, 6 and 8 kHz. The F2/F1 ratio was 1.2 for each primary pair. The level of F1 was 65 
dB SPL and F2 was 55 dB SPL. For the purpose of screening in this study, the 
DPOAE findings at 1.5 and 8 kHz were not used. Hence, the pass criteria included (i) 
DPOAE-to-noise ratio of at least 6 dB in at least three out of four frequencies from 2 
to 6 kHz (Sanford et al., 2009; Hunter et al., 2010) and (ii) DPOAE amplitude of at 
least -6 dB at 2, 3, 4 and 6 kHz (Sanford et al., 2009; Merchant et al., 2010).      
 
WBA measurements were carried out using an Interacoustics Reflwin research 
system which consisted of a Windows-based computer, a 24-bit resolution sound card, 
a pressure pump and controller system contained in an acoustic immittance instrument 
(AT235), and custom software for stimulus generation and data acquisition. 
Calibration was performed every day to determine the source reflectance and incident 
sound pressure associated with the probe and its transducers based on acoustic 
measurements in two rigid walled cylindrical calibration tubes 232.3 cm and 5.6 cm in 
length (Keefe and Simmons, 2003).  
 
WBA was measured at ambient pressure by recording the acoustic response to 
clicks presented to the neonate’s ear. Absorbance was calculated by averaging 
responses from a total of 16 clicks. The WBA response consisted of 16 data points (at 
1/3 octave frequencies from 0.25 to 8 kHz). During testing, high absorbance at 
frequencies below 1 kHz indicated a possible probe leak. When this occurred, testing 
was aborted and resumed when a hermetic seal was obtained. A visual prompt also 
alerted the tester if the noise level was high.  
 
5.4.3 Procedure   
All measurements were performed by an experienced audiologist in a quiet 
room in the maternity unit of the hospital. The mean ambient noise level in the testing 
room was 35.7 dB A (SD = 2.1, Range = 31.1 to 43.8 dB A). Neonates were usually 
tested after feeding while in natural sleep or in an awake but quiet state. The most 
accessible ear was tested first. All the tests were completed on one ear and the second 
ear was tested if the neonate was well settled and there was adequate time for testing. 
AABR screening was done using click stimuli at the level of 35 dBnHL. Only the ears 
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that passed the AABR screen were included in the study. A pass in AABR suggested 
normal hearing and, thus, a refer for either or both of the DPOAE and HFT screening 
tests was suggestive of a middle ear dysfunction not detected by the AABR. While 
passing AABR indicates global normal auditory function, AABR is not sensitive to 
subtle middle ear and cochlear conditions (Mazlan et al., 2009; Kei, 2012). Following 
the AABR screen, the audiologist performed HFT, DPOAE and WBA tests, in no 
particular order.   
 
Driscoll et al. (2000) recommended that tympanometry should be used along 
with otoacoustic emissions (OAEs) if identifying middle ear disorders is the goal of 
screening. Therefore, a test battery of HFT and DPOAE was used to screen for 
conductive conditions in the present study. Although tympanometry and DPOAE 
screening tests are useful for assessing the function of the conductive pathway, they 
could not be regarded as a gold standard for middle ear function. In the present study, 
in the presence of a pass in AABR, a pass in both tympanometry and DPOAE tests in 
the test battery was considered to indicate an efficient conductive pathway, while a 
fail in both tests was indicative of an inefficient conductive pathway. 
  
5.4.4 Statistical analysis 
Significance of difference between the proportion of Aboriginal and Caucasian 
neonates with normal or abnormal results on tests of outer/middle ear function was 
analysed using a two-proportion Z-test with a significance level of 0.05.    
 
A mixed model analysis of variance (ANOVA) was used to analyse data 
obtained from Aboriginal and Caucasian neonates who passed or failed the HFT and 
DPOAE screening test battery. The Greenhouse and Geisser G-G approach (1959) 
was used to compensate for the violation of compound symmetry and sphericity. An 
alpha level of 0.05 was used for all analyses. Data from neonates in both groups who 
passed the test battery were analysed using three between-group factors: gender (male 
versus female), ear (right versus left) and ethnicity (Aboriginal versus Caucasian) and 
one within-group factor (frequency). Data from neonates who failed the test battery 
were analysed using ethnicity as between-group factor and frequency as within-group 
factor. Post hoc analyses were performed using multiple pairwise comparison tests 
with Bonferroni adjustment to determine the frequencies at which significant 
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differences existed between Aboriginal and Caucasian neonates who passed and those 
who failed the test battery.   
 
5.5 Results  
5.5.1 Test battery pass/fail.  
Table 5.1 illustrates the proportion of ears of Aboriginal and Caucasian 
neonates who passed or failed the HFT and DPOAE screening test battery. A total of 
208 ears (36 Aboriginal, 172 Caucasian) passed the test battery and 96 ears (19 
Aboriginal and 77 Caucasian) failed the test battery. Approximately 61% of neonates 
in both ethnic groups passed the test battery. Further analysis using a Z-test showed 
no significant difference in the proportions of Aboriginal and Caucasian ears that 
passed or failed the test battery. About 6% of Aboriginal ears and 11 % of Caucasian 
ears did not have results for all of the three tests (HFT, DPOAE and/or WBA) as the 
neonates were unsettled during testing.   
 
Table 5.1: Results of a Z test for evaluating the significant difference in proportions 
between neonate ears that passed or failed in a test battery of HFT and DPOAE 
screening tests 
 
Aboriginal          
n (%) 
Caucasian               
n (%) 
Z value Significance 
p 
Pass 36 (61.02%) 172 (61.21%) -0.028 0.98 
Fail 19 (32.20%) 77 (27.40%) 0.745 0.46 
Incomplete 
data 
4 (6.78%) 32 (11.39%)   
 
 
5.5.2 WBA in neonates who passed or failed the test battery. 
5.5.2.1 WBA in Aboriginal and Caucasian neonates who passed the  
HFT and DPOAE screening test battery 
The demographic details of Aboriginal and Caucasian neonates who passed 
the test battery are shown in Table 5.2. The results of t-tests showed no significant 
differences in gestational age, age at time of testing and birth weight between 
Aboriginal and Caucasian neonates. 
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Table 5.2: Details of Aboriginal and Caucasian neonates who passed the test battery 
of HFT and DPOAE tests. The results of a t-test showed no significant difference in 
gestational age, age at time of testing and birth weight between Aboriginal and 
Caucasian neonates.  
 Aboriginal Caucasian Significance of 
difference  (p)  
Number of subjects 23 113  
                  Males 15 57  
                  Females 8 56  
Number of ears 36 172  
                   Right 17 86  
                   Left 19 86  
Gestational age (weeks)    
                    Mean 39.22 39.20 0.53 
                    SD 1.28 1.16  
                   Range 36-41 36-42  
Age at time of testing (hours)    
                             Mean 51.90 43.14 0.98 
                              SD 18.17 20.49  
                             Range 22.10-86.16 9.02-116.5  
Birth weight (grams)    
                             Mean 3368.70 3529.91 0.07 
                              SD 496.87 440.87  
                            Range 2200-4260 2290-4640  
 
 
Table 5.3 shows the results of an ANOVA to evaluate the effect of ear, gender and 
frequency on WBA for neonates who passed the test battery.  One ear per infant was 
chosen and, when both ears passed the test battery, right or left ear was chosen 
randomly. A total of 23 Aboriginal and 113 Caucasian neonates were included in this 
ANOVA analysis.  While the main effect for frequency was significant, the effects of 
ear and gender and their interactions were not significant for either the Aboriginal or 
Caucasian group.  In view of insignificant ear and gender effects, the WBA data were 
pooled across ears and genders for both ethnic groups.  
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Table 5.3: ANOVA results of WBA obtained from Aboriginal (n=23) and Caucasian 
(n=113) neonates with a pass in the test battery of HFT and DPOAE.  
 
  F 
value 
df P 
value  
Observed 
Power 
 Ear 2.79 1 0.11 0.35 
 Gender 
Ear x Gender 
Error 
2.75 
1.10 
4.07 
1 
1 
19 
0.11 
0.30 
0.21 
0.35 
0.17 
 
Aboriginal Frequency 16.87 4 0.00* 1.00 
 Ear x Frequency 0.75 4 0.54 0.22 
 Frequency x Gender 0.80 4 0.52 0.23 
 Ear x Gender x Frequency 
Error 
0.98 
4.583 
4 
67 
0.42 
0.07 
0.28 
 
      
 Ear 1.52 1 0.22 0.23 
 Gender 
Ear x Gender 
Error 
5.60  
1.82 
18.69 
1 
1 
109 
0.02 
0.18 
0.17 
0.65 
0.27 
  
Caucasian Frequency 75.12  4 0.00* 1.00 
 Ear x Frequency 0.70 4 0.61 0.24 
 Frequency x Gender 0.65 4 0.65 0.23 
 
 
Ear x Gender x Frequency 
Error 
1.40  
28.220 
4 
495 
0.23 
0.06 
0.47 
Note: * indicates significant difference at an alpha level of  <.05 
 
 
Table 5.4 illustrates the various WBA percentile values (0, 10, 50, 90 and 100) for 
both Aboriginal (n= 36 ears) and Caucasian (n= 172 ears) neonates with a pass in the 
HFT and DPOAE screening test battery. Normative range for WBA was determined 
as the region between 10th and 90th percentiles (Aithal et al., 2012). Figure 5.1 
illustrates the median WBA and normative region across 16 one-third octave 
frequencies from 0.25 to 8 kHz for Aboriginal and Caucasian neonates. The median 
WBA in Aboriginal neonates was lower than that of Caucasian neonates at all 
frequencies except 0.3, 3 and 4 kHz with an average magnitude of difference of 0.06. 
At the 10th percentile, the WBA of Aboriginal neonates was lower than that of 
Caucasian neonates at all frequencies except 0.25 kHz. At the 90th percentile, the 
WBA was similar for both groups across all frequencies except at 0.4 and 0.5 kHz 
where Caucasian neonates had slightly higher WBA than Aboriginal neonates.   
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Table 5.4:  Absorbance values for various percentiles (0, 10, 50, 90 and 100) for 
Aboriginal (36 ears pass, 19 ears fail) and Caucasian (172 ears pass, 77 ears fail) 
neonates who passed or failed the test battery 
 
  Percentiles 
  Aboriginal Caucasian 
Freq- 
uency 
(kHz) 
Test 
battery 
0 10 50 90 100 0 10 50 90 100 
0.25 Pass 
Fail 
0.17 
0.00 
0.32 
0.00 
0.51 
0.29 
0.67 
0.66 
0.73 
0.76 
 
0.00 
0.00 
0.30 
0.08 
0.53 
0.44 
0.66 
0.63 
0.76 
0.79 
0.30 Pass 
Fail 
0.10 
0.00 
0.30 
0.00 
0.49 
0.40 
0.64 
0.67 
0.74 
0.80 
0.00 
0.00 
0.35 
0.12 
0.49 
0.46 
0.63 
0.61 
0.75 
0.76 
 
0.4 Pass 
Fail 
0.05 
0.00 
0.24 
0.00 
0.38 
0.37 
0.53 
0.58 
0.69 
0.76 
0.00 
0.00 
0.31 
0.18 
0.43 
0.40 
0.58 
0.56 
0.77 
0.67 
0.5 Pass 
Fail 
0.06 
0.00 
0.19 
0.00 
0.36 
0.36 
0.52 
0.52 
0.59 
0.69 
 
0.00 
0.00 
0.27 
0.22 
0.41 
0.37 
0.56 
0.56 
0.73 
0.64 
 
0.6 Pass 
Fail 
0.11 
0.00 
0.23 
0.04 
0.39 
0.37 
0.56 
0.57 
0.60 
0.59 
0.02 
0.00 
0.31 
0.23 
0.45 
0.39 
0.58 
0.57 
0.71 
0.67 
 
0.8 Pass 
Fail 
0.16 
0.00 
0.29 
0.05 
0.44 
0.38 
0.64 
0.56 
0.71 
0.69 
0.21 
0.00 
0.37 
0.23 
 
0.50 
0.45 
0.66 
0.63 
0.88 
0.74 
 
1 Pass 
Fail 
0.20 
0.00 
0.30 
0.02 
0.60 
0.45 
0.79 
0.76 
0.92 
0.80 
0.22 
0.00 
0.40 
0.22 
0.64 
0.52 
0.81 
0.76 
0.93 
0.92 
1.25 Pass 
Fail 
0.18 
0.00 
0.37 
0.00 
0.65 
0.41 
0.88 
0.82 
0.94 
0.83 
0.19 
0.00 
0.50 
0.10 
0.74 
0.59 
0.91 
0.86 
0.96 
0.95 
1.5 Pass 
Fail 
0.15 
0.00 
0.36 
0.00 
0.68 
0.36 
0.91 
0.89 
0.93 
0.90 
0.29 
0.00 
0.51 
0.17 
0.77 
0.67 
0.90 
0.91 
0.99 
0.98 
2 Pass 
Fail 
0.21 
0.00 
0.36 
0.07 
0.63 
0.40 
0.87 
0.79 
0.96 
0.84 
0.32 
0.03 
0.45 
0.21 
0.72 
0.60 
0.89 
0.88 
0.99 
0.95 
2.5 Pass 
Fail 
0.07 
0.00 
0.22 
0.00 
0.53 
0.30 
0.76 
0.61 
0.81 
0.68 
0.06 
0.00 
0.28 
0.08 
0.56 
0.49 
0.78 
0.76 
0.90 
0.92 
3 Pass 
Fail 
0.00 
0.00 
0.20 
0.00 
0.52 
0.26 
0.68 
0.57 
0.72 
0.58 
0.00 
0.00 
0.25 
0.07 
0.50 
0.45 
0.69 
0.71 
0.86 
0.82 
4 Pass 
Fail 
0.00 
0.00 
0.02 
0.00 
0.46 
0.24 
0.66 
0.66 
0.81 
0.67 
0.00 
0.00 
0.22 
0.02 
0.45 
0.39 
0.67 
0.66 
0.90 
0.88 
5 Pass 
Fail 
0.00 
0.00 
0.14 
0.00 
0.55 
0.48 
0.85 
0.86 
0.87 
0.94 
0.00 
0.00 
0.31 
0.01 
0.61 
0.46 
0.84 
0.77 
0.94 
0.91 
6 Pass 
Fail 
0.10 
0.00 
0.30 
0.00 
0.67 
0.62 
0.96 
0.95 
 
0.99 
0.97 
0.00 
0.00 
0.35 
0.11 
0.75 
0.50 
0.92 
0.87 
0.97 
0.96 
8 Pass 
Fail 
0.00 
0.00 
0.16 
0.00 
0.56 
0.45 
0.93 
0.81 
0.98 
0.87 
0.00 
0.00 
0.23 
0.09 
0.65 
0.56 
0.95 
0.92 
0.99 
0.99 
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Figure 5.1: Median and normative range of WBA in Aboriginal and Caucasian ears 
that passed the test battery containing HFT and DPOAE 
 
To compare WBA between the two ethnic groups, a repeated measure 
ANOVA was performed with ethnicity as between-subject factor and frequency (16 
levels) as a within-subject factor. All the ears that passed the test battery (36 
Aboriginal, 172  Caucasian) were included in the analysis. There were significant 
main effects for ethnicity [F(1, 206) = 4.380, p = 0.04, observed power = 0.55] and 
frequency [F(5, 945) = 77.70, p = 0.00, observed power = 1.00]. The Ethnicity x 
Frequency interaction [F(5, 945) = 0.764, p = 0.57, observed power = 0.27] was not 
significant. Post hoc analysis with Bonferroni correction was performed at each of the 
16 one-third octave frequencies to analyse the effect of ethnicity. Columns 1 of Table 
5.5 show the frequencies between the two groups for neonates who passed the hearing 
screening test battery.   The WBA was significantly different between Aboriginal and 
Caucasian neonates from 0.4 to 2 kHz.   
 
5.5.2.2 WBA in Aboriginal and Caucasian neonates who failed the HFT and 
DPOAE screening test battery 
          A total of 19 ears of Aboriginal neonates and 77 ears of Caucasian neonates 
who did not pass either one or both the tests in the screening test battery were 
considered for analysis and determination of various percentile measures (Table 5.4). 
The WBA of Aboriginal and Caucasian neonates with a fail in the test battery were 
compared with each other as well as with their respective counterparts who passed the 
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test battery. As illustrated in Figure 5.2 and column 2 of Table 5.5, the median WBA 
of Aboriginal neonates who failed the test battery was lower than that of the 
Caucasian neonates who failed the test battery. The median WBA in Aboriginal 
neonates was lower than that of Caucasian neonates at all frequencies except 5 and 6 
kHz with an average magnitude of difference of 0.12.  Difference between median 
WBA between Aboriginal and Caucasian neonates was highest (0.21) between 1.25 
and 4 kHz. Furthermore, both Aboriginal and Caucasian neonates who failed the test 
battery had lower WBA across most frequencies than their counterparts who passed 
the test battery (columns 3 and 4 of Table 5.5).   
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Figure 5.2: Comparison of median WBA in Aboriginal and Caucasian ears that  
passed or failed a test battery of HFT and DPOAE 
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Table 5.5: Significance of difference in WBA between Aboriginal and Caucasian 
neonates with a pass or fail in the test battery of HFT and DPOAEs (post-hoc 
ANOVA with Bonferroni correction)  
 
Frequency 
(kHz) 
 Significance of 
difference in 
WBA between 
Aboriginal and 
Caucasian   
neonates who 
passed the test 
battery  
Significance of 
difference in 
WBA between 
Aboriginal and 
Caucasian   
neonates who 
failed the test 
battery   
Significance of 
difference in 
WBA between 
Aboriginal 
neonates who 
passed or failed 
the test battery 
Significance of 
difference in 
WBA between 
Caucasian  
neonates who 
passed or failed 
the test battery  
 t Signifi-
cance 
(p) 
t Signifi-
cance 
(p) 
T Signifi-
cance 
(p) 
t Signifi-
cance 
(p) 
0.25 -0.17 0.86 -1.36 0.18 3.25 0.02* 4.80  0.00* 
0.30 -1.25  0.21 -1.51 0.13 2.33  0.02* 3.78  0.01* 
0.40 -2.25  0.03* -0.94  0.35 0.70 0.49 2.48  0.01* 
0.50 -2.38  0.02* -0.85  0.40 0.49 0.63 2.39  0.02* 
0.60 -2.45  0.01* -1.43  0.16 1.23  0.22  3.08  0.00* 
0.80 -2.43  0.01* -1.60  0.11 1.95  0.05 4.40  0.00* 
1 -2.18  0.03* -1.91 0.05  3.02  0.00* 5.64  0.00* 
1.25 -2.61  0.01* -1.91  0.05  3.55  0.00* 6.32  0.00* 
1.5 -2.36  0.02* -2.18  0.03* 3.60 0.00* 5.46  0.00* 
2 -2.27 0.02* -2.69  0.01* 3.70  0.00* 4.22  0.00* 
2.5 -1.08 0.28 -2.66  0.01* 4.11  0.00* 3.66  0.00* 
3 -0.32  0.75 -2.49  0.02* 3.45 0.00* 2.42  0.02* 
4 -0.84  0.40 -1.38  0.10 2.15  0.04* 3.14  0.00* 
5 -0.59  0.56  0.35  0.99  1.30  0.20 4.97  0.00* 
6 -0.79  0.43  0.43  0.88 1.23  0.22 4.89  0.00* 
8  0.97 0.33 -1.05 0.32 1.50 0.14 2.26  0.02* 
Note: * indicates significant difference at an alpha level of <.05 
 
 
 
5.5.2.3 Effects of ethnicity and test battery outcome 
To compare WBA between the two groups of neonates that failed the test 
battery, an ANOVA was performed with ethnicity (Aboriginal vs Caucasian) as 
between subject factor and frequency as within subject factor. There were no 
significant main effects for ethnicity [F(1, 53) = 3.018, p>0.05]. The main effect of 
frequency [F(4, 405) =  12.91, p=0.00, observed power = 1.00] and interaction 
between frequency and ethnicity [F(4, 405) = 2.91, p = 0.02, observed power = 0.80] 
were significant. A further ANOVA to analyse the effects of test battery outcome 
(pass or fail) on WBA in Aboriginal neonates revealed a significant effect for test 
battery outcome [F(1, 53) = 8.63, p = 0.00, observed power = 0.82], and frequency 
    158 
[F(4, 256) = 17.32, p = 0.00, observed power = 1.00]. There was a significant 
interaction between test battery outcome and frequency [F(4, 256) = 3.65, p = 0.00, 
observed power = 0.98]. Similarly, for Caucasian neonates, there was a significant 
main effect for test battery outcome [F(1, 247) = 30.46, p = 0.00, observed power = 
0.98], and frequency [F (4, 1154) = 97.89, p = 0.00, observed power = 1.00]. There 
was also a significant interaction between test battery outcome and frequency [F (4, 
1154) = 5.76, p = 0.00, observed power = 0.99].  
 
Figures 5.3 and 5.4 illustrate group means for the Aboriginal and Caucasian 
neonates who passed or failed the test battery, respectively. The vertical bars denote ± 
one standard error of the mean (SEM). Columns 3 and 4 of Table 5.5 illustrate the 
results of post hoc analysis using Bonferroni correction factor to analyse the mean 
differences between neonates who passed or failed the test battery. As illustrated in 
Table 5.5, the means for WBA of Aboriginal neonates who passed the test battery 
were significantly lower at frequencies between 0.4 and 2 kHz when compared with 
their Caucasian counterparts who passed the test battery. Similarly, the means for 
WBA between Aboriginal and Caucasian neonates who failed the test battery were 
significantly lower at frequencies between 1.5 and 3 kHz.  Furthermore, means for 
WBA of Aboriginal neonates with a pass were significantly higher between 0.2 and 
0.3 kHz and between 0.8 and 4 kHz when compared with the Aboriginal neonates 
with a fail in the test battery. In comparison, the mean WBA values of Caucasian 
neonates with a pass were significantly higher than those with a fail in the test battery 
at all frequencies.   
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Figure 5.3: Mean WBA for Aboriginal (n = 36) and Caucasian (n = 172) ears that  
passed the test battery. Vertical bars denote Mean ± 1SEM. 
 
 
 
Figure 5.4: Mean WBA for Aboriginal (n = 19) and Caucasian (n = 77) ears that 
failed the test battery. Vertical bars denote Mean ± 1SEM. 
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5.6 Discussion   
The present study evaluated the function of the conductive auditory pathway 
in Australian Aboriginal and Caucasian neonates. The results revealed no significant 
difference in the proportion of Aboriginal (61%) and Caucasian (61%) neonates who 
passed a test battery containing HFT and DPOAE screening tests. This contrasts with 
the findings of earlier studies that have reported a significant difference in the pass 
rates between these two groups. For instance, using a combination of otoscopy and 
226-Hz tympanometry tests with 1- to 14-day-old infants, Boswell and Nienhuys 
(1995) reported that 86% of Aboriginal and 61% of Caucasian neonates passed the 
two tests. Similarly, Lehman et al. (2008) found a significant difference in pass rates 
between Aboriginal (90%) and Caucasian (99%) neonates using TEOAEs. 
 
Differences in pass rates can be attributed to methodological differences 
across studies. First, the age of neonates was different across the studies. The mean 
age of the Aboriginal neonates in the present study was 51.9 hours, while the infants 
in the Boswell and Nienhuys (1995) and Lehmann et al. (2008) were older (up to 
three weeks of age). The difference in age of participants among studies would 
account, at least partly, for the difference in pass rates given that pass rates improve 
with time for the first few days of life due to the clearing of external and middle ear 
fluids (Sanford et al., 2009; Hunter et al., 2010).   
 
Second, Boswell and Nienhuys (1995) used a combination of otoscopy and 
226-Hz tympanometry and Lehmann et al. (2008) used TEOAEs, while the present 
study employed a combination of HFT and DPOAE tests. Neither otoscopy nor 226-
Hz tympanometry are recommended for use with neonates in view of inaccurate test 
outcomes (Sprague et al., 1985; Doyle et al., 1997; Rhodes et al., 1999; Margolis and 
Hunter, 2000). Additionally, the use of a single test such as HFT, TEOAE or DPOAE 
alone to determine outer/middle ear function has been found to be less than ideal in 
assessing the outer/middle ear conditions (Kei et al., 2003; Swanepoel et al., 2007; 
Shahnaz, 2008;  Sanford et al., 2009; Hunter et al., 2010; Aithal et al., 2013). Instead, 
a test battery approach with appropriate measures for cochlear and middle ear 
function may provide more clinical information for identifying outer/middle ear 
conditions than that provided by a single measure (Mazlan and  Kei, 2012;  Aithal et 
al., 2013).   
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5.6.1 WBA in neonates who passed or failed the screening test battery 
5.6.1.1 WBA in neonates who passed the HFT and DPOAE screening test 
battery 
Aboriginal neonates who passed the test battery had significantly lower WBA 
than their Caucasian counterparts, especially between 0.4 and 2 kHz, the frequencies 
important in the determination of the status of the outer and middle ear (see Table 5.5 
and Figure 5.3). This low energy absorbance into the middle ear of Aboriginal 
neonates in this study suggests that these neonates had more significant outer/middle 
ear conditions than Caucasian neonates.  The Aboriginal neonates may have 
outer/middle ear disorders that are not detected when they are assessed shortly after 
birth using HFT and DPOAE screening tests, but identified by the WBA test. This has 
implications for the proportion of Aboriginal and Caucasian neonates who passed or 
failed the test battery. It is likely that a greater proportion of Aboriginal neonates 
would have failed the screening if a more sensitive test, such as WBA was included in 
the test battery. Although addition of WBA to the HFT and DPOAE test battery 
would still not be a gold standard, it would likely be more accurate than the HFT and 
DPOAE test battery. Further research could consider using a large sample size to 
evaluate the use of WBA during neonatal hearing screening in Aboriginal and 
Caucasian infants.   
Shahnaz and Bork (2006) attributed WBA differences between two ethnic 
groups (Caucasian and Chinese) to differences in body size.  An increase in body size 
in animal models is associated with an increase in the size of their middle ear 
structures, such as increased ossicle and footplate size and increased tympanic 
membrane area (Werner et al., 1998; Saunders et al., 2000; Werner and Igic, 2002). 
Additionally, Voss et al. (2008) studied normal cadaver ears and demonstrated that at 
frequencies below 2000 Hz, large increases in middle ear cavity volume 
systematically reduce the energy reflectance, with more variable changes above 2000 
Hz. Relkin (1988) postulated that this increased middle ear volume could decrease the 
stiffness of the air in this space. Nevertheless, it is not known whether increasing body 
size in humans is related to increase in the volume of the external and middle ear 
(Shahnaz and Bork, 2006). It is also unclear how differences in the mass of the 
conductive mechanism relate to differences in WBR (Beers et al., 2010). The present 
study did not find a significant difference in birth weight (which is assumed to be 
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proportional to body size) between the two groups. Nevertheless, birth weight 
approached significance levels (p = 0.07), with Aboriginal neonates having smaller 
birth weight than Caucasian neonates, suggesting that there could be a possible link 
between birth weight and WBA. Further investigation using a larger sample size is 
recommended to explore the association between WBA and body weight.   
 
  Another possible explanation for the ethnic differences in WBA might be 
related to possible dissimilarities in anatomical structure and physiological function of 
the auditory system between the two ethnic groups, given that the Aboriginal neonates 
had lower WBA than their Caucasian counterparts irrespective of their outer/middle 
ear status as determined by the test battery. However, this hypothesized difference in 
anatomical and physiological characteristics between Aboriginal and Caucasian 
neonates has not been addressed in the literature to date.  
 
The present study did not find any ear or gender effects for either Aboriginal 
or Caucasian neonates who passed the test battery. This is consistent with the findings 
of Hunter et al. (2008) in neonates and toddlers. Beers et al. (2010) also found no ear 
or gender effects in children. Although Keefe et al. (2000) found ear and gender 
differences in WBR in neonates, their study did not include comparative measures of 
outer and middle ear function, such as HFT or TEOAE.  
 
In light of the WBA differences between Aboriginal and Caucasian neonates 
despite a pass in the test battery, further research is warranted to investigate the 
factors that may account for these differences. For instance, research using pressurised 
WBA might contribute to a better understanding of the physiological differences in 
outer/middle ear characteristics between Aboriginal and Caucasian neonates, such as 
comparisons of WBA at peak tympanometric pressure. Furthermore, if absorbance is 
influenced by body size, further research could consider including measures of body 
size such as birth weight, height and head circumference as possible influential 
factors.  
 
5.6.1.2 WBA in neonates who failed the HFT and DPOAE screening test 
battery 
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Aboriginal and Caucasian neonates with a fail in the test battery had 
significantly lower WBA than their counterparts who passed. The WBA was 
significantly different between 0.8 and 4 kHz in the Aboriginal group and across the 
entire frequency region in the Caucasian group (Table 5.5). Hunter et al (2010) 
reported that regions involving 2kHz, particularly 1 to 2 kHz, 1 to 4 kHz and 2kHz, 
provide the greatest discriminability between neonates with a pass or refer during 
newborn screening using DPOAE.  Similarly, Sanford et al (2009) reported that the 
best separation of neonates with a pass or refer in DPOAE screening was achieved 
from 1 to 2 kHz.  
 
The finding that neonates with a fail in test battery had lower absorbance is 
consistent with findings of earlier studies that have shown higher reflectance 
(therefore, reduced absorbance) values in children with OM and conductive hearing 
loss (Keefe and Levi, 1996; Hunter and Margolis, 1997; Piskorski et al., 1999; Hunter 
et al., 2008; Sanford et al., 2009; Keefe et al., 2012).  Congenital middle ear effusion, 
a commonly reported condition in neonates (Orlando and Prieve, 1998; Gorga et al., 
2001; Boone et al., 2005) increases the mass and stiffness of the middle ear system. 
The measured increase in WBR in the mid to high frequency range (1 to 6 kHz) may 
be a direct result of the increased mass load on the middle ear system due to middle 
ear effusion (Beers et al., 2010; Hunter et al., 2010; Shahnaz, 2010).  
 
Aboriginal neonates who failed the test battery in the present study had 
significantly lower WBA in the frequencies between 1.5 and 3 kHz compared to their 
Caucasian counterparts who failed the test battery (see Table 5.5 and Figure 5.4). In 
this frequency range, WBA ranged from 0.26 to 0.40 in Aboriginal neonates and from 
0.45 to 0.67 in Caucasian neonates.  This suggests that the Aboriginal neonates have 
more significant outer/middle ear conditions than Caucasian neonates. To date, there 
are no studies that have investigated anatomical and physiological differences in the 
outer/middle ear between these two groups of neonates. Further research using 
radiological evidence in infants undergoing cochlear implant surgery or investigations 
of head and neck as part of other investigations as well as temporal bone studies of 
neonates would assist in determining if a difference in the volume of the middle ear 
cavity is associated with difference in stiffness between Aboriginal and Caucasian 
neonates across frequencies that are important for speech perception (1 to 4 kHz). 
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Studies have shown that newborns with persistent middle ear effusion are 
more likely to develop chronic OM, compared with newborns without persistent 
middle ear effusion (Jaffe et al., 1970; Doyle et al., 2004; Pereira et al., 2010).  
Lehmann et al. (2008) found that Aboriginal infants who failed TEOAEs at age 1 to 2 
months were 2.6 times more likely to develop OM subsequently than those who 
passed. In comparison, a failed TEOAE outcome did not predict subsequent OM in 
non-Aboriginal infants aged 1 to 2 months. Future research could follow the 
Aboriginal and Caucasian neonates with lower absorbance up to two years of age to 
see if they went on to develop OM.  
 
5.6.2 Strengths and limitations of the study 
This is the first study to compare WBA between Aboriginal and Caucasian 
neonates who passed or failed a test battery. Since WBA provides detailed 
information about the efficiency of sound conduction in the auditory system, this 
study holds relevance for investigating the anatomical and physiological differences 
in the outer/middle ear between Aboriginal and Caucasian neonates.  
 
Although the proportion of ears that passed the test battery was the same for 
both groups, this finding may not be confidently generalized in view of the small 
sample size. The proportion of Aboriginal neonates who failed the test battery was 
slightly larger compared to that of Caucasian neonates. A larger sample is required to 
determine WBA test performance in both groups and to draw conclusions regarding 
ethnic differences in outer/middle ear function.   
 
While testing was often done when a neonate was well settled, the use of 
multiple tests such as HFT, DPOAE and WBA required a lengthy testing time. 
Insertion and adjustment of various probe tips might have disturbed the neonate. 
Testing had to be discontinued for some neonates who became unsettled, resulting in 
a small number of neonates included in the study. Further modification of the 
equipment could incorporate a single probe to perform multiple tests to minimise this 
problem.  
 
5.6.3 Summary and conclusions   
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The present study showed that Aboriginal and Caucasian neonates had almost 
identical pass rates of 61% as determined by a test battery containing HFT and 
DPOAE screening tests. However, the Aboriginal neonates who either passed or 
failed the HFT and DPOAE test battery had significantly lower WBA than their 
Caucasian counterparts, suggesting that Aboriginal neonates are more likely to have 
abnormal outer/middle ear status than Caucasian neonates. These findings may have 
two clinical implications. First, WBA appears to be more sensitive than HFT and 
DPOAE screening tests in the identification of inefficient conductive pathways in 
neonates. Second, there may be subtle differences in anatomical and physiological 
characteristics of the outer and middle ear which resulted in differences in WBA 
between Aboriginal and Caucasian neonates. However, the causal factors for the 
ethnic differences have not been identified. Further research is warranted to determine 
the factors which may account for the difference in WBA between the two ethnic 
groups. Given that Aboriginal infants are more likely to develop OM later in life than 
their non-Aboriginal counterparts (Lehmann et al., 2008), further research should 
consider measuring WBA in Aboriginal neonates from birth to two years of age using 
a longitudinal design. This longitudinal study may determine whether the Aboriginal 
neonates with outer and middle ear dysfunction during the first few days of life are 
prone to OM later in life.  Future research may also consider evaluating ethnic 
differences in the relative risk of OM in infants during the first two years of life. 
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Chapter Six: Wideband Absorbance In Young 
Infants (0-6 Months): A Cross-sectional Study 
 
6.1 Background 
The outer and middle ears undergo significant developmental changes during 
the first few months of life. These rapid developmental changes in early infancy could 
have an effect on the acoustic properties of the ear.  While the standard audiological 
tests of middle ear function used with older children and adults are limited in their 
ability to determine the status of conductive mechanism in young infants, wideband 
absorbance (WBA) has been proposed as an emerging tool to assess outer/middle ear 
in this population. Thus far, the results of previous studies have been equivocal 
regarding the changes in WBA with increasing age especially in the first 12 months of 
life (Kei et al., 2013). Due to significant developmental changes during early infancy, 
there is a need to include infants at various age intervals in order to more closely 
describe the developmental effects on the outer and middle ear (Sanford and Feeney, 
2008).  
 
Results of the study comparing WBA across age groups are presented in 
Chapter six of this thesis. This chapter is based on the article accepted for publication 
in the Journal of the American Academy of Audiology. This article is inserted into this 
thesis with minor modifications. Only the formatting of section sub-headings and 
numbering of tables and figures have been modified from the original publication to 
match the thesis format. The referencing format of the article is retained as per the 
Journal of the American Academy of Audiology format.  
Aithal, S., Kei, J. & Driscoll, C. Wideband Absorbance in young infants (0-6 
Months): A cross-sectional study. Article accepted for publication in special 
supplement of Journal of the American Academy of Audiology.  
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6.2 Abstract  
Background:  Wideband acoustic immittance (WAI) studies on infants have shown 
changes in WAI measures with age. These changes are attributed, at least partly, to 
developmental effects. However, the developmental effects of young infants (0-6 
months) on WAI have not been systematically investigated. 
Purpose: The objective of this study was to compare wideband absorbance (WBA) in 
healthy neonates and infants aged 1-, 2-, 4- and 6-months. 
Research Design: This was a prospective, cross-sectional study. All participants were 
assessed using 1-kHz tympanometry, distortion product otoacoustic emission and 
WBA tests. 
Study Sample: Participants included 35 newborns (35 ears), 16 one-month-old (29 
ears), 16 two-month-old (29 ears), 15 four-month-old (28 ears) and 14 six-month-old 
infants (27 ears). For each participant, the ears that passed both high frequency (1-
kHz) tympanometry and distortion product otoacoustic emission tests were included 
for analysis. 
Data collection and analysis: WBA was recorded at ambient pressure conditions and 
the response consisted of 16 data points at one-third octave frequencies from 0.25 to 8 
kHz.  A mixed model analysis of variance (ANOVA) was applied to the data in each 
age group to evaluate the effects of gender, ear and frequency on WBA. WBA was 
compared between various age groups. In addition, a separate mixed model ANOVA 
was applied to WBA data and post hoc analyses using Bonferroni correction were 
performed at each of the 16 one-third-octave frequencies across age groups to 
examine the effect of age on WBA.   
Results: For all age groups, WBA was highest between 1.5 and 5 kHz and lowest at 
frequencies below 1.5 kHz and above 5 kHz.  A developmental trend was evident 
with both the 0- and 6-month-old infants being significantly different to other age 
groups at most of the frequencies. The WBA results exhibited a multi-peaked pattern 
for infants aged 0 to 2 months, whereas a single broad peaked pattern for 4- and 6-
month-old infants was observed. The difference in WBA between 0- and 6-month-old 
infants was statistically significant across most frequencies. In contrast, the WBA 
results for 1- and 2-month-old infants were comparable. There were no significant 
gender or ear effects on WBA for all age groups.    
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Conclusions: Developmental effects of WBA were evident for infants during the first 
6 months of life. The WBA data can be used as a reference for detecting disorders in 
the sound conductive pathways (outer and middle ear) in young infants. Further 
development of age-specific normative WBA data in young infants is warranted.  
 
Key words: developmental effects, infants, middle ear, wideband absorbance 
 
Abbreviations:   
                                   ABR – Auditory Brainstem Response 
                                   DPOAE- Distortion product otoacoustic emissions 
   HFT – High frequency tympanometry 
                                    OAE – Otoacoustic emissions 
   SD – Standard deviation 
   WAI – Wideband acoustic immittance 
WBA – Wideband absorbance  
                                    WBR – Wideband reflectance 
 
Key words: developmental effects, infants, middle ear, wideband absorbance 
 
6.3 Introduction  
Assessing conductive disorders in young infants (aged 0 to 6 months) is a real 
challenge (Kei and Zhao, 2012) as there are, currently, no effective tools for detecting 
these disorders for this population. Nevertheless, wideband acoustic immittance 
(WAI) (Feeney et al., 2013), a physiological measure that provides information about 
the conduction properties of the outer and middle ear across a wide frequency range 
has been found to be a promising tool for detecting disorders in the conductive 
pathway (Feeney and Sanford, 2012).  
 
Studies of WAI have often measured either wideband reflectance (WBR) or 
wideband absorbance (WBA) in humans. WBR is defined as the ratio of reflected 
power to incident power (Voss and Allen, 1994). To date, the vast majority of studies 
have focused on measuring WBR in young infants. In the present paper, the findings 
of these studies are discussed in terms of WBA (1-WBR) because the pattern of 
absorbance results is similar to the traditional admittance pattern which is familiar to 
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clinicians. WBA ranges from 1 (where all of the sound energy is absorbed by the 
middle ear) to 0 (where all the energy is reflected back from the middle ear) (Stinson, 
1990).   
The WBA test measures the absorbance at either ambient or variable pressure 
using a wideband stimulus, such as a click or chirp. WBA has been found useful in 
the evaluation of middle ear function in neonates (Keefe et al, 2000; Sanford et al, 
2009; Hunter et al, 2010; Aithal et al, 2013), infants and young children (Jeng et al, 
1999; Margolis et al, 2000; Hunter et al, 2008), and older children and adults 
(Piskorski et al, 1999; Feeney et al, 2003; Keefe & Simmons, 2003; Allen et al, 2005).  
Studies of WBA in infants have found changes to WBA with age (e.g., Keefe 
et al, 1993; Sanford and Feeney, 2008). These changes may be attributed mainly to 
developmental effects of the peripheral auditory system.   In particular, the acoustical 
properties of the outer and middle ear undergo significant changes during this fast 
developing period of the auditory system. The developmental aspects of the outer and 
middle ear, as summarized by Wilson (2012), include: (1) changes in the shape and 
increase in length and diameter of the external auditory canal (Saunders et al, 1983; 
Keefe et al, 1993; Qi et al, 2006), (2) decrease in the cartilaginous portion and 
increase in the bony portion of the canal wall (McLennan and Webb, 1957; Fung, 
1993), (3) changes in tympanic membrane orientation (Eby and Nadol, 1986; Ikui et 
al, 1997; Qi et al, 2006), (4) reduction in the thickness of the tympanic membrane 
(Ruah et al, 1991), (5) reduction in vascular and cellular content (Richany et al, 1954), 
(6) increase in the volume of the tympanic cavity (Ikui et al, 2000), (7) increase in 
pneumatisation and growth of the temporal bone as a whole, particularly the mastoid 
process (Anson et al, 1955), and (8)  increase in weight and size of the ossicles 
(Anson and Donaldson, 1981). 
 
As developmental changes in early infancy influence the acoustical properties 
of the ear, it is very important to have accurate, age appropriate WBA measures in 
order to determine the outer and middle ear status in infants. This would be useful 
during newborn hearing screening, rescreening and follow up, as well as assisting in 
accurate interpretation of otoacoustic emission (OAE) and auditory brainstem 
response (ABR) results (Sanford and Feeney, 2008).   
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Normative WBA data for neonates have recently been established (Keefe et al, 
2000; Shahnaz, 2008; Sanford et al, 2009; Hunter et al, 2010; Merchant et al, 2010; 
Aithal et al, 2013). In comparison, WBA data sets for young infants (1-12 months) are 
limited (Feeney and Sanford, 2012).  Several studies have shown that, at all ages, 
WBA is the lowest at frequencies below 1 kHz and above 4 kHz and highest in the 
frequency region between 1 and 4 kHz, which corresponds to the most effective 
frequency region of the acoustic transfer function (Keefe et al, 1993; Hunter et al, 
2008; Sanford and Feeney, 2008; Sanford et al, 2009).  Nevertheless, the results of 
previous studies have been equivocal regarding the changes in WBA with increasing 
age especially in the first 12 months of life (Kei et al, 2013).  
 
Keefe et al (1993) were the first to compare WBA among adults, infants aged 
1-, 3-, 6-, 12- and 24 months. For all infant age groups, WBA was lowest at low 
frequencies and highest between 1 and 4 kHz. There was a significant age effect 
below 1 kHz with decreasing WBA up to six months of age. Keefe et al suggested that 
the development of the infant’s external and middle ear (such as growth of the area 
and length of the ear canal), resonance in the ear canal walls of younger infants and 
growth of middle ear cavities were the contributing factors for the changes in WBA 
with age.  Differences in WBA between 24-month-old infants and adults suggested 
that maturation of the peripheral auditory system is not complete by 24 months of age. 
Although healthy infants with no history of outer or middle ear disorders were 
included in Keefe et al’s study, there were no other tests performed on the infants to 
check for conductive conditions in the outer and middle ear prior to their inclusion.   
   
Sanford and Feeney (2008) provided useful information on the maturation 
effects of the peripheral auditory system on WBA. They measured WBA in 60 
healthy, full-term infants with 20 infants in each age group of 4-, 12-, and 24- weeks 
with normal conductive pathway as determined by a pass in distortion product 
otoacoustic emissions (DPOAE) and high frequency (1-kHz) tympanometry (HFT). 
They found a 30% decrease in the mean WBA for frequencies from 0.25 to 0.75 kHz 
with increasing age, which concurred with the findings of Keefe et al (1993).  
Likewise, Werner et al (2010) analysed WBA in 198 infants aged 2 to 3 months, 260 
infants aged 5 to 9 months and 210 healthy adults with normal middle ear function as 
determined by a pass in traditional 226-Hz tympanometry. They reported a significant 
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age effect for WBA from 0.25 to 3 kHz with WBA decreasing progressively with age.  
However, 226-Hz tympanometry has been found to be unreliable in assessing middle 
ear function in infants up to six months of age (Paradise et al, 1976; Holte et al, 1990; 
Hunter and Margolis, 1992; Williams et al, 1995; McKinley et al, 1997).   
In contrast, Merchant et al (2010) investigated WBA in seven neonates (12 
ears) and eleven 1-month-old infants (19 ears). Except for a slight difference at 2000 
Hz between newborns and 1-month-old infants, there was no significant distinction in 
WBA and transmittance between the two age groups across frequencies. Similarly, 
Hunter et al (2008) studied 97 infants and children, aged between 3 days and 47 
months, with 138 ears classified as normal hearing status and 21 ears having ‘poor 
ear’ status as determined by a combination of DPOAE, tympanometry (226- or 1000-
Hz) along with pneumatic otoscopy performed by a physician. The infants were 
pooled into five age ranges, namely, 3 days to 2 months, 3 to 5 months, 6 to 11 
months, 12 to 23 months and 24 to 47 months.  Hunter et al did not find any 
significant difference in WBA as a function of age except at 6 kHz. Hunter et al. 
suggested that differences in probe design and calibration methods might account for 
differences in the developmental trends with age. 
In view of the disagreement regarding developmental trends in WBA, Kei et al 
(2013) suggested that clinicians should be cognizant of variations in WBA 
measurements caused by developmental changes in anatomy and physiology, and 
recommended further research to replicate the findings of previous studies with 
appropriate reference standards for normal middle ear status.  If the WBA measure is 
to be considered as a diagnostic tool for evaluating the function of the conductive 
pathway in young infants, it is imperative that age appropriate norms be developed. 
Age appropriate norms will aid in understanding the developmental trends of WBA 
and will be useful during evaluation of test performance of WBA in young infants. 
Additionally, due to significant developmental changes during early infancy, there is a 
need to include infants at various age intervals in order to more closely describe 
developmental effects of the outer and middle ear (Sanford and Feeney, 2008). The 
objective of the present study was to compare WBA in healthy newborns and infants 
aged 1-, 2-, 4- and 6- months.  
6.4 Method 
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6.4.1 Subjects and test environment 
Ethical approval for the study was obtained from the Townsville Health 
Service District Institutional Ethics Committee and the University of Queensland 
Behavioural and Social Sciences Ethical Review Committee. Parents of healthy 
neonates at the maternity ward of Townsville Hospital were informed of the study by 
nurses prior to the hearing screening of neonates. Parents consented for their babies to 
participate in the study by completing a consent form approved by the above Ethics 
committees. All infants were born at term, with normal birth weight and no medical 
complications. Testing was offered at birth with follow up at one, two, four and six 
months of age.  Nevertheless, very few infants attended more than one follow up 
appointment. When an infant attended more than one follow up appointment, data 
obtained at only one of the appointments were included for analysis. Hence, this study 
describes cross-sectional data of infants at various age intervals. The number of 
subjects enrolled included 50 newborns, 36 infants at 1 month of age, 30 infants at 2 
months of age, 33 infants at 4 months of age and 28 infants at 6 months of age. All 
infants enrolled in the study were Caucasian.  None of the infants in the present study 
participated in the Aithal et al (2013) study.  
 
All measurements with the neonates were performed in a quiet room in the 
maternity unit. Evaluations with the infants aged one to six months were performed in 
a sound treated room at the Audiology department. Mean ambient noise levels in the 
maternity room and sound booths were 35.7 and 32.0 dB A, respectively. Infants at all 
ages were seen after feeding while in natural sleep or in an awake but quiet state.   
 
For infants in each age group, only the ears that passed both HFT and DPOAE 
screening tests were included in the study. Inclusion of HFT in the test battery is 
imperative to identify middle ear disorders that are not detectable by the otoacoustic 
emission test (Driscoll et al, 2001). Details of infants included in the study are 
provided in Table 6.1. The total number of infants included in the study is less than 
the total number recruited because some infants failed either one or both tests in the 
test battery or data were not available for all three tests (HFT, DPOAE or WBA test). 
With neonates, although both ears of most neonates passed the screening test battery, 
only one ear per infant was randomly chosen for the study.  
 
    178 
Table 6.1: Details of infants included in the study (inclusion criteria – pass in HFT 
and DPOAE) 
 Number of subjects Number of ears Age 
Age 
Group 
(in 
months) 
 
Male Female Total Right Left Total Mean SD Range 
0 14 21 35 18 17 35 41.49 
hours 
14.82 21.51-
70.37 
hours 
1 10 6 16 15 14 29 32.81 
days 
5.82 29-47 
days 
2 11 5 16 14 15 29 58.31 
days 
3.55 54-66 
days 
4 11 4 15 15 13 28 124.13 
days 
8.53 105-
135 
days 
6 11 3 14 14 13 27 179.43 
days 
5.00 169-
189 
days 
 
6.4.2 Procedure   
6.4.2.1 Screening test battery 
A test battery consisting of HFT and DPOAE tests was used to determine the 
status of the outer and middle ear. While a pass in the test battery provides some 
assurance of an unobstructed conductive pathway, it should not be regarded as a gold 
standard for detecting ears with a conductive condition in view of the limitations of 
the test battery when used with young infants. As the pass criteria of the individual 
tests for all age groups were not available, the pass criteria for use with neonates were 
adopted in the present study.        
 
6.4.2.1.1 Tympanometry. 
HFT was performed using a GN Otometrics Otoflex acoustic immittance 
device with a 1000 Hz probe tone. During the test, the admittance (Y) was measured 
as the pressure was changed from +200 to -400 daPa at a rate of 400 daPa/sec. A 
visual classification system was used to classify the tympanometric results. The pass 
criterion was a single positively peaked tympanogram as described by Baldwin 
(2006).  
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6.4.2.1.2 DPOAE. 
DPOAE was performed using a Biologic Navigator Plus. DPOAEs were 
measured in response to pairs of primary tones with F2 set at 2, 3, 4, and 6 kHz. The 
F2/F1 ratio was 1.2 for each primary pair. The stimulus level of F1 was 65 dB SPL 
and F2 was 55 dB SPL. Pass criteria included (i) a noise level of less than 0 dB SPL, 
(ii) the difference between the amplitude of the emission and associated noise floor to 
be at least 6 dB in at least three out of four frequencies from 2 to 6 kHz (Sanford et al, 
2009; Hunter et al, 2010), and (iii) a DPOAE magnitude with a level of at least -6 dB 
at 2, 3, 4 and 6 kHz (Sanford et al, 2009; Merchant et al, 2010).   
 
6.4.2.1.3 WBA. 
WBA was measured using a prototype research system developed by 
Interacoustics A/S (Denmark). The Reflwin computerised system consisted of a 
Windows-based computer, a 24 bit resolution sound card, a pressure pump and 
controller system contained in an acoustic immittance instrument (AT235), and 
custom software for stimulus generation and data acquisition. Calibration was 
performed every day (Keefe and Simmons, 2003; Sanford and Feeney, 2008) at 
ambient pressure to determine the source reflectance and incident sound pressure 
associated with the probe and its transducers based on acoustic measurements in four 
rigid-walled, cylindrical calibration tubes that were open at one end and closed at the 
other end with a steel rod. The infant calibration tubes had lengths of 232.11 and 
5.319 mm, each with a diameter of 4.8 mm. The adult calibration tubes had lengths of 
290.50 and 8.10 mm, each with a diameter of 7.9 mm. Root mean squared (RMS) 
reflectance error function was generated to determine the error in the acoustical 
estimate of the length of each tube relative to the acoustic wave propagation model. 
An RMS reflectance error of less than 0.009 was required for a successful calibration. 
Any calibration that did not meet the criteria was repeated following probe 
reinsertion.  
 
Ambient WBA measurements were obtained by recording acoustic response to 
clicks, presented at 55 dB SPL and at a rate of one click per 46 msec. Responses from 
a total of 16 clicks were averaged for each measurement and reflectance was 
calculated for each response. The WBA response consisted of 16 data points (at 1/3 
octave frequencies from 0.25 to 8 kHz). A visual display with high absorbance at 
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frequencies below 1 kHz served as an on-screen prompt that alerted the tester to a 
potential probe leak. A visual prompt also alerted the tester if the noise level was high. 
The data acquisition was very quick and the typical test time in a sleeping or well 
settled infant was less than 10 seconds.  
 
6.5 Results 
6.5.1 WBA within age groups 
A mixed model analysis of variance (ANOVA) was fitted to the WBA data 
obtained from each age group with gender and ear as between-group factors and 
frequency as a within-group factor. An alpha level of 0.05 was used for all analyses. 
The Greenhouse and Geisser (G-G) (1959) approach was used to compensate for the 
violation of compound symmetry and sphericity.  
 
As illustrated in Table 6.2, ANOVA results showed a significant main effect 
for frequency for each age group.  The effects of ear and gender and their interactions 
were not significant for any age group. WBA data from right and left ears were 
treated as independent samples.  
 
Table 6.2: Analysis of variance results illustrating significant effect of frequency 
across all age groups 
Age Type III 
sum of 
square 
Df Mean 
square 
F Significance Observed 
Power 
0-months 6.31 4 1.49 25.18 0.00 1.00 
1-month 4.33 3 1.84 18.67 0.00 1.00 
2-month 3.15 3 0.99 6.31 0.00 0.96 
4-month 8.89 3 3.27 27.15 0.00 1.00 
6-month 7.84 3 2.47 21.26 0.00 1.00 
 
6.5.2 WBA across age groups 
Figure 6.1 illustrates the pattern of median WBA results for 0-, 1-, 2-, 4- and 
6- month-old infants at 16 one-third-octave frequencies. WBA results for the 0-, 1-, 
and 2-month-old infants exhibited a multipeaked pattern, with the peaks occurring 
around 1.5 and 5 kHz. This multipeaked pattern was less distinct for the 4- and 6-
month-old infants and shifted to a single, broad-peaked pattern with the peak 
occurring between 2 and 5 kHz.  
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Figure 6.1:  Median WBA in newborns (0-month-old), 1-, 2-, 4- and 6-month-old 
infants. 
 
At all ages, WBA was highest between 1 and 5 kHz, and lowest between 0.25 
and 0.8 kHz and between 6 and 8 kHz.    The median WBA of 6-month-old infants 
was lowest especially between 0.25 and 1.5 kHz compared to infants in 0-, 1-, 2- and 
4- month age groups. The median WBA between 2 and 4 kHz was highest in infants 
aged 4- months, followed by infants aged 1-, 2- and 6- months and lowest in 0-month-
old infants.  On the other hand, the median WBA between 5 and 8 kHz decreased with 
increasing age with the median WBA of 6-month-old infants being the lowest and that 
of 0-month-old infants being the highest in this frequency range.   
 
Figure 6.2 illustrates the standard deviation (SD) of WBA across frequencies 
for the age groups. SDs were calculated as a measure of variability since the mean and 
median values of WBA were similar for all age groups. The SDs generally increased 
with increase in frequency for 0-, 1-, 2-, and 4- month old infants. The SDs for 0- and 
1- month old infants were lower than that of 2- and 4-month-old infants. On the other 
hand, with the 6-month-old infants, the SD increased from 0.25 to 1 kHz and 
remained the same between 1 and 2 kHz and decreased from 2 to 3 kHz and again 
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increased from 4 to 8 kHz. The SDs for 6-month-old infants were similar to those for 
0- and 1-month-old infants at frequencies between 0.25 and 0.6 kHz and between 2.5 
and 8 kHz. The SDs for 6-month-old infants between 1.25 and 2 kHz were higher than 
those of the other age groups.  
 
  To compare WBA among the five age groups, a mixed model ANOVA was 
performed with age as between-subject factor and frequency (16 levels) as a within-
subject factor. An alpha level of 0.05 was used for analysis. There were significant 
main effects for age [F(4, 143)= 15.01, p=0.00] and frequency [F(5, 766) = 132.77, 
p=0.00] and age x frequency interaction [F(21, 766)= 9.75, p= 0.00]. This means that 
the pattern of WBA was significantly different across the age groups.  Post hoc 
analysis using Bonferroni correction was performed at each of the 16 one-third-octave 
frequencies to examine the effect of age on WBA. Table 6.3 shows the results of the 
Post hoc analysis.  A developmental trend is evident with both the 0- and 6-month-old 
infants being significantly different to other age groups at most of the frequencies. In 
general, the WBA of 0-month-old infants was significantly different to that of 1-
month-old infants between 1.5 and 5 kHz. The WBA of 0-month-olds was 
significantly different to that of 2- and 4-month-old infants at all frequencies except 
between 1 and 1.5 kHz.   The WBA of 1-month-old infants was significantly different 
to that of 2-month-old infants only at 0.8 kHz.  The WBA of 4-month-old infants was 
significantly different from that of 1- and 2-month-old infants mainly in the low 
frequencies from 0.25 to 0.4 kHz but similar at other frequencies. The WBA of 6-
month-old infants was significantly different to the WBA of 0-, 1-, 2- and 4- month-
old infants at most frequencies.  
 
6.5.3 Comparison of WBA across different studies 
Since there are very few studies on age specific WBA norms for infants, it is 
important to compare the results between available studies to identify similarities and 
differences. WBA results for neonates from Hunter et al. (2010) (mean age 29 hours, 
SD 15.5 hours), Merchant et al (2010) (age 3 to 5 days) and Aithal et al (2013) (mean 
age 46 hours, SD = 21 hours) are plotted along with median WBA data from the 
present study in Figure 6.3. The results from the Hunter et al (2010) and Aithal et al 
(2013) studies are consistent with the results of the present study. Results from the 
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Merchant et al (2010) study were similar to findings of other studies up to 2 kHz with 
a large disparity observed between 2.5 and 8 kHz.   
 
 
Table 6.3:  Results of a Post hoc analysis using multiple comparisons with 
Bonferroni correction comparing WBA between age groups 
. 
 
*Significant at 0.05 level 
 
Median WBA results for 1-month-old infants from the present study are 
plotted along with results from Keefe et al (1993) (age 1 month), Sanford and Feeney 
(2008) (mean age = 4.5 weeks, SD = 0.34) and Merchant et al (2010) (age 28 to 34 
days) in Figure 6.4. Apart from some differences in the magnitude of WBA obtained 
across studies, the WBA pattern was consistent across all the four studies. Figure 6.5 
illustrates the median WBA results for 2-month-old infants from the present study 
along with the results from Prieve et al (2013) for 10-week-old infants. Despite the 
large magnitude of WBA in the present study, the WBA pattern was again similar 
across both the studies.   
 
 
 Groups by Age (months) 
 
Frequency 
(kHz) 
0-1 0-2 0-4 0-6 1-2 1-4 1-6 2-4 2-6 4-6 
0.25 0.00* 0.00* 0.00* 0.00* 0.44 0.00* 0.00* 0.00* 0.00* 0.00* 
0.3 0.38 0.04* 0.00* 0.00* 0.22 0.00* 0.00* 0.00* 0.00* 0.00* 
0.4 0.06 0.31 0.00* 0.00* 0.74 0.00* 0.00* 0.00* 0.00* 0.00* 
0.5 0.16 0.00* 0.66 0.00* 0.07 0.61 0.00* 0.08 0.00* 0.00* 
0.6 0.45 0.37 0.01* 0.00* 0.72 0.07 0.00* 0.27 0.00* 0.00* 
0.8 0.95 0.01* 0.39 0.00* 0.01* 0.36 0.00* 0.19 0.00* 0.00* 
1 0.69 0.45 0.40 0.00* 0.27 0.60 0.00* 0.18 0.00* 0.00* 
1.25 0.77 0.80 0.31 0.00* 0.99 0.22 0.00* 0.28 0.00* 0.00* 
1.5 0.01* 0.16 0.82 0.00* 0.44 0.06 0.00* 0.32 0.00* 0.00* 
2 0.00* 0.04* 0.02* 0.89 0.14 0.14 0.00* 0.92 0.053 0.03* 
2.5 0.00* 0.04* 0.00* 0.00* 0.35 0.29 0.96 0.11 0.40 0.30 
3 0.00* 0.06 0.00* 0.00* 0.60 0.04* 0.68 0.04* 0.43 0.10 
4 0.00* 0.00* 0.00* 0.00* 0.47 0.01* 0.06 0.15 0.47 0.36 
5 0.01* 0.19 0.04* 0.83 0.28 0.72 0.03* 0.53 0.35 0.12 
6 0.85 0.09 0.01* 0.00* 0.10 0.02* 0.00* 0.50 0.00* 0.05* 
8 0.13 0.00* 0.00* 0.00* 0.13 0.10 0.00* 0.92 0.00* 0.00* 
    184 
0.25k 0.4k 0.6k 1k 1.5k 2.5k 4k 6k
Frequency (Hz)
0.05
0.1
0.15
0.2
0.25
0.3
St
an
da
rd
 
de
v
ia
tio
n
Legend
0- month
1- month
2- month
4- month
6- month
 
Figure 6.2: Standard deviations of WBA for frequencies from 0.25 to 8 kHz in 
newborns (0-month-old), 1-, 2-, 4- and 6-month-old infants 
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Figure 6.3: Comparison of WBA in neonates across four studies 
 
 
Median WBA results for 6-month-old infants from the present study are 
plotted along with results from Keefe et al (1993)(age 6 months) and Sanford and 
Feeney (2008) (mean age 24.1 weeks, SD =0.31 weeks) in Figure 6.6. Although the 
general pattern of WBA obtained was the same across the frequencies, there were 
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differences in the magnitudes of WBA especially from 0.5 to 2 kHz. Across the entire 
frequency range, the WBA values were highest in Sanford and Feeney’s (2008) study 
and lowest in the present study.  
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Figure 6.4: Comparison of WBA in 1-month-old infants across four studies 
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Figure 6.5: Comparison of WBA in 2-month-old infants between Prieve et al. (2013) 
and the present study 
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                   Figure 6.6: Comparison of WBA in 6-month-old infants across three 
studies 
 
 
6.6 Discussion   
The objective of the present study was to compare WBA obtained from young 
infants with a view to examine the developmental characteristics of infants in their 
first six months of life. Normative data were provided for each age group (Appendix 
A). These data can be used as a reference for detecting disorders in the sound 
conduction pathway (outer and middle ears) in young infants.  
 
The results revealed significant changes in WBA with age, indicating 
maturation effects. First, the multipeaked pattern of absorbance seen at 0, 1 and 2 
months of age became less prominent with a shift towards a single peak at 4 and 6 
months of age (Figure 1). Similar results have been reported by Sanford and Feeney 
(2008) who found that the multipeaked effect across frequency at 4 weeks of age 
became less distinct for the 12- and 24-week-old infants and shifted towards a single 
peaked function. 
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Second, the median WBA decreased with increasing age, especially for 
frequencies from 0.25 to 0.5 kHz (Figure 1). The median WBA of 1-month-old 
infants was the highest, while the WBA of 6-month-old infants was the lowest. The 
differences in median WBA were the smallest between newborns and 1-month-old 
infants, and between 2- and 4-month-old infants, but greatest between 1-month-old 
and 6-month-old infants. These results are similar to the findings of Keefe et al (1993) 
who reported higher WBA in 1-month-old infants than older infants aged 3 and 6 
months. Factors contributing to developmental differences include growth in the outer 
and middle ear, and stiffening of the compliant ear-canal wall which is more resistant 
to changes in pressure with age (Keefe et al, 1993; Sanford and Feeney, 2008).  
 
Third, the newborns had lower WBA than other infants (aged 1-6 months) in 
the high frequencies between 2.5 and 5 kHz (Figure 1). This is a distinctive feature of 
the developmental aspects of the newborns. Acoustic effects at high frequencies in 
infancy have been attributed to changes in the properties of the ossicular chain 
(Saunders et al, 1983). Eby and Nadol (1986) reported that while the neonatal ossicles 
have obtained adult dimensions, they are histologically immature and composed of 
cartilage. Additionally, temporal bone studies suggest that residual mesenchyme 
adhering to the ossicular chain can lead to mass loading of the ossicles.  From one 
month of age onwards, infants showed an increase in WBA in the high frequencies to 
reach a level at par with that of the older infants. This phenomenon may be explained 
in terms of the diminishing mass and resistance of the middle ear in older infants due 
to changes in bone density of the ossicles and loss of mesenchyme and fluids in the 
middle ear (Olszewski, 1990; Richany et al, 1954). 
 
Finally, the 6-month-old infants had significantly lower WBA than other age 
groups in the low to mid frequencies (0.25 to 2 kHz) (Figure 1). Similarly, Sanford 
and Feeney (2008) and Keefe et al (1993) have reported the most dramatic decrease in 
WBA in low frequencies for infants between 4 and 12 weeks of age. The low WBA of 
the 6-month-old infants in this frequency range indicates increased stiffness of the 
outer and middle ear. The increase in stiffness may be attributed to a myriad of factors 
in the maturation process including the ossification of the inner two-thirds of the ear 
canal, changes in the orientation and fibre structure of the tympanic membrane, fusion 
of the tympanic ring, and tightening of the ossicular joints.   
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There was no significant difference in WBA between the right and left ears for 
any age group in the present study. In contrast, other studies have reported small, 
albeit significant, differences in WAI between right and left ears.  For instance, in 
their study of eight neonates and eleven 1-month-old infants, Merchant et al (2010) 
found a significant difference in WBA between right and left ears. Similarly, Werner 
et al (2010) studied 458 infants from two to nine months of age and found that right 
ears had lower WBA than left ears.  In contrast, Keefe et al (2000) found that WBA 
was lower in left ears than in right ears for frequencies below 1.4 kHz, but higher in 
left ears at higher frequencies.  
 
There were no significant differences in WBA values between males and 
females in any of the age groups in the present study. This result is in agreement with 
the findings of Werner et al (2010) and Merchant et al (2010) who found no gender 
effect in their studies. In contrast, Keefe et al (2000) found that WBA was lower for 
males than for females at frequencies below 2 kHz.  
 
The present study found a significant frequency effect in WBA across all age 
groups with WBA being the highest in the frequency region between 1 and 4 kHz. 
These results are consistent with the findings of Keefe et al (1993), Vander Werff et al 
(2007), Sanford and Feeney (2008), Sanford et al (2009), Hunter et al (2010), 
Merchant et al (2010) and Werner et al (2010).  The median absorbance obtained for 
various age groups in the present study compares favourably with those reported in 
previous studies (Figures 3-5).  Although the WBA against frequency patterns were 
the same, there were differences in WBA across the studies. The discrepancies across 
studies may be attributed to differences in subject sampling, equipment, test 
conditions and reference standards for middle ear function.  
 
6.6.1 Limitations of the study 
Several limitations have been identified in the present study which may have 
affected the interpretation of results. First, the difficulty of completing all tests 
increased with the age of infants. Older infants were more likely to be tested while 
they were awake, and therefore, jaw movements and suckling might have contributed 
to variations in estimating WBA. Second, the sample size was small for neonates and 
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infants aged between 1 and 6 months. This limits the generalisation of results to the 
infant population. It is, therefore, necessary to develop age specific normative WBA 
data using large sample sizes and established middle ear reference standards such as 
diagnostic otoacoustic emissions. . Third, the use of test battery necessitated change of 
probes for each test which could disturb an infant. Further research is recommended 
using equipment that allows all the tests to be done using a single probe. Last, the use 
of a cross-section design of the study has restricted, to some extent, the investigation 
of maturation of the outer and middle ear of infants especially during the fast 
developing period. It was not possible to track developmental changes in an individual 
from birth to six months. Future studies may employ a longitudinal design to track 
developmental changes in WBA. 
 
6.6.2 Conclusion 
The present study provided evidence of maturation in the outer and middle ear 
of infants in their first 6 months of life. The WBA in the low to mid frequencies 
decreased with increasing age from birth to 6 months, indicating increasing stiffness 
due to growth in the outer and middle ear, and stiffening of the compliant ear-canal 
wall.  From birth to 1 month, neonates showed significant increase in WBA in the 
high frequencies (≥ 2.5 kHz). The WBA continued to increase with age up to 4-6 
months of age. These developmental changes may be attributed to changes in bone 
density of the ossicles and loss of mesenchyme and fluids in the middle ear, resulting 
in a smaller mass and resistive component of the middle ear. In particular, the WBA 
of 6-month-old infants was significantly different to that of 0-, 1-, 2- and 4- month-old 
infants at most frequencies, suggesting rapid development of the outer and middle ear 
during this period. Due to significant developmental changes in the first six months of 
life, it is necessary to develop age specific WBA normative data using a large sample 
for each age group. 
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Chapter Seven: General Discussion and Conclusions 
 
7.1 Introduction  
              WBA is reported to predict the outcomes of DPOAE better than HFT and, 
hence, recommended as a clinical tool during NHS. Nevertheless, clinical application 
of WBA requires development of normative data and evaluation of pathologic effects 
against robust reference standards of middle ear function as well as exploration of 
developmental effects and application with special populations where prevalence of 
middle ear dysfunction is high.   
 
              This chapter revisits the rationale and aims of the study (as described in 
chapter one) and discusses the main findings presented in the previous chapters 
(chapters two to six). Clinical application, limitations of the study, implications for 
further research in the area of WBA in neonates and young infants are also presented 
in this chapter.  
 
7.2 Rationale For The Study (Revisited) 
The current study was devised to study applications of WBA in the Australian 
context. Although NHS programs have been introduced in several states and 
territories in Australia for more than a decade, there are no published studies on the 
prevalence of conductive hearing loss and false positive rates in this population.  In 
particular, it is important to determine the prevalence of conductive hearing loss in the 
Australian Aboriginal infants because this group is prone to otitis media. The study, 
described in Chapter 2, determined the prevalence of middle ear dysfunction and 
conductive hearing loss in Aboriginal and non-Aboriginal infants referred through a 
NHS program in Australia.  
 
Due to its ability to assess the middle ear independent of the inner ear, WBA is 
suggested as a feasible tool to be used in conjunction with the NHS program (Keefe et 
al., 2003a, b; Hunter et al., 2010; Sanford et al., 2009; Vander Werff et al., 2009) or 
during diagnostic assessment of infants (Prieve et al., 2013).   For successful 
application of WBA, development of norms is crucial for clinicians to distinguish 
normal ears from ears with a conductive condition. To date, normative WBA data 
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have been developed using DPOAE as a reference standard for middle ear function 
(Hunter et al., 2010; Merchant et al., 2010; Sanford et al., 2009). Nevertheless, 
DPOAE may not identify minor or sub-clinical middle ear pathologies (Kemp, 2002) 
and, hence, may not be an ideal gold standard (Hunter et al., 2010; Sanford et al., 
2009).  Perhaps, a test battery reference standard may provide a better measure of 
middle ear function than a single test reference standard (Mazlan & Kei, 2012). To 
date, development of normative WBA data based on a test battery reference standard 
has not been investigated. The study, described in chapter 3, provided normative 
WBA data in healthy neonates who passed a battery of tests including AABR, HFT, 
ASR, TEOAE and DPOAE.  
 
Evaluation of test performance of WBA is challenging. Even though air and 
bone conduction (AC and BC) tone burst ABR may be regarded as a surrogate gold 
standard for comparison with WBA results, this threshold ABR measure requires long 
testing time to complete and is not commonly performed during the hearing screening 
period. In view of this, most studies circumvent this issue by using DPOAE as the 
gold standard because it is commonly used as a screening tool in NHS programs 
(Sangster, 2011). As mentioned, DPOAE may not accurately identify minor or sub-
clinical conductive pathologies (Kemp, 2002) and may not serve as an ideal reference 
standard. Use of DPOAE in this manner represents a significant shortcoming in the 
evaluation of WBA (Sangster, 2011).  Since myringotomy is not ethical or feasible in 
normal neonates, an alternate would be to determine the test performance against a 
battery of tests of middle ear function. The study, described in chapter 4, evaluated the 
test performance of WBA against various reference standards to determine whether 
WBA can provide a more effective alternate to either single tests or test batteries for 
determining the outer and middle ear status in neonates.  
 
Australian Aboriginal children have high rates of OM that starts early in life. 
Nonetheless, there is limited research regarding the status of the middle ear of 
Aboriginal infants at birth. Previous studies have used 226 Hz tympanometry, 
otoscopy and TEOAE to evaluate middle ear function in young Aboriginal infants. 
Unfortunately, 226 Hz tympanometry, otoscopy and TEOAE do not accurately 
identify OM or conductive conditions in infants below six months of age.  To date, 
there have been no studies that have used WBA to evaluate outer and middle ear 
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function in Aboriginal neonates. Additionally, differences in WBA have been 
reported between ethnic groups lending support to the development of ethnic specific 
norms for WBA (Shahnaz & Bork, 2006). The study, described in chapter 5, 
compared the WBA between Aboriginal and Caucasian neonates with and without 
middle ear dysfunction.  
 
The outer and middle ear of infants undergoes significant developmental 
changes in the first few months of life. Differences in size and structure of the outer 
and middle ears relative to age could have an effect on the transmission of sound 
through the middle ear (Shahnaz, 2010). Hence, age specific normative WBA data 
need to be established in the first few months in order to more accurately assess outer 
and middle ear dysfunction in this population. The study, presented in chapter 6, 
described the developmental aspects of WBA for healthy infants in their first six 
months of life.   
 
7.3 Aims of the Thesis (Restated) 
Given the above rationales for the study, the aims of this thesis were to  
(1) Evaluate the prevalence of conductive hearing loss and middle ear pathology in 
infants referred by a NHS program in Australia and compare the prevalence rates 
of conductive hearing loss and middle ear pathology in Aboriginal and non-
Aboriginal infants (see chapter 2).  
(2) Obtain normative WBA data in healthy neonates who pass a combination of tests 
including AABR, HFT, ASR, TEOAE and DPOAE (see chapter 3). 
(3) Compare test performance of WBA using individual measures such as AABR, 
HFT, TEOAE or DPOAE and a combination of tests (Eg: HFT+DPOAE) to 
determine whether WBA can provide a more effective alternate to either single 
tests or test battery (composite) reference standards for determining the outer and 
middle ear status in neonates (see chapter 4).  
(4) Compare WBA measures obtained from healthy Aboriginal neonates with that 
obtained from non-Aboriginal neonates (see chapter 5). 
(5)  Conduct a cross sectional study on a sample of normal infants to determine the 
developmental trend of WBA results at birth and at 1, 2, 4,  and 6 months of age 
(see chapter 6). 
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7.4 Hypotheses of the Study (Restated) 
The present investigation of WBA and middle ear status in young infants 
contained four null hypotheses to be tested. They were: 
 
HO1: There will be no significant difference in the prevalence of conductive hearing 
loss between Aboriginal and Caucasian infants who are referred for diagnostic 
evaluation through a NHS program.  
HO2: There will be no significant difference in the test performance of WBA between 
single tests and test battery reference standards.   
HO3: There will be no significant difference in WBA results between Aboriginal and 
Caucasian neonates.  
HO4:   There will be no significant age effects on WBA results obtained from infants 
aged from 0- to six months.    
 
7.5 Discussion of the Main Findings 
 
7.5.1 Middle ear pathology and conductive hearing loss in neonates  
 In spite of high rates of middle ear dysfunction in Australian Aboriginal 
children, at the commencement of this study, there were no data available on the 
prevalence of middle ear pathology and conductive hearing in infants referred through 
a NHS program in Australia. Therefore, this study was undertaken to determine and 
compare the prevalence of conductive hearing loss and middle ear pathology between 
Australian Aboriginal and Torres Strait Islanders (ATSI) and non-ATSI infants 
referred through an Australian NHS program.   
 
Retrospective chart review of 234 infants referred to the Audiology 
department of the Townsville Hospital, a tertiary referral centre for north Queensland, 
was conducted. The mean age at the time of first diagnostic assessment was 47.5 days 
(SD = 31.30, range = 2 – 121 days). A battery of tests including HFT, TEOAE and 
ABR was performed to determine middle ear pathology with normal hearing or with 
conductive hearing loss.  Prevalence of conductive hearing loss was found to be 2.97 
per 1000 which was 1.8 times that of sensorineural hearing loss (1.64 per thousand).  
This was in agreement with findings of Boone et al. (2005) who also found prevalence 
of conductive hearing loss to be 1.8 times that of sensorineural hearing loss in infants 
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referred through an American NHS program. There were differences in the prevalence 
rate of conductive hearing loss between the present study and those reported in the 
literature, and the differences were attributed to differences in the screening methods 
used in the hearing screening programs.  
 
ATSI infants had a higher prevalence of middle ear pathology with 44.45% 
(24 of 54) of ATSI and 28.66% (45 of 171) of non-ATSI infants demonstrating 
middle ear pathology with normal hearing or with conductive or mixed hearing loss. 
The prevalence of conductive hearing loss was twice as high in ATSI infants (19 of 
54, 35.19%) compared to non-ATSI infants (28 of 157, 17.83%). Additionally, ATSI 
infants showed poor resolution of conductive hearing loss with 75% (12 of 16) of 
ATSI and 27.78% (non-ATSI) infants demonstrating persistent conductive hearing 
loss.   Consequently, the null hypothesis (HO1) that predicted no significant difference 
in the prevalence of conductive hearing loss between Aboriginal and Caucasian 
infants referred for diagnostic evaluation through a NHS program was confidently 
rejected.  
 
The findings of this study supported the use of an adjunct tool such as WBA to 
determine the status of the middle ear at the time of screening to facilitate 
prioritisation of infants for evaluation and streamline the management strategies for 
the respective types of hearing loss. The study also recommended longitudinal studies 
to evaluate natural history and resolution of MEE in the first twelve months of life to 
determine whether MEE is a precursor for later persistent middle ear infections.  
 
7.5.2 Normative WBA measures in neonates 
  As mentioned earlier and detailed in Chapter Three, DPOAE is often used to 
develop normative WBA data. Since DPOAE is not an optimal tool of middle ear 
function, the aim of the second study in the thesis was to develop normative WBA 
measures in healthy neonates using a stringent reference standard to identify 
conductive conditions. WBA at ambient pressure was measured between 250 and 
8000 Hz in one third octave frequencies in 66 infants (mean age = 46.0 hours, SD = 
21.0, range = 13.3 – 116.5 hours) who passed a test battery of AABR, HFT, ASR, 
TEOAE and DPOAE.  
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The results showed no significant ear or gender difference in WBA although a 
significant difference in WBA among frequencies was observed. Various percentile 
values (0, 5, 10, 25, 50, 75, 90, 95, 100) were developed. The median absorbance 
reached a maximum of 0.76 to 0.79 between 1000 and 2000 Hz but decreased from 
0.41 to 0.55 below 1000 Hz and 0.48 to 0.76 above 2000 Hz. The inter-quartile range 
(25th to 75th percentiles) at 2000 Hz and above was generally greater than that at 
frequencies below 2000 Hz. A general trend of increasing normative range (10th to 
90th percentiles) with frequency was observed. Adjacent frequencies that did not differ 
significantly from each other were averaged to obtain absorbance area indices (AAIs). 
The AAIs determined in this study were 250 to 310, 400 to 800, 1000, 1250 to 2000, 
2500, 3000 to 4000 and 5000 to 8000 Hz. The absorbance values obtained in this 
study were in agreement with studies by Shahnaz (2008) and Hunter et al. (2010), 
although the magnitude of absorbance in the 1000 to 4000 Hz region was smaller in 
the present study.  
 
The requirement that all neonates should pass a test battery constituted a new 
robust reference standard for evaluating middle ear function in neonates without 
resorting to invasive procedures. Normative data developed in this study could be 
used as a reference to determine the outer and middle ear status of neonates.   
 
7.5.3 Evaluation of test performance of WBA 
Although the use of DPOAE as a reference standard for evaluating the test 
performance of WBA is reported to be a limitation (Sangster, 2011), to date, there are 
no studies that have compared the test performance of WBA with other reference 
standards of middle ear function.  In the third study, test performance of WBA on 298 
ears of 192 neonates was evaluated against nine reference standards that included four 
single tests (AABR, HFT, TEOAE and DPOAE) and five test batteries  
(HFT+TEOAE, HFT+DPOAE, TEOAE+DPOAE, HFT+TEOAE+DPOAE and 
AABR+TEOAE+DPOAE).  Test performance of WBA was assessed in terms of its 
ability to identify conductive conditions in neonates across each reference standard.   
 
The AROC of WBA for the test battery reference standards, were, in general, 
significantly higher than that for single tests. The test performance of WBA measured 
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against the HFT+TEOAE+DPOAE, HFT+TEOAE+DPOAE or HFT+DPOAE test 
battery reference standards was higher than that of single test batteries. In comparison, 
the AROC of WBA for HFT and AABR reference test standards were lower than 
AROC of WBA for other test batteries. Consequently, the null hypothesis (HO2) 
which predicted that there will be no significant difference in the test performance of 
WBA between single tests and test battery reference standards was rejected.   
 
The region between 1000 and 2500 Hz provided the best discriminability to 
evaluate the conductive status compared to other frequencies. The median WBA for 
the pass group ranged between 0.40 and 0.76, with two maxima occurring at 1500 and 
6000 Hz across all reference standards. The median WBA for the fail group showed a 
relatively flat pattern across the entire frequency range for all reference standards 
except HFT. The ears that passed each of the reference standards had significantly 
higher absorbance than the ears that failed.   
 
The low performance of WBA against the single test reference standards 
suggests that a single test (such as AABR, HFT or OAE) per se may not accurately 
diagnose conductive condition in neonates. A plethora of reasons may account for the 
low performance. These may include: (1) the pass criteria of single tests were not 
optimal, (2) the tests are not sensitive to slight/mild conductive hearing losses, (3) 
some tests were susceptible to environmental and/or physiologic noise that could 
confound results, and (4) the tests provided limited clinical information about the 
properties of the conductive pathway. While acknowledging the limitations of single 
test reference standards, the use of a test battery consisting of HFT and OAE as a 
reference standard was recommended due to improved test performance compared to 
single test reference standards. WBA could provide a more effective alternate to a 
combination of tests for determining the outer and middle ear status in neonates. This 
finding is promising as it suggests that WBA is a valid measure of outer and middle 
ear function. Therefore, it has great potential to be used as an adjunct tool of middle 
ear function in newborn hearing screening programs or during diagnostic assessment.   
 
7.5.4 WBA in Australian Aboriginal and Caucasian neonates  
Although the prevalence of middle ear dysfunction is high in Australian 
children, there is very limited research on their middle ear status at birth. Although 
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conductive dysfunction at birth related to otitis prone conditions in the first year of 
life has been documented in Caucasian infants (Doyle et al., 2004; Pereira et al., 
2010), there have been no such studies with Aboriginal infants. Hence there is a need 
to investigate the middle ear status of Aboriginal neonates using an efficient clinical 
tool such as WBA. A comparison of WBA results between Aboriginal and Caucasian 
neonates may reveal ethnic variances. The fourth study in the thesis explored the 
efficiency of the conductive pathway (outer and middle ear) using WBA between 
Aboriginal and Caucasian neonates at birth.   
 
Testing was performed on 32 Aboriginal neonates and 158 Caucasian neonates 
who passed or failed a test battery comprising HFT and DPOAE. Interestingly, both 
groups showed identical pass rates of 61% with the test battery. However, both 
Aboriginal and Caucasian neonates who failed the test battery had significantly lower 
WBA than their counterparts who passed the test battery. The WBA of Aboriginal 
neonates that passed the test battery was significantly lower than that of their 
Caucasian counterparts at frequencies between 400 and 2000 Hz. WBA of Aboriginal 
neonates that failed the test battery was significantly lower at frequencies between 
1500 and 3000 Hz compared to their Caucasian counterparts. Hence, the null 
hypothesis (HO3) that predicted that there will be no significant difference in the 
WBA results between the Aboriginal and Caucasian neonates was confidently 
rejected.  
 
 This study provided convincing evidence that although both groups had equal 
pass rates as determined by a test battery containing HFT and DPOAE, Aboriginal 
neonates had significantly lower WBA than their Caucasian counterparts. The low 
energy absorbance in Aboriginal neonates compared to Caucasian neonates suggests 
that these infants may have significant outer/middle ear disorders that were identified 
by WBA but not detected by the test battery. It is likely that a greater proportion of 
Aboriginal neonates would have failed the screening if a more sensitive test, such as 
WBA, was included in the test battery. Since WBA is a sensitive test of middle ear 
function, addition of WBA to the test battery could improve the outcomes of hearing 
screening in this population. While the two ethnic groups showed significant 
differences in WBA, the factors contributing to the differences remain undetermined 
and require further investigation.  
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7.5.5 WBA in young infants  
The rapid developmental changes in the outer and middle ear system of infants 
in the first few months of life warrant investigation of age related changes in the 
acoustic properties of the conductive pathway. The fifth study in the thesis used a 
prospective, cross-sectional design to investigate the developmental effects of WBA 
in the first six months of life. WBA was measured in 35 ears of neonates, 29 ears of 
one-month-olds, 29 ears of two-month-olds, 28 ears of four-month-olds and 27 ears of 
six-month-olds who passed HFT and DPOAE. There were no significant ear effects or 
gender effects on WBA across any of the ages.  For all the age groups, WBA was 
highest between 1500 and 5000 Hz and lowest at frequencies below 1500 and above 
5000 Hz. Both the WBA of 0- and 6-month-old infants were significantly different to 
other age groups at most of the frequencies. The infants aged 0 to 2 months 
demonstrated a multipeaked pattern while the 4- and 6-months-olds exhibited a single 
broad-peaked pattern. There was a significant difference in WBA across most 
frequencies between 0- and 6-month-old infants. Therefore, the null hypothesis (HO4) 
that predicted that there will be no significant age effects on WBA results obtained 
from infants aged 0- to six months was rejected. Although the WBA patterns were the 
same between the present study and those reported in the literature, there were 
differences in magnitude of WBA across the studies that were attributed to differences 
in subject sampling, equipment, test conditions and reference standards for middle ear 
function  
 
 The significant changes in WBA with age were suggestive of maturational 
effects in the first six months of development.  These developmental changes may be 
attributed to changes in bone density of the ossicles and loss of mesenchyme and 
fluids in the middle ear, resulting in a smaller mass and resistive component of the 
middle ear. Normative data provided in the study (Chapter Six - Appendix A) could 
be used as a reference for detecting disorders of the conductive pathway in young 
infants.  
 
7.6 Implications for Clinical Practice 
 
7.6.1 Application of WBA as an adjunct tool during NHS  
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Based on the results of the study, WBA appears to be a valid tool of middle 
ear evaluation that shows promise as an adjunct device in a NHS program. This 
recommendation is based on the following research findings: (1) WBA had higher test 
performance against composite test batteries compared to single test reference 
standards in identifying disorders of the conductive system (see Chapter 4), (2) WBA 
was significantly lower in ears that failed either individual tests or test batteries 
compared to ears that passed (see Chapter 4). (3) WBA of ears that failed test battery 
reference standards were below the normative range across most of the frequency 
range between 250 and 8000 Hz (see Chapter 4), and (4)  WBA identified Aboriginal 
infants with a significant middle ear condition that was not identified by a battery of 
screening tests (see Chapter 5).  
 
WBA could be used as an adjunct tool to reduce false positive referrals as well 
as prioritise infants referred for diagnostic evaluation through a NHS program. By 
incorporating a set of WBA pass criteria into the equipment, an automated response 
(pass or refer result) could be displayed similar to that used in automated OAE or 
AABR devices. Since the results do not need to be analysed by the screening staff, the 
WBA equipment could be employed by the screening personnel in conjunction with 
other NHS tools.   
 
A model for incorporating WBA into UNHS is provided in Figure 7.1. 
According to this model, infants who do not pass their first AABR/OAE screening 
would be rescreened, preferably before discharge from the hospital. If the infants do 
not pass their second screening in one or both ears, WBA would be administered. 
Neonates who receive a refer result during second AABR/OAE screening but have 
normal WBA (i.e., normal outer/middle ear function), would be considered to have a 
high risk of permanent hearing loss. Hence these neonates would be referred to an 
audiologist immediately and diagnostic evaluation recommended within two weeks. 
Neonates with a refer result in both WBA and second screening would receive a third 
AABR/ OAE screening within four to six weeks time. If they receive a refer result in 
the third screening, further diagnostic audiology evaluation would be recommended. 
This proposed model could reduce the referral rates for diagnostic audiology as well 
as assist in prioritising infants for diagnostic assessment. Use of WBA as an adjunct 
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tool following second AABR/OAE screen could determine if a conductive condition 
exists in the presence of a refer result.  
 
Neonates with sensorineural hearing loss would be identified when normal 
WBA results are obtained along with a refer result on second AABR/OAE screen. 
Alternately, neonates with refer for both second screen and WBA, are likely to have a 
conductive condition. These neonates should receive a third AABR/OAE screen 
between four and six weeks’ time. This time frame is recommended for the third 
screen, because, as described in Chapter 2, most conductive conditions in infants were 
reported to be resolved by four weeks following screening. Therefore, the majority of 
infants would pass their third screen due to resolution of their conductive condition. 
Those infants who refer in their third screen are likely to have either conductive or 
mixed hearing loss and therefore require further diagnostic assessments.  
 
Studies by Boshuizen et al. (2001) and Dalzell, Orlando and Seeger (1996) 
recommend a three-stage screening model for NHS since it reduces the referral rate 
and costs less than a two stage process because of the lower cost of diagnostic 
facilities.  The proposed model with addition of WBA as an adjunct tool to a three-
stage screening model has further advantages.  First, false positive referral rate could 
be reduced further with the use of WBA as an adjunct tool, since only neonates with 
hearing loss would be referred for diagnostic assessment. During the second 
screening, infants with risk of sensorineural hearing loss would be referred while 
during the third screening, infants with persisting conductive and mixed hearing loss 
would be identified. The majority of infants whose hearing returns to normal with the 
resolution of middle ear function would not be referred for diagnostic evaluation. As 
shown in Chapter 2, about 55% of infants had normal hearing during their initial 
diagnostic evaluation. Thus, the false positive referral rate could be reduced by more 
than half with the use of WBA as an adjunct test.  
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Figure 7.1: Proposed model for NHS with WBA as an adjunct tool for assessment of 
middle ear 
First screen 
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Pass 
Second screen 
(AABR/OAE) 
Discharge 
Pass Refer 
Discharge Administer 
WBA 
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Pass Refer 
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Refer 
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Second, neonates with high risk of sensorineural hearing loss would be 
prioritised for diagnostic assessment. This would ensure early diagnosis of 
sensorineural hearing loss. Since diagnostic evaluation is recommended within two 
weeks’ time, there would be no delay in the diagnosis of hearing loss in these infants. 
Third, the follow up of infants at risk of sensorineural hearing loss could also be 
prioritised. For instance, the follow up of those neonates who do not pass second 
screening but pass WBA and miss their diagnostic appointment, could be prioritised 
for follow up due to their high risk for sensorineural hearing loss.  Health resources 
could be better utilised to target these infants to ensure their attendance for follow up 
so that they receive timely diagnostic evaluation and early intervention. This could 
reduce neonates lost to follow up and improve the efficacy of the program. Fourth, the 
use of WBA could provide additional information about the middle ear status, and, 
therefore, reduce the number of instances where ambiguous results are obtained 
during diagnostic evaluation. This would reduce the need for multiple reviews for 
these infants, and, again ensure early identification of hearing loss without delay. This 
would reduce unnecessary cost for those families who need to travel long distances 
with young infants for diagnostic assessments.  
 
7.6.2 Application of WBA during diagnostic evaluation of neonates and  
infants 
 7.6.2.1 WBA during diagnostic evaluation of neonates  
In view of its superior performance against composite tests compared to single 
test reference standards, WBA shows promise as a clinical tool for assessing the 
conductive pathway in neonates (see Chapter 4). WBA could be used as a single 
clinical tool with test performance which is as good as the test battery reference 
standards.  
 
 The present study obtained normative data using a robust reference standard 
for middle ear function and defined the normative range for WBA as between the 10th 
and 90th percentiles (see Chapter 2). These normative WBA measures could be used 
clinically to determine the status of the conductive mechanism in neonates. The WBA 
of neonates could be plotted against this normative range. Neonates with WBA values 
falling within this normative range are regarded as having an effective conductive 
pathway, while those with WBA falling outside this range would require further 
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medical investigation. This is also supported by the finding wherein WBA was 
significantly lower for ears with middle ear dysfunction compared to ears with a 
normal conductive pathway.   
 
 The present study found the frequency region of WBA between 1000 and 
2500 Hz to have the highest discriminability for conductive conditions. This is 
consistent with the results of other studies (Hunter et al., 2010; Sanford et al., 2009).  
Therefore, greater weight should be apportioned to this frequency region in clinical 
assessments of neonates.  
 
7.6.2.2 WBA during diagnostic evaluation of young infants  
 The present study provided normative data for infants at 0, 1, 2, 4 and 6 
months of age (chapter 6). These data could be used as a reference for detecting 
disorders in the conductive pathway in young infants.  Normative regions could be 
described as the region between the 10th and 90th percentiles, similar to that for 
neonates described in chapter 3. WBA of infants could be plotted against the 
normative data to determine if values fall within or outside of the normative range.  
 
7.7 Limitations of the Investigation 
 In spite of the encouraging findings of this research, several limitations have 
been identified that could affect the clinical application of WBA. First, multiple tests 
were performed that involved inserting multiple probes into the ear canal of an infant. 
This procedure had the potential to disturb a well settled infant. This problem was 
partially overcome by testing the infants after feeding when they were well settled.  
Further research is recommended using equipment that allows all the tests to be done 
using a single probe. 
 
Second, the test battery was time consuming. As the time for data collection 
was limited to certain hours of the day, all testing could not be completed in both ears 
of all infants recruited into the study. During the test, only the ear accessible easily 
was tested first and the second ear was only tested if time permitted and the infant was 
settled. This could have resulted in less number of ears that could be tested during any 
given testing session. Further studies could consider adapting flexible hours for data 
collection to allow data collection on a large number of infants.  
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Third, the sample size of the present study was small compared to the number 
of infants initially recruited. The present study has adopted a strict parallel protocol in 
which an ear was regarded as having a normal conductive pathway if and only if the 
ear passed all tests of the test battery.  This strict protocol excluded the ears that 
passed one test but failed the others in a composite test reference standard, and 
therefore, reduced the sample size. The small sample size could have reduced the 
power of the statistical analyses especially in evaluating test performance of WBA 
and drawing conclusions regarding ethnic and gender differences in WBA.  In order 
to overcome this, further studies need to consider methods to maximise recruitment of 
infants, such as, working flexible hours to collect data prior to discharge from 
hospital.  
 
Fourth, the sample sizes were unequal during comparison of WBA between 
Aboriginal and Caucasian neonates (Chapter 5). The sample size for Aboriginal group 
was smaller than that of the Caucasian neonates and hence the finding of the study 
may not be confidently generalised.  Further studies could incorporate larger sample 
of Aboriginal neonates and compare the test performance of WBA between 
Aboriginal and Caucasian neonates to draw conclusions regarding ethnic differences 
in outer/middle ear function.  
 
 Fifth, the results of the study could have been influenced by the lenient 
pass/fail criteria of some tests. For instance, the pass criterion for HFT was a single 
positive peak while double or multiple peaks were considered a fail. Similarly, the 
OAE pass criteria of at least a 3 dB SNR at 2000, 3000 and 4000 Hz may not be 
optimal for detecting conductive conditions, especially when the pass criteria did not 
assess frequencies below 2000 Hz where the effect of middle ear disorder may be 
more significant. Further studies could incorporate 1500 Hz into the protocol to 
investigate if the inclusion of these frequencies could improve the identification of 
conductive conditions.   
 
 Sixth, the time of testing can be a factor that influences test performance in 
neonates. Due to the possible clearing of vernix and mesenchyme in the first few 
days, the referral rates with tests such as HFT, OAE and WBA vary with the time of 
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testing. Sanford et al. (2009) reported a similar effect wherein the test performance of 
WBA in two-day-old infants was lower than that of one-day-old neonates. The mean 
age of neonates in the present study was higher than that of the other normative and 
test performance studies in neonates. Further studies should explore the time of testing 
further by assigning the infants into different assessment time groups and comparing 
the referral rates and the test performance between these groups.  
 
 Last, although the present study described developmental changes in the first 
six months of life, the use of a cross-sectional design could have, to some extent, 
restricted the investigation of maturation of the outer and middle ear of infants. To 
date, there is only one study by Shahnaz et al. (2014) that has followed the 
maturational changes in WBA in 18 infants from birth to six months of age. Future 
studies should employ a longitudinal design with larger sample size to more 
accurately track developmental changes in the conductive properties of the outer and 
middle ear of infants at shorter time intervals from birth to six months.  
  
7.8 Conclusion 
  The present thesis explored the use of WBA in neonates and young infants. 
This research is the first to have used a combination of tests as a reference standard to 
develop normative WBA data and evaluate its test performance in healthy neonates.  
This research is also the first to have systematically compared the prevalence of 
conductive hearing loss and determined the outer and middle ear status of Australian 
Aboriginal and Caucasian neonates using WBA. This thesis has enhanced the minimal 
literature concerning the clinical application of WBA in young infants.   
 
 From the results of the series of studies described in this thesis, the following 
conclusions can be drawn:  
 
1. Conductive hearing loss is a common diagnosis among infants referred 
through NHS in Australia. This finding is similar to that reported by NHS 
programs in other countries.   
2. In view of the prevailing conductive hearing loss in neonates, an adjunct 
test of the outer and middle ear is recommended at the time of screening to 
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determine the status of the conductive pathway and prioritise the infants 
for diagnostic assessment.   
3. Australian Aboriginal infants referred from screening have a higher 
prevalence of conductive hearing loss at birth and show poor resolution of 
middle ear dysfunction over time.   
4. Use of a test battery to develop normative WBA data in neonates 
constitutes a new reference standard for the determination of outer and 
middle ear status. This composite tests reference standard represents the 
best available reference standard since invasive procedures such as 
myringotomy cannot be used in healthy neonates 
5. WBA is a valid and sensitive test of outer and middle ear function in 
neonates. It has great promise to be used as a diagnostic test in paediatric 
clinics.  
6. Furthermore, WBA could be used as a single clinical tool with high test 
performance which is as good as that of the composite tests reference 
standards.  
7. Australian Aboriginal neonates have a subtle conductive condition that 
may not detected by a battery of screening tests including HFT and 
DPOAE, but identified by WBA which is sensitive to outer and middle ear 
dysfunction. 
8. Maturation of the outer and middle ear of infants in the first six months of 
life could be demonstrated using WBA. The results showed changes in 
WBA with age during this fast developing period. 
 
7.9 Directions for Future Research 
Although WBA has shown great promise in the determination of middle ear 
function in young infants, further research is warranted prior to its implementation as 
an adjunct screening tool in NHS programs or as a diagnostic instrument in clinics. 
For example, it would be ideal to evaluate the test performance of WBA against an 
ideal gold standard to determine middle ear status in neonates. In the absence of an 
ideal gold standard, the use of a surrogate gold standard such as the test battery 
standard or air/bone conduction ABR may be a viable alternative.  To date, only one 
study has determined the accuracy of WBA using air and bone conduction ABR in 
young infants aged three to 26 weeks (Prieve et al., 2013). Further large scale studies 
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incorporating air and bone conduction ABR as the gold standard for conductive status 
would contribute to improvements in the precision of WBA normative data for 
neonates and young infants.  
 
The WBA pass/fail criteria were based on the normative range for each 
frequency or limited range of frequencies (Chapter 2).  However, such criteria for 
interpretation of WBA results are not quick enough to be used in a clinical setting. For 
optimal use in the clinical context, fast, efficient and objective methods for 
interpreting WBA findings need to be developed. This is especially important if WBA 
is to be used as an adjunct tool in NHS programs. Objective pass/fail criteria could be 
developed and built into the equipment so that a pass or refer result could be visually 
displayed on the screen similar to that used for AABR testing.  
 
 Persistent MEE in the neonatal period is reported to be a precursor for middle 
ear infections later in life. The present study has shown that many Aboriginal 
neonates have a significant conductive condition at birth. Further longitudinal studies 
are needed to establish the natural history and resolution of conductive disorders such 
as MEE in early infancy in both Aboriginal and Caucasian neonates to determine 
whether early MEE is a precursor for later persistent middle ear infections. Such 
studies would be useful in determining if targeted monitoring of infants at a high risk 
of recurrent OM is required. Additionally, it would also be helpful to develop 
appropriate public education programs and management strategies for infants at risk 
of developing recurrent OM. 
 
 Although Aboriginal neonates have been found to have lower WBA than 
Caucasian neonates, the reasons for the difference are not known.  To date, there are 
no studies that have investigated anatomical and physiological differences in the outer 
and middle ear between Aboriginal and Caucasian neonates. Further research is 
needed to investigate the effects of body size on WBA in Aboriginal and Caucasian 
neonates and compare the findings with other ethnic groups with significantly 
different body size indices. Additional research using radiological evidence in infants 
is also required to investigate if a difference in the volume of middle ear cavity is 
associated with difference in WBA between the two groups.   
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 The present study found developmental changes in WBA in the first six 
months of life. As development of the outer and middle ear continues beyond six 
months, further research is needed to establish normative WBA at close age intervals 
up to three years of age to provide additional maturation information.  Such age 
appropriate norms are also necessary to differentiate normal ears from ears with a 
disorder of the conductive pathway. In addition to the developmental changes 
described using the cross-sectional sample in this study, further WBA research is 
needed to investigate individual differences in the developmental time course of the 
outer and middle ear.   
 
 WBA can be measured under ambient or pressurised conditions. Most often, 
studies have investigated middle ear function and maturational changes in the middle 
ear of infants using WBA under ambient pressure conditions. There is less 
understanding regarding the effects of introducing ear canal pressure in neonates 
(Feeney and Sanford, 2012). In comparison, wideband tympanometry (WBT) that 
involves measurement of WBA under conditions of varying ear canal pressure has 
been found to be useful in the determination of middle ear condition in adults. In view 
of the need for improved assessment techniques of middle ear function in neonates 
and young infants, application of WBT should be further explored in neonates and 
young infants. Further research is needed to develop fast and efficient methods of 
interpretation of results and identify predictive variables for determination of the 
middle ear condition using WBT.   
 
 In essence, the present study demonstrated that WBA is a feasible measure of 
middle ear function in neonates and young infants. Future investigations of WBA 
need to focus on determining the potential value of various WAI measures in large 
samples of infants. Objective, automated protocols developed using these measures 
could be used during screening and diagnostic evaluation of infants.  The current 
thesis has shown direction in this undertaking by providing data for better 
interpretation of middle ear status in neonates and young infants.  
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